The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
nervonic acid binds to and results in decreased activity of POLB protein; nervonic acid binds to and results in decreased activity of POLB protein mutant form
docosapentaenoic acid results in decreased expression of PTGS2 protein docosapentaenoic acid inhibits the reaction [Dimethoate results in increased expression of PTGS2 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of KIAA2013 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of AARS1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ABCA13 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ABCD3 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ACO2 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ACP2 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ADAM10 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ADCY6 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ADH5 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ALCAM protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ANKFY1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ANO6 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ANPEP protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ANXA11 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of AP2S1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ASPH protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ATG3 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ATP11B protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of AUP1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of BLMH protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of BRCA2 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of C12ORF50 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of C12ORF75 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CALHM5 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CALR protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CAPRIN1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CCDC174 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CCDC86 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CD151 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CD276 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CD68 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CD81 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CD9 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CDC42SE2 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CDK12 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CLCN6 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CLCN7 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CNN3 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CNST protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of COL12A1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of COL1A1 mRNA]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of COPS3 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CREBRF protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CSNK1G3 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CSPG4 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CTDSP1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CTDSP2 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CTNNA2 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CTSB protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CTSL protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CYB5B protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CYCS protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CYRIB protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CYSTM1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of DAD1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of DAGLB protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of DCTN2 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of DDOST protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of DERL2 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of DHX15 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of DKC1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of DNAJC13 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of DNAJC5 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of DOT1L protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of DPP4 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of DSG1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of DSG2 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of DSP protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of EEA1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of EFCAB14 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of EIF1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of EIF3L protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of EIF4A1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of EIF5A protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of EIF6 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ELOVL1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ELOVL5 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of EMILIN1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ENG protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ENPP2 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ERGIC1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ERGIC3 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ERH protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of KIAA1217 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of FABP5 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of FAM114A1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of FAM171A1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of FAU protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of FBN1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of FIBCD1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of FIP1L1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of FKBP9 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of FKRP protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of FLII protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of FLOT2 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FN1 mRNA]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of FNDC3A protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of FNDC5 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of GALNT2 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of GART protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of GDI2 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of GNA11 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of GNAQ protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of GPC1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of GPI protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of GPRC5A protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of GPX4 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of GRAMD2B protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of GRIN3A protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of GSN protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of GSTO1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of HACD3 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of HAS2 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of HBA2 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of HBB protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of HMOX2 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of HNRNPA2B1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of HNRNPH1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of HRG protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of HSF2 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of HSPB1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of HSPH1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of HUWE1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of IDH2 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of IKBIP protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of IPO7 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ITGA5 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ITGAV protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ITM2C protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of JUP protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of KCNMA1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of KIDINS220 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of KNTC1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of KPNA6 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of KRT1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of KRT31 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of KRT83 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of KRT83 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of KRT9 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of LAMB1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of LAMB2 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of LAMP1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of LAMP2 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of LARS1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of LBR protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of LHFPL2 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of LMAN1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of LRRC15 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of LRRC59 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of MAB21L4 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of MAT2B protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of MCM6 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of MED27 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of MGST1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of MIF protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MMP2 mRNA]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of MOXD1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of MTDH protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of MYH14 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of MYO1B protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of MYO1C protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of NACA protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of NAP1L1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of NCKAP1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of NCL protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of NCOA1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of NDUFS8 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of NDUFV1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of NEK9 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of NME2 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of NPC1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of NPLOC4 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of OAT protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of OXGR1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of P4HA1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PABPC1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PACC1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PARP1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PBK protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PCNA protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PDCD6IP protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PDE6C protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PDIA6 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PDLIM5 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PGD protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PGLS protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PHGDH protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PI4K2A protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PI4K2B protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PIEZO1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PLBD2 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PLD3 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PLIN3 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PLOD2 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PLP2 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PLPP7 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PLRG1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PLSCR3 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PLXNB2 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of POLR2B protein]
2-bromopalmitate results in increased activity of PPARD protein 2-bromopalmitate results in increased activity of [RXRA protein binds to PPARD protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PPAT protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PPP1CA protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PPP2R1A protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PRDX6 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PREP protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PRKCSH protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PRMT1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PSMB2 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PSMB3 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PSMC1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PSMC2 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PSMC3 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PSMD14 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PSMD6 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PTK7 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PTPN11 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PTPRO protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PTRH2 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of RAB1A protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of RAB2A protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of RAB3B protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of RANGAP1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of RAP1B protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of RAP2B protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of RAP2C protein]
2-bromopalmitate binds to and results in increased expression of RARA protein; 2-bromopalmitate inhibits the reaction [Am 580 results in decreased expression of RARA protein]; 2-bromopalmitate inhibits the reaction [Tretinoin results in decreased expression of RARA protein]; [2-bromopalmitate results in increased susceptibility to Tretinoin] which results in increased expression of RARA protein
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of RBM39 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of RECQL protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of REEP5 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of RGS19 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of RGS20 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of RPL11 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of RPL17 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of RPL31 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of RPL39 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of RPLP0 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of RPN1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of RPS13 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of RPS27L protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of RPS5 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of RPS7 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of RPSA protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of RRM1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of S100A16 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SAMD9 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SCAMP1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SCAMP2 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SCN7A protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SDHB protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SEC24D protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SELENBP1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SERINC1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SFT2D2 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SIDT2 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SKIC3 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SLC17A5 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SLC1A5 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SLC30A1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SLC35F6 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SLC39A14 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SLC44A1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SLC44A2 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SLC7A1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SLC8A1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SLC9A7 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SNCA protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SNRNP70 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SPRYD7 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SRRM2 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ST6GALNAC4 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of STRAP protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SYNCRIP protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of TCP1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of TEAD1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of TECR protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of TENM3 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of THY1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of TM9SF2 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of TM9SF3 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of TMED1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of TMEM184C protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of TMEM214 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of TMEM44 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of TMEM87A protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of TNKS1BP1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of TPP1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of TPP2 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of TRIM25 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of TRIP6 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of TSPAN4 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of TSPAN9 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of TTR protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of TTYH3 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of TUBA1A protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of TUBB3 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of TUBB6 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of UBAP2L protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of UBC protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of UBE2L3 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of UBE2R2 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of UBR4 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of UGP2 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of UHRF1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of USP5 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of UTY protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of VAC14 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of VIM protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of VPS50 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of WDR5 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of YES1 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of YWHAB protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of YWHAZ protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ZDHHC18 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ZDHHC5 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ZNF207 protein]
2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ZNF670 protein]
[EPHX3 gene mutant form results in decreased hydrolysis of Epoxy Compounds] results in decreased abundance of [9,10,13-trihydroxy-11-octadecenoic acid binds to Ceramides]; [EPHX3 gene mutant form results in decreased hydrolysis of Epoxy Compounds] which results in decreased chemical synthesis of 9,10,13-trihydroxy-11-octadecenoic acid
eleostearic acid inhibits the reaction [methylmercuric chloride results in decreased activity of CAT protein]; eleostearic acid inhibits the reaction [sodium arsenite results in decreased activity of CAT protein] eleostearic acid results in decreased activity of CAT protein
[trans-10,cis-12-conjugated linoleic acid co-treated with cis-9, trans-11-conjugated linoleic acid] results in decreased phosphorylation of IRS1 protein cis-9, trans-11-conjugated linoleic acid inhibits the reaction [TNF protein results in decreased expression of IRS1 mRNA]
[cis-9, trans-11-conjugated linoleic acid co-treated with trans-10,cis-12-conjugated linoleic acid] results in increased phosphorylation of and results in increased activity of MAP2K1 protein; cis-9, trans-11-conjugated linoleic acid results in increased phosphorylation of and results in increased activity of MAP2K1 protein
[cis-9, trans-11-conjugated linoleic acid co-treated with trans-10,cis-12-conjugated linoleic acid] results in increased phosphorylation of and results in increased activity of MAP2K3 protein; cis-9, trans-11-conjugated linoleic acid results in increased phosphorylation of and results in increased activity of MAP2K3 protein
[trans-10,cis-12-conjugated linoleic acid co-treated with cis-9, trans-11-conjugated linoleic acid] results in increased expression of PPARA mRNA; [trans-10,cis-12-conjugated linoleic acid co-treated with cis-9, trans-11-conjugated linoleic acid] results in increased expression of PPARA protein
[cis-9, trans-11-conjugated linoleic acid co-treated with trans-10,cis-12-conjugated linoleic acid] results in increased expression of PPARG protein; bisphenol A diglycidyl ether inhibits the reaction [[cis-9, trans-11-conjugated linoleic acid co-treated with trans-10,cis-12-conjugated linoleic acid] results in increased expression of PPARG protein]
cis-9, trans-11-conjugated linoleic acid results in increased expression of SLC2A4 protein cis-9, trans-11-conjugated linoleic acid inhibits the reaction [TNF protein results in decreased expression of SLC2A4 mRNA]
cis-9, trans-11-conjugated linoleic acid inhibits the reaction [TNF protein results in decreased expression of IRS1 mRNA]; cis-9, trans-11-conjugated linoleic acid inhibits the reaction [TNF protein results in decreased expression of SLC2A4 mRNA] cis-9, trans-11-conjugated linoleic acid affects the expression of TNF mRNA
[caffeic acid results in decreased activity of ALOX15 protein] which results in decreased chemical synthesis of 13-hydroxy-9,11-octadecadienoic acid; [caffeic acid results in decreased activity of ALOX15 protein] which results in increased abundance of 13-hydroxy-9,11-octadecadienoic acid; [Masoprocol results in decreased activity of ALOX15 protein] which results in increased abundance of 13-hydroxy-9,11-octadecadienoic acid; [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in increased expression of ALOX15 protein] which results in increased chemical synthesis of 13-hydroxy-9,11-octadecadienoic acid; [Sulindac results in increased expression of ALOX15 protein] which results in increased chemical synthesis of 13-hydroxy-9,11-octadecadienoic acid; [Vorinostat results in increased expression of ALOX15 protein] which results in increased abundance of 13-hydroxy-9,11-octadecadienoic acid
alpha-Linolenic Acid inhibits the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of CCL2 protein]; alpha-Linolenic Acid inhibits the reaction [Particulate Matter promotes the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of CCL2 mRNA]]; alpha-Linolenic Acid inhibits the reaction [Particulate Matter promotes the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of CCL2 protein]]; Particulate Matter inhibits the reaction [alpha-Linolenic Acid inhibits the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of CCL2 protein]]
CYP2C19 protein results in increased metabolism of [alpha-Linolenic Acid co-treated with NADP] alpha-Linolenic Acid results in decreased activity of CYP2C19 protein
[[alpha-Linolenic Acid co-treated with Estradiol] results in increased expression of FADS1 mRNA] which affects the abundance of Fatty Acids, Unsaturated; [[alpha-Linolenic Acid co-treated with Testosterone] results in decreased expression of FADS1 mRNA] which affects the abundance of Fatty Acids, Unsaturated; [alpha-Linolenic Acid co-treated with Estradiol] results in increased expression of FADS1 mRNA; [alpha-Linolenic Acid co-treated with Testosterone] results in decreased expression of FADS1 mRNA; fulvestrant inhibits the reaction [[alpha-Linolenic Acid co-treated with Estradiol] results in increased expression of FADS1 mRNA]
alpha-Linolenic Acid results in increased expression of GSTA1 mRNA NFE2L2 protein promotes the reaction [alpha-Linolenic Acid results in increased expression of GSTA1 mRNA]
alpha-Linolenic Acid results in increased expression of HMOX1 mRNA alpha-Linolenic Acid inhibits the reaction [Particulate Matter promotes the reaction [Cholesterol results in increased expression of HMOX1 mRNA]]
alpha-Linolenic Acid inhibits the reaction [[Cholesterol co-treated with Particulate Matter] results in increased expression of IFNG protein]; alpha-Linolenic Acid inhibits the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of IFNG mRNA]; alpha-Linolenic Acid inhibits the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of IFNG protein]; alpha-Linolenic Acid inhibits the reaction [Particulate Matter promotes the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of IFNG mRNA]]; alpha-Linolenic Acid inhibits the reaction [Particulate Matter promotes the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of IFNG protein]]
[Eicosapentaenoic Acid co-treated with Docosahexaenoic Acids co-treated with alpha-Linolenic Acid] results in increased expression of IL1B protein alpha-Linolenic Acid inhibits the reaction [[Cholesterol co-treated with Particulate Matter] results in increased expression of IL1B protein]
alpha-Linolenic Acid inhibits the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of IL6 mRNA]; alpha-Linolenic Acid inhibits the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of IL6 protein]; alpha-Linolenic Acid inhibits the reaction [Cholesterol promotes the reaction [Particulate Matter results in increased expression of IL6 protein]]; alpha-Linolenic Acid inhibits the reaction [Particulate Matter promotes the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of IL6 mRNA]]; alpha-Linolenic Acid inhibits the reaction [Particulate Matter promotes the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of IL6 protein]]; Particulate Matter inhibits the reaction [alpha-Linolenic Acid inhibits the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of IL6 mRNA]]
NFE2L2 protein promotes the reaction [alpha-Linolenic Acid results in increased expression of CYP2A6 mRNA]; NFE2L2 protein promotes the reaction [alpha-Linolenic Acid results in increased expression of CYP2A6 protein]; NFE2L2 protein promotes the reaction [alpha-Linolenic Acid results in increased expression of GSTA1 mRNA] alpha-Linolenic Acid inhibits the reaction [Cholesterol promotes the reaction [Particulate Matter results in increased expression of NFE2L2 mRNA]]; alpha-Linolenic Acid inhibits the reaction [Cholesterol results in increased expression of NFE2L2 mRNA]; alpha-Linolenic Acid inhibits the reaction [Particulate Matter promotes the reaction [Cholesterol results in increased expression of NFE2L2 mRNA]]
alpha-Linolenic Acid inhibits the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of NOS2 mRNA]; alpha-Linolenic Acid inhibits the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of NOS2 protein]; alpha-Linolenic Acid inhibits the reaction [Particulate Matter promotes the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of NOS2 mRNA]]; alpha-Linolenic Acid inhibits the reaction [Particulate Matter promotes the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of NOS2 protein]]; Particulate Matter inhibits the reaction [alpha-Linolenic Acid inhibits the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of NOS2 mRNA]]; Particulate Matter inhibits the reaction [alpha-Linolenic Acid inhibits the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of NOS2 protein]]
alpha-Linolenic Acid inhibits the reaction [Chenodeoxycholic Acid results in increased activity of NR1H4 protein] alpha-Linolenic Acid binds to NR1H4 protein
alpha-Linolenic Acid binds to and results in increased activity of PPARA protein PPARA protein affects the abundance of alpha-Linolenic Acid alpha-Linolenic Acid results in increased expression of PPARA mRNA alpha-Linolenic Acid binds to and results in increased activity of PPARA protein; Calcitriol promotes the reaction [alpha-Linolenic Acid results in increased expression of PPARA mRNA] alpha-Linolenic Acid binds to and results in increased activity of PPARA protein; Diethylhexyl Phthalate inhibits the reaction [PPARA protein affects the abundance of alpha-Linolenic Acid]
alpha-Linolenic Acid results in increased expression of PPARD mRNA; Calcitriol results in increased expression of [alpha-Linolenic Acid results in increased expression of PPARD mRNA] alpha-Linolenic Acid binds to and results in increased activity of PPARB protein
alpha-Linolenic Acid results in increased expression of PPARG mRNA alpha-Linolenic Acid results in increased activity of PPARG protein alpha-Linolenic Acid binds to and results in increased activity of PPARG protein
alpha-Linolenic Acid results in increased expression of PTGS2 mRNA alpha-Linolenic Acid results in increased expression of PTGS2 protein alpha-Linolenic Acid results in decreased expression of PTGS2 mRNA
alpha-Linolenic Acid inhibits the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of TNF mRNA]; alpha-Linolenic Acid inhibits the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of TNF protein]; alpha-Linolenic Acid inhibits the reaction [Cholesterol promotes the reaction [Particulate Matter results in increased expression of TNF protein]]; alpha-Linolenic Acid inhibits the reaction [Particulate Matter promotes the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of TNF mRNA]]; alpha-Linolenic Acid inhibits the reaction [Particulate Matter promotes the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of TNF protein]]; Particulate Matter inhibits the reaction [alpha-Linolenic Acid inhibits the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of TNF protein]]
alpha-Linolenic Acid inhibits the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of VCAM1 mRNA]; alpha-Linolenic Acid inhibits the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of VCAM1 protein]; alpha-Linolenic Acid inhibits the reaction [Particulate Matter promotes the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of VCAM1 mRNA]]; alpha-Linolenic Acid inhibits the reaction [Particulate Matter promotes the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of VCAM1 protein]]; Particulate Matter inhibits the reaction [alpha-Linolenic Acid inhibits the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of VCAM1 protein]]
alpha-Linolenic Acid results in increased expression of VDR mRNA [Calcitriol co-treated with alpha-Linolenic Acid] results in increased expression of VDR mRNA
Butyric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of AGO2 mRNA]; Butyric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of AGO2 protein]
Butyric Acid results in increased expression of AKR1C3 mRNA [Butyric Acid co-treated with Benzo(a)pyrene] results in increased expression of AKR1C3 mRNA; Benzo(a)pyrene promotes the reaction [Butyric Acid results in increased expression of AKR1C3 mRNA]; Butyric Acid inhibits the reaction [Benzo(a)pyrene results in increased expression of AKR1C3 mRNA]; Butyric Acid promotes the reaction [Benzo(a)pyrene results in increased expression of AKR1C3 mRNA]
Butyric Acid results in decreased phosphorylation of AKT1 protein Acetylcysteine inhibits the reaction [Butyric Acid results in decreased phosphorylation of AKT1 protein]
[Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of APAF1 mRNA]; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of APAF1 protein]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of APAF1 mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of APAF1 protein]
[ATF3 protein binds to SLC7A11 promoter] promotes the reaction [Butyric Acid results in decreased expression of SLC7A11 mRNA]; ATF3 protein promotes the reaction [Butyric Acid results in decreased expression of SLC7A11 mRNA] Butyric Acid results in increased expression of ATF3 mRNA
Butyric Acid results in increased expression of ATG5 protein Acetylcysteine inhibits the reaction [Butyric Acid results in increased expression of ATG5 protein]
Butyric Acid analog inhibits the reaction [Doxorubicin results in increased expression of BAX mRNA] [Butyric Acid co-treated with Sulfaphenazole] inhibits the reaction [Oxalic Acid results in increased expression of BAX mRNA] [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX mRNA]; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX protein]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX protein] Butyric Acid results in increased expression of BAX protein
[Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein] [Butyric Acid co-treated with Sulfaphenazole] inhibits the reaction [Oxalic Acid results in decreased expression of BCL2 mRNA]
Butyric Acid results in increased expression of BECN1 protein Acetylcysteine inhibits the reaction [Butyric Acid results in increased expression of BECN1 protein]
Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BMI1 mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BMI1 protein] BMI1 protein results in decreased susceptibility to Butyric Acid
[Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP3 protein]; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 mRNA]; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 protein]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP3 protein]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 protein] [Butyric Acid co-treated with Sulfaphenazole] inhibits the reaction [Oxalic Acid results in increased expression of CASP3 mRNA]
[Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP9 protein]; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 mRNA]; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 protein]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP9 protein]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 protein]
Butyric Acid results in increased expression of CCL2 mRNA [Butyric Acid co-treated with Sulfaphenazole] inhibits the reaction [Oxalic Acid results in increased expression of CCL2 mRNA] Butyric Acid inhibits the reaction [[Ethylene Glycol co-treated with Calcium Oxalate] results in increased expression of CCL2 mRNA]; Butyric Acid inhibits the reaction [[Ethylene Glycol co-treated with Calcium Oxalate] results in increased expression of CCL2 protein] Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of CCL2 mRNA]
Butyric Acid affects the expression of CD44 mRNA Butyric Acid inhibits the reaction [[Ethylene Glycol co-treated with Calcium Oxalate] results in increased expression of CD44 mRNA]; Butyric Acid inhibits the reaction [[Ethylene Glycol co-treated with Calcium Oxalate] results in increased expression of CD44 protein] [Butyric Acid co-treated with Sulfaphenazole] inhibits the reaction [Oxalic Acid results in increased expression of CD44 mRNA]
Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of CD68 mRNA]
[Butyric Acid results in increased expression of SRSF2 protein] which results in increased expression of CDKN1A mRNA; [Butyric Acid results in increased expression of SRSF2 protein] which results in increased expression of CDKN1A protein; Butyric Acid results in increased expression of CDKN1A protein [Butyric Acid co-treated with Quercetin] results in increased expression of CDKN1A protein [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A mRNA]; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A protein]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A protein]
Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN2A mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN2A protein]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased methylation of CDKN2A promoter]
Butyric Acid results in decreased stability of CGA mRNA Butyric Acid results in increased expression of CGA mRNA; Butyric Acid results in increased expression of CGA protein [Theophylline co-treated with Butyric Acid] results in increased expression of CGA mRNA; Theophylline inhibits the reaction [Butyric Acid results in decreased stability of CGA mRNA]; Theophylline promotes the reaction [Butyric Acid results in increased expression of CGA protein]
Butyric Acid results in increased expression of CGN mRNA Butyric Acid results in increased expression of and results in increased localization of CGN protein
Butyric Acid inhibits the reaction [CHD4 protein binds to OGT protein]; Butyric Acid inhibits the reaction [thiamet G results in increased O-linked glycosylation of CHD4 protein] Butyric Acid results in decreased O-linked glycosylation of CHD4 protein
[Benzo(a)pyrene co-treated with Butyric Acid] results in increased expression of CYP1A1 mRNA; Benzo(a)pyrene promotes the reaction [Butyric Acid results in increased expression of CYP1A1 mRNA]; Butyric Acid inhibits the reaction [HDAC1 protein binds to CYP1A1 enhancer]; Butyric Acid promotes the reaction [[Benzo(a)pyrene results in increased expression of CYP1A1 protein] which results in increased chemical synthesis of benzo(a)pyrene-DNA adduct]; Butyric Acid promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]; Butyric Acid promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 protein]; Butyric Acid promotes the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]; Butyric Acid promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]
Benzo(a)pyrene promotes the reaction [Butyric Acid results in increased expression of CYP1A2 mRNA]; Butyric Acid promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]
Butyric Acid promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1B1 mRNA]; Butyric Acid promotes the reaction [biochanin A results in increased expression of CYP1B1 mRNA]; Butyric Acid promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA]
Butyric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of DICER1 mRNA]; Butyric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of DICER1 protein]
Butyric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of DNMT1 mRNA]; Butyric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of DNMT1 protein]
Butyric Acid results in increased expression of ERN1 protein Cycloheximide inhibits the reaction [Butyric Acid results in increased expression of ERN1 protein]; Plicamycin inhibits the reaction [Butyric Acid results in increased expression of ERN1 protein]
Acetylcysteine inhibits the reaction [Butyric Acid results in increased expression of GATA1 mRNA]; chebulinic acid inhibits the reaction [Butyric Acid results in increased expression of GATA1 mRNA]; pyrrolidine dithiocarbamic acid inhibits the reaction [Butyric Acid results in increased expression of GATA1 mRNA]; Quercetin inhibits the reaction [Butyric Acid results in increased expression of GATA1 mRNA]; tellimagrandin I inhibits the reaction [Butyric Acid results in increased expression of GATA1 mRNA]
chebulinic acid promotes the reaction [Butyric Acid results in increased expression of GATA2 mRNA]; tellimagrandin I promotes the reaction [Butyric Acid results in increased expression of GATA2 mRNA]
Butyric Acid results in decreased expression of H2AX mRNA Butyric Acid promotes the reaction [Benzo(a)pyrene results in increased expression of and results in increased phosphorylation of H2AX protein] Butyric Acid results in increased expression of H2AX protein
Butyric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of HDAC1 mRNA]; Butyric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of HDAC1 protein] Butyric Acid inhibits the reaction [[Ethylene Glycol co-treated with Calcium Oxalate] results in increased expression of HDAC1 mRNA] Butyric Acid inhibits the reaction [HDAC1 protein binds to CYP1A1 enhancer]; Butyric Acid inhibits the reaction [Oxalic Acid results in increased expression of HDAC1 mRNA]
Butyric Acid inhibits the reaction [[Ethylene Glycol co-treated with Calcium Oxalate] results in increased expression of HDAC2 mRNA] Butyric Acid inhibits the reaction [Oxalic Acid results in increased expression of HDAC2 mRNA]
Butyric Acid inhibits the reaction [Oxalic Acid results in increased expression of HDAC3 mRNA] Butyric Acid inhibits the reaction [[Ethylene Glycol co-treated with Calcium Oxalate] results in increased expression of HDAC3 mRNA]
Butyric Acid promotes the reaction [SRSF2 protein binds to HDAC6 protein]; HDAC6 protein promotes the reaction [Butyric Acid results in increased expression of SRSF2 protein]
Butyric Acid inhibits the reaction [[Ethylene Glycol co-treated with Calcium Oxalate] results in increased expression of HDAC8 mRNA] Butyric Acid inhibits the reaction [Oxalic Acid results in increased expression of HDAC8 mRNA]
Butyric Acid results in decreased expression of HIF1A protein Butyric Acid promotes the reaction [Cycloheximide results in decreased expression of HIF1A protein]; Chloroquine inhibits the reaction [Butyric Acid results in decreased expression of HIF1A protein]; SIRT4 protein affects the reaction [Butyric Acid results in decreased expression of HIF1A protein]
Butyric Acid results in increased expression of HMBS mRNA Acetylcysteine inhibits the reaction [Butyric Acid results in increased expression of HMBS mRNA]; chebulinic acid inhibits the reaction [Butyric Acid results in increased expression of HMBS mRNA]; pyrrolidine dithiocarbamic acid inhibits the reaction [Butyric Acid results in increased expression of HMBS mRNA]; Quercetin inhibits the reaction [Butyric Acid results in increased expression of HMBS mRNA]; tellimagrandin I inhibits the reaction [Butyric Acid results in increased expression of HMBS mRNA]
Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased secretion of HMGB1 protein]
Cycloheximide inhibits the reaction [Butyric Acid results in increased expression of HSPA5 protein]; Plicamycin inhibits the reaction [Butyric Acid results in increased expression of HSPA5 protein]
Butyric Acid results in increased expression of HSPB1 mRNA Butyric Acid results in decreased expression of and results in increased phosphorylation of HSPB1 protein
[Gallic Acid co-treated with Butyric Acid co-treated with verbascose] affects the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IFNG protein] results in increased secretion of IL1B protein]; Butyric Acid affects the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IFNG protein] results in increased secretion of IL1B protein]; Butyric Acid promotes the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IFNG protein] results in increased secretion of TNF protein] [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of IFNG mRNA]
[Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of IKBKB mRNA]; [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of IKBKB protein]
Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of and results in increased secretion of IL1B protein]; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of IL1B mRNA] [Gallic Acid co-treated with Butyric Acid co-treated with verbascose] affects the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IFNG protein] results in increased secretion of IL1B protein]; Butyric Acid affects the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IFNG protein] results in increased secretion of IL1B protein]
Butyric Acid results in increased expression of IL6 mRNA [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of IL6 mRNA]
Butyric Acid promotes the reaction [KAT5 protein results in increased acetylation of SRSF2 protein]; Butyric Acid promotes the reaction [SRSF2 protein binds to KAT5 protein]; KAT5 protein promotes the reaction [Butyric Acid results in increased expression of SRSF2 protein] Butyric Acid results in increased expression of KAT5 mRNA; Butyric Acid results in increased expression of KAT5 protein
Butyric Acid results in increased expression of KLK3 mRNA; Butyric Acid results in increased expression of KLK3 protein Butyric Acid results in decreased expression of KLK3 mRNA
SIRT4 protein affects the reaction [Butyric Acid results in decreased expression of LDHA mRNA]; SIRT4 protein affects the reaction [Butyric Acid results in decreased expression of LDHA protein] Butyric Acid results in decreased expression of LDHA mRNA; Butyric Acid results in decreased expression of LDHA protein
Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased secretion of LEP protein]
[1'-acetoxychavicol acetate co-treated with Butyric Acid] results in increased phosphorylation of MAPK1 protein; Acetylcysteine inhibits the reaction [Butyric Acid results in increased phosphorylation of MAPK1 protein]
[1'-acetoxychavicol acetate co-treated with Butyric Acid] results in increased phosphorylation of MAPK3 protein; Acetylcysteine inhibits the reaction [Butyric Acid results in increased phosphorylation of MAPK3 protein]
Butyric Acid results in increased phosphorylation of MAPK8 protein Acetylcysteine inhibits the reaction [Butyric Acid results in increased phosphorylation of MAPK8 protein]
Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene affects the expression of MIR203 mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased methylation of MIR203 promoter]
Butyric Acid results in decreased phosphorylation of MTOR protein Acetylcysteine inhibits the reaction [Butyric Acid results in decreased phosphorylation of MTOR protein]
Butyric Acid results in decreased expression of MYC mRNA Butyric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MYC mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MYC protein]
[Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of MYD88 mRNA]
Acetylcysteine inhibits the reaction [Butyric Acid results in increased expression of NFE2 mRNA]; chebulinic acid inhibits the reaction [Butyric Acid results in increased expression of NFE2 mRNA]; pyrrolidine dithiocarbamic acid inhibits the reaction [Butyric Acid results in increased expression of NFE2 mRNA]; Quercetin inhibits the reaction [Butyric Acid results in increased expression of NFE2 mRNA]; tellimagrandin I inhibits the reaction [Butyric Acid results in increased expression of NFE2 mRNA]
[Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in decreased expression of NFKBIA protein]
[Benzo(a)pyrene co-treated with Butyric Acid] results in increased activity of NQO1 protein; Benzo(a)pyrene promotes the reaction [Butyric Acid results in increased activity of NQO1 protein]; Benzo(a)pyrene promotes the reaction [Butyric Acid results in increased expression of NQO1 mRNA]
Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of OCLN protein] Butyric Acid results in increased expression of OCLN mRNA
Butyric Acid inhibits the reaction [CHD4 protein binds to OGT protein] Butyric Acid results in decreased expression of OGT mRNA; Butyric Acid results in decreased expression of OGT protein
Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of PFKP mRNA]
Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of PPARA mRNA]
Butyric Acid results in increased expression of PPARG mRNA; Butyric Acid results in increased expression of PPARG protein Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of PPARG mRNA] [Butyric Acid co-treated with Lipopolysaccharides] results in increased expression of PPARG mRNA
[Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of and results in increased phosphorylation of RELA protein]; [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of RELA mRNA]
SIRT4 protein affects the reaction [Butyric Acid results in decreased expression of HIF1A protein]; SIRT4 protein affects the reaction [Butyric Acid results in decreased expression of LDHA mRNA]; SIRT4 protein affects the reaction [Butyric Acid results in decreased expression of LDHA protein]; SIRT4 protein affects the reaction [Butyric Acid results in decreased expression of SLC2A1 mRNA]; SIRT4 protein affects the reaction [Butyric Acid results in decreased expression of SLC2A1 protein] Butyric Acid results in increased expression of SIRT4 mRNA; Butyric Acid results in increased expression of SIRT4 protein
Butyric Acid inhibits the reaction [SLC16A1 protein results in increased transport of Benzoic Acid] SLC16A1 protein results in increased import of Butyric Acid
Butyric Acid inhibits the reaction [Manganese results in decreased expression of SLC1A2 mRNA] Butyric Acid inhibits the reaction [Manganese results in decreased expression of SLC1A2 mRNA]; Butyric Acid inhibits the reaction [Manganese results in decreased expression of SLC1A2 protein]
Butyric Acid inhibits the reaction [Manganese results in decreased expression of SLC1A3 mRNA]; Butyric Acid inhibits the reaction [Manganese results in decreased expression of SLC1A3 protein]
Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A1 mRNA] SIRT4 protein affects the reaction [Butyric Acid results in decreased expression of SLC2A1 mRNA]; SIRT4 protein affects the reaction [Butyric Acid results in decreased expression of SLC2A1 protein] Butyric Acid results in decreased expression of SLC2A1 mRNA; Butyric Acid results in decreased expression of SLC2A1 protein
Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A4 mRNA]
[ATF3 protein binds to SLC7A11 promoter] promotes the reaction [Butyric Acid results in decreased expression of SLC7A11 mRNA]; ATF3 protein promotes the reaction [Butyric Acid results in decreased expression of SLC7A11 mRNA]
Butyric Acid results in increased expression of SPP1 mRNA [Butyric Acid co-treated with Sulfaphenazole] inhibits the reaction [Oxalic Acid results in increased expression of SPP1 mRNA] Butyric Acid inhibits the reaction [[Ethylene Glycol co-treated with Calcium Oxalate] results in increased expression of SPP1 mRNA]; Butyric Acid inhibits the reaction [[Ethylene Glycol co-treated with Calcium Oxalate] results in increased expression of SPP1 protein]
Butyric Acid inhibits the reaction [Lipopolysaccharides results in increased expression of SREBF1 mRNA] Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SREBF1 mRNA]
Butyric Acid promotes the reaction [KAT5 protein results in increased acetylation of SRSF2 protein]; Butyric Acid promotes the reaction [SRSF2 protein binds to HDAC6 protein]; Butyric Acid promotes the reaction [SRSF2 protein binds to KAT5 protein]; HDAC6 protein promotes the reaction [Butyric Acid results in increased expression of SRSF2 protein]; KAT5 protein promotes the reaction [Butyric Acid results in increased expression of SRSF2 protein] [Butyric Acid results in increased expression of SRSF2 protein] which results in increased expression of CDKN1A mRNA; [Butyric Acid results in increased expression of SRSF2 protein] which results in increased expression of CDKN1A protein; Butyric Acid results in increased expression of SRSF2 protein Butyric Acid results in decreased phosphorylation of SRSF2 protein
[Butyric Acid co-treated with Benzo(a)pyrene] results in increased expression of SULT1A1 mRNA Butyric Acid results in increased expression of SULT1A1 mRNA
Butyric Acid results in increased expression of TGFB1 mRNA [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of TGFB1 mRNA]
Butyric Acid results in decreased expression of THRB mRNA Butyric Acid inhibits the reaction [Triiodothyronine results in increased expression of THRB mRNA]
[Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of TLR2 mRNA]; [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of TLR2 protein]
[Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of TLR4 mRNA]; [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of TLR4 protein]; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of TLR4 protein]
Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of TLR5 protein]
Butyric Acid results in increased expression of TNF mRNA Butyric Acid promotes the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IFNG protein] results in increased secretion of TNF protein] [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of TNF mRNA]; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of TNF mRNA]
[1'-acetoxychavicol acetate co-treated with Butyric Acid] results in increased phosphorylation of TP53 protein Butyric Acid results in increased expression of TP53 mRNA Butyric Acid results in decreased expression of TP53 mRNA [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 mRNA alternative form]; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 protein]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 mRNA alternative form]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 protein]
[Butyric Acid co-treated with Benzo(a)pyrene] results in increased expression of UGT1A1 mRNA; Benzo(a)pyrene promotes the reaction [Butyric Acid results in increased expression of UGT1A1 mRNA]; Butyric Acid promotes the reaction [Benzo(a)pyrene results in increased expression of UGT1A1 mRNA]; Butyric Acid promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of UGT1A1 mRNA]
Butyric Acid results in increased expression of UGT1A4 mRNA Benzo(a)pyrene promotes the reaction [Butyric Acid results in increased expression of UGT1A4 mRNA]
Linoleic Acids, Conjugated results in increased expression of ADGRE1 mRNA; Linoleic Acids, Conjugated results in increased expression of ADGRE1 protein
[picolinic acid co-treated with Linoleic Acids, Conjugated] results in increased expression of ADIPOQ protein Linoleic Acids, Conjugated results in decreased expression of ADIPOQ protein
Linoleic Acids, Conjugated results in decreased expression of ADIPOR2 mRNA rosiglitazone inhibits the reaction [Linoleic Acids, Conjugated results in decreased expression of ADIPOR2 mRNA]
Linoleic Acids, Conjugated results in decreased expression of CD36 mRNA rosiglitazone inhibits the reaction [Linoleic Acids, Conjugated results in decreased expression of CD36 mRNA]
Linoleic Acids, Conjugated results in decreased phosphorylation of and results in decreased activity of ESR1 protein; Okadaic Acid inhibits the reaction [Linoleic Acids, Conjugated results in decreased phosphorylation of ESR1 protein]
Linoleic Acids, Conjugated results in increased activity of GCLC protein [Linoleic Acids, Conjugated results in increased activity of GCLC protein] which results in decreased susceptibility to tert-Butylhydroperoxide Linoleic Acids, Conjugated results in increased expression of GCLC mRNA
Linoleic Acids, Conjugated results in increased activity of GSK3B protein Linoleic Acids, Conjugated results in decreased phosphorylation of GSK3B protein
Linoleic Acids, Conjugated results in increased expression of IL1B mRNA resveratrol inhibits the reaction [Linoleic Acids, Conjugated results in increased expression of IL1B mRNA]
Linoleic Acids, Conjugated results in increased expression of IL6 mRNA; Linoleic Acids, Conjugated results in increased expression of IL6 protein Linoleic Acids, Conjugated results in decreased expression of IL6 protein [Chromium co-treated with Linoleic Acids, Conjugated] results in decreased expression of IL6 protein resveratrol inhibits the reaction [Linoleic Acids, Conjugated results in increased expression of IL6 mRNA]
[Linoleic Acids, Conjugated co-treated with Chromium] results in decreased expression of INS1 protein Linoleic Acids, Conjugated results in decreased expression of INS1 protein
Linoleic Acids, Conjugated results in decreased expression of INS protein Linoleic Acids, Conjugated results in increased susceptibility to INS protein
[Linoleic Acids, Conjugated co-treated with Chromium] results in decreased expression of LEP protein Linoleic Acids, Conjugated results in decreased expression of LEP protein Linoleic Acids, Conjugated results in increased expression of LEP protein
rosiglitazone inhibits the reaction [Linoleic Acids, Conjugated results in decreased expression of LPL mRNA] Linoleic Acids, Conjugated results in increased activity of LPL protein
Linoleic Acids, Conjugated inhibits the reaction [Acrolein results in decreased activity of OGDH protein] Linoleic Acids, Conjugated results in increased activity of OGDH protein
Linoleic Acids, Conjugated results in decreased activity of PPARG protein Linoleic Acids, Conjugated results in increased expression of PPARG mRNA Linoleic Acids, Conjugated results in increased expression of PPARG mRNA; Linoleic Acids, Conjugated results in increased expression of PPARG protein Linoleic Acids, Conjugated results in increased phosphorylation of and results in increased activity of PPARG protein; resveratrol inhibits the reaction [Linoleic Acids, Conjugated results in decreased activity of PPARG protein]; resveratrol inhibits the reaction [Linoleic Acids, Conjugated results in increased phosphorylation of and results in increased activity of PPARG protein] Linoleic Acids, Conjugated results in decreased expression of PPARG protein
Linoleic Acids, Conjugated results in increased expression of PTGS2 mRNA; Linoleic Acids, Conjugated results in increased expression of PTGS2 protein [Linoleic Acids, Conjugated results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprost; Resveratrol inhibits the reaction [[Linoleic Acids, Conjugated results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprost]; Resveratrol inhibits the reaction [Linoleic Acids, Conjugated results in increased expression of PTGS2 mRNA]
[bisphenol A co-treated with Resveratrol co-treated with Corn Oil] results in decreased expression of CAT protein Corn Oil results in decreased expression of CAT protein
Corn Oil results in decreased expression of CLDN1 mRNA [(5'-(4-amino-7,7-dimethyl-2-trifluoromethyl-7H-pyrimido(4,5-b)(1,4)oxazin-6-yl)-2',3'-dihydrospiro(cyclohexane-1,1'-inden)-4-yl)acetic acid co-treated with Corn Oil] results in decreased expression of CLDN1 mRNA
Corn Oil results in increased expression of CPT1A mRNA [bisphenol A co-treated with Resveratrol co-treated with Corn Oil] results in increased expression of CPT1A mRNA Corn Oil affects the expression of CPT1A mRNA
Corn Oil affects the expression of CROT mRNA [bisphenol A co-treated with Resveratrol co-treated with Corn Oil] results in increased expression of CROT mRNA
[(5'-(4-amino-7,7-dimethyl-2-trifluoromethyl-7H-pyrimido(4,5-b)(1,4)oxazin-6-yl)-2',3'-dihydrospiro(cyclohexane-1,1'-inden)-4-yl)acetic acid co-treated with Corn Oil] results in increased activity of GPT protein; [Corn Oil co-treated with (5'-(4-amino-7,7-dimethyl-2-trifluoromethyl-7H-pyrimido(4,5-b)(1,4)oxazin-6-yl)-2',3'-dihydrospiro(cyclohexane-1,1'-inden)-4-yl)acetic acid] results in increased activity of GPT protein; Dactinomycin inhibits the reaction [[Corn Oil co-treated with (5'-(4-amino-7,7-dimethyl-2-trifluoromethyl-7H-pyrimido(4,5-b)(1,4)oxazin-6-yl)-2',3'-dihydrospiro(cyclohexane-1,1'-inden)-4-yl)acetic acid] results in increased activity of GPT protein]; Orlistat inhibits the reaction [[Corn Oil co-treated with (5'-(4-amino-7,7-dimethyl-2-trifluoromethyl-7H-pyrimido(4,5-b)(1,4)oxazin-6-yl)-2',3'-dihydrospiro(cyclohexane-1,1'-inden)-4-yl)acetic acid] results in increased activity of GPT protein]
Corn Oil results in increased expression of IL4 mRNA Corn Oil results in increased secretion of IL4 protein Corn Oil results in decreased expression of IL4 mRNA
[(5'-(4-amino-7,7-dimethyl-2-trifluoromethyl-7H-pyrimido(4,5-b)(1,4)oxazin-6-yl)-2',3'-dihydrospiro(cyclohexane-1,1'-inden)-4-yl)acetic acid co-treated with Corn Oil] results in decreased expression of OCLN mRNA
Corn Oil results in decreased activity of SOD1 protein [Corn Oil co-treated with Iron, Dietary] results in decreased activity of SOD1 protein; [Corn Oil co-treated with Iron] results in decreased activity of SOD1 protein; Iron promotes the reaction [Corn Oil results in decreased activity of SOD1 protein]; Iron, Dietary promotes the reaction [Corn Oil results in decreased activity of SOD1 protein]
[(5'-(4-amino-7,7-dimethyl-2-trifluoromethyl-7H-pyrimido(4,5-b)(1,4)oxazin-6-yl)-2',3'-dihydrospiro(cyclohexane-1,1'-inden)-4-yl)acetic acid co-treated with Corn Oil] results in decreased expression of TJP1 mRNA
Curcumin inhibits the reaction [lauric acid promotes the reaction [NOD2 protein binds to NOD2 protein]]; lauric acid promotes the reaction [NOD2 protein binds to NOD2 protein]
lauric acid results in increased expression of PCNA protein lauric acid inhibits the reaction [deoxynivalenol results in decreased expression of PCNA protein]
Curcumin inhibits the reaction [lauric acid results in increased activity of RELA protein]; parthenolide inhibits the reaction [lauric acid results in increased activity of RELA protein]
lauric acid inhibits the reaction [deoxynivalenol results in decreased expression of TJP1 protein] lauric acid results in increased expression of TJP1 protein
erucic acid results in increased expression of NOS2 protein erucic acid promotes the reaction [Doxorubicin results in increased expression of NOS2 protein]
erucic acid promotes the reaction [Doxorubicin results in increased expression of NOS3 protein] erucic acid results in increased expression of NOS3 protein
[gamma-Linolenic Acid co-treated with Iodine co-treated with Selenium] results in increased expression of and results in increased localization of CLDN5 protein; [gamma-Linolenic Acid co-treated with Iodine] results in increased expression of and results in increased localization of CLDN5 protein; [Selenium co-treated with gamma-Linolenic Acid] results in increased expression of and results in increased localization of CLDN5 protein; gamma-Linolenic Acid results in increased expression of and results in increased localization of CLDN5 protein
[gamma-Linolenic Acid co-treated with Iodine co-treated with Selenium] results in increased expression of and results in increased localization of OCLN protein; [gamma-Linolenic Acid co-treated with Iodine] results in increased expression of and results in increased localization of OCLN protein; [Selenium co-treated with gamma-Linolenic Acid] results in increased expression of and results in increased localization of OCLN protein; gamma-Linolenic Acid results in increased expression of and results in increased localization of OCLN protein
[gamma-Linolenic Acid co-treated with Iodine co-treated with Selenium] results in increased expression of and results in increased localization of TJP1 protein
[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of ABCA1 mRNA; [Palmitic Acid co-treated with Oleic Acid] affects the expression of ABCA1 mRNA; [Palmitic Acid co-treated with Oleic Acid] results in decreased expression of ABCA1 mRNA Palmitic Acid results in decreased expression of ABCA1 mRNA; Palmitic Acid results in decreased expression of ABCA1 protein morroniside inhibits the reaction [Palmitic Acid results in decreased expression of ABCA1 mRNA]; morroniside inhibits the reaction [Palmitic Acid results in decreased expression of ABCA1 protein]
Palmitic Acid results in increased expression of ABCG1 mRNA morroniside inhibits the reaction [Palmitic Acid results in decreased expression of ABCG1 mRNA]; morroniside inhibits the reaction [Palmitic Acid results in decreased expression of ABCG1 protein] Palmitic Acid results in decreased expression of ABCG1 mRNA; Palmitic Acid results in decreased expression of ABCG1 protein
Palmitic Acid results in decreased phosphorylation of ACACA protein Palmitic Acid results in increased expression of ACACA mRNA amlexanox inhibits the reaction [Palmitic Acid results in increased expression of ACACA mRNA] [Fructose co-treated with Palmitic Acid] results in decreased expression of ACACA protein modified form; [Fructose co-treated with Palmitic Acid] results in increased expression of ACACA protein; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of ACACA mRNA; dorsomorphin inhibits the reaction [nuciferine inhibits the reaction [Palmitic Acid results in increased expression of ACACA mRNA]]; Escin inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in increased expression of ACACA mRNA]; Fenofibrate inhibits the reaction [[Fructose co-treated with Palmitic Acid] results in decreased expression of ACACA protein modified form]; Fenofibrate inhibits the reaction [[Fructose co-treated with Palmitic Acid] results in increased expression of ACACA protein]; Ivermectin inhibits the reaction [Palmitic Acid results in decreased phosphorylation of ACACA protein]; nuciferine inhibits the reaction [Palmitic Acid results in increased expression of ACACA mRNA]
[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of ACADM mRNA; Bezafibrate inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of ACADM mRNA]; quercetin 3-O-glucuronide inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of ACADM mRNA]
2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA]; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA]
[Palmitic Acid co-treated with Arsenic] affects the expression of ACKR3 mRNA CXCR7 protein promotes the reaction [CXCL12 protein inhibits the reaction [Palmitic Acid results in decreased expression of KLF15 protein]]; CXCR7 protein promotes the reaction [CXCL12 protein inhibits the reaction [Palmitic Acid results in increased expression of CCN2 protein]]
acanthoic acid inhibits the reaction [Palmitic Acid results in increased expression of ACLY mRNA]; GW 3965 inhibits the reaction [Palmitic Acid results in increased expression of ACLY mRNA]; pregna-4,17-diene-3,16-dione inhibits the reaction [Palmitic Acid results in increased expression of ACLY mRNA]
[Glucose co-treated with Palmitic Acid] results in decreased expression of ACOX1 mRNA; [Palmitic Acid co-treated with Oleic Acid] results in decreased expression of ACOX1 mRNA; Escin inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of ACOX1 mRNA]; nuciferine inhibits the reaction [Palmitic Acid results in decreased expression of ACOX1 mRNA]; PPARGC1A protein promotes the reaction [nuciferine inhibits the reaction [Palmitic Acid results in decreased expression of ACOX1 mRNA]]
[Glucose co-treated with Palmitic Acid] results in decreased expression of ACSL1 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of ACSL1 mRNA; [Palmitic Acid co-treated with Oleic Acid] affects the expression of ACSL1 mRNA
[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of ACSL4 mRNA salvianolic acid A inhibits the reaction [Palmitic Acid results in decreased expression of ACSL4 protein] Palmitic Acid results in increased expression of ACSL4 protein
[ACSL5 protein affects the susceptibility to Palmitic Acid] which affects the abundance of Adenosine Triphosphate Palmitic Acid results in decreased expression of ACSL5 mRNA Palmitic Acid results in increased expression of ACSL5 mRNA
[[Palmitic Acid co-treated with Oleic Acid] results in increased abundance of Fatty Acids, Nonesterified] which results in increased expression of ADAM17 mRNA; lactucin inhibits the reaction [[[Palmitic Acid co-treated with Oleic Acid] results in increased abundance of Fatty Acids, Nonesterified] which results in increased expression of ADAM17 mRNA]
Palmitic Acid results in increased expression of ADGRE1 mRNA amlexanox inhibits the reaction [Palmitic Acid results in increased expression of ADGRE1 mRNA]
Palmitic Acid results in decreased expression of ADIPOQ mRNA Palmitic Acid results in increased expression of ADIPOQ protein [Palmitic Acid co-treated with sodium arsenite] results in decreased expression of ADIPOQ mRNA; [Palmitic Acid co-treated with sodium arsenite] results in decreased expression of and results in decreased secretion of ADIPOQ protein; [sodium arsenite co-treated with Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of ADIPOQ mRNA; [sodium arsenite co-treated with Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of ADIPOQ protein; Palmitic Acid inhibits the reaction [[sodium arsenite co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased secretion of ADIPOQ protein]; sodium arsenite inhibits the reaction [Palmitic Acid results in increased expression of ADIPOQ protein] [osteum co-treated with Palmitic Acid] results in decreased expression of ADIPOQ mRNA; [osteum co-treated with Palmitic Acid] results in decreased expression of ADIPOQ protein; MRI-1867 inhibits the reaction [[osteum co-treated with Palmitic Acid] results in decreased expression of ADIPOQ mRNA]; MRI-1867 inhibits the reaction [[osteum co-treated with Palmitic Acid] results in decreased expression of ADIPOQ protein] AICA ribonucleotide inhibits the reaction [Palmitic Acid results in decreased expression of ADIPOQ mRNA]; Metformin inhibits the reaction [Palmitic Acid results in decreased expression of ADIPOQ mRNA]; Resveratrol inhibits the reaction [Palmitic Acid results in decreased expression of ADIPOQ mRNA]; Salicylic Acid inhibits the reaction [Palmitic Acid results in decreased expression of ADIPOQ mRNA]
[osteum co-treated with Palmitic Acid] results in decreased expression of ADIPOR1 protein; MRI-1867 inhibits the reaction [[osteum co-treated with Palmitic Acid] results in decreased expression of ADIPOR1 protein]
palmitic acid decreases expression of ADIPOR2 mRNA and protein in hepatocellular carcinoma cells [osteum co-treated with Palmitic Acid] results in decreased expression of ADIPOR2 protein; MRI-1867 inhibits the reaction [[osteum co-treated with Palmitic Acid] results in decreased expression of ADIPOR2 protein] palmitic acid cotreated with ethanol increases expression of adipor2 mRNA in rat primary hepatocytes
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [ADORA2B protein affects the reaction [Palmitic Acid results in decreased expression of and results in decreased activity of GPX4 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [ADORA2B protein affects the reaction [Palmitic Acid results in decreased expression of NFE2L2 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [ADORA2B protein affects the reaction [Palmitic Acid results in decreased expression of SLC7A11 protein]]; ADORA2B protein affects the reaction [Palmitic Acid results in decreased expression of and results in decreased activity of GPX4 protein]; ADORA2B protein affects the reaction [Palmitic Acid results in decreased expression of NFE2L2 protein]; ADORA2B protein affects the reaction [Palmitic Acid results in decreased expression of SLC7A11 protein]; ADORA2B protein affects the reaction [Palmitic Acid results in decreased phosphorylation of AKT1 protein]; ADORA2B protein affects the reaction [Palmitic Acid results in decreased phosphorylation of PIK3CG protein]; ADORA2B protein inhibits the reaction [MYC protein inhibits the reaction [Palmitic Acid results in decreased expression of and results in decreased activity of GPX4 protein]]; ADORA2B protein inhibits the reaction [MYC protein inhibits the reaction [Palmitic Acid results in decreased expression of SLC7A11 protein]]; ADORA2B protein inhibits the reaction [MYC protein inhibits the reaction [Palmitic Acid results in decreased phosphorylation of AKT1 protein]]; ADORA2B protein inhibits the reaction [MYC protein inhibits the reaction [Palmitic Acid results in decreased phosphorylation of PIK3CG protein]]; ADORA2B protein promotes the reaction [Palmitic Acid results in decreased expression of and results in decreased activity of GPX4 protein]; ADORA2B protein promotes the reaction [Palmitic Acid results in decreased expression of SLC7A11 protein]; ADORA2B protein promotes the reaction [Palmitic Acid results in decreased phosphorylation of AKT1 protein]; ADORA2B protein promotes the reaction [Palmitic Acid results in decreased phosphorylation of PIK3CG protein]; MYC protein inhibits the reaction [Palmitic Acid results in increased expression of ADORA2B mRNA]; MYC protein inhibits the reaction [Palmitic Acid results in increased expression of ADORA2B protein] Palmitic Acid results in increased expression of ADORA2B mRNA; Palmitic Acid results in increased expression of ADORA2B protein
[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of AGPAT2 mRNA; [Palmitic Acid co-treated with Oleic Acid] affects the expression of AGPAT2 mRNA
[Palmitic Acid co-treated with Arsenic] affects the expression of AHR mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of AHR mRNA; [Palmitic Acid co-treated with Oleic Acid] affects the expression of AHR mRNA
Palmitic Acid results in decreased phosphorylation of AKT1 protein Palmitate increases phosphorylation of Akt1 protein in myotubes [Oleic Acid co-treated with Palmitic Acid] results in decreased phosphorylation of AKT1 protein; ADORA2B protein affects the reaction [Palmitic Acid results in decreased phosphorylation of AKT1 protein]; ADORA2B protein inhibits the reaction [MYC protein inhibits the reaction [Palmitic Acid results in decreased phosphorylation of AKT1 protein]]; ADORA2B protein promotes the reaction [Palmitic Acid results in decreased phosphorylation of AKT1 protein]; MYC protein inhibits the reaction [Palmitic Acid results in decreased phosphorylation of AKT1 protein] Palmitic Acid results in increased phosphorylation of AKT1 protein 4-phenylbutyric acid inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of AKT1 protein]]; [Palmitic Acid co-treated with Arsenic] affects the expression of AKT1 mRNA; [Palmitic Acid co-treated with Glucose] results in increased phosphorylation of AKT1 protein; Agmatine inhibits the reaction [Palmitic Acid results in decreased phosphorylation of AKT1 protein]; albiflorin inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased phosphorylation of AKT1 protein]; Cyclosporine inhibits the reaction [Palmitic Acid results in decreased phosphorylation of AKT1 protein]; dorsomorphin inhibits the reaction [Agmatine inhibits the reaction [Palmitic Acid results in decreased phosphorylation of AKT1 protein]]; ferric ammonium citrate inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of AKT1 protein]]; Palmitic Acid inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of AKT1 protein]; Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of AKT1 protein]; Palmitic Acid inhibits the reaction [TNF protein results in increased phosphorylation of AKT1 protein]; STF 083010 inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of AKT1 protein]]; zhenwu decoction inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased phosphorylation of AKT1 protein] 4-hydroxyisoleucine inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of AKT1 protein]]; geniposide inhibits the reaction [Palmitic Acid results in decreased phosphorylation of AKT1 protein]; Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of AKT1 protein]; Palmitic Acid inhibits the reaction [INS1 protein results in increased phosphorylation of AKT1 protein]
[ALB protein binds to Palmitic Acid] promotes the reaction [ALB protein results in increased reduction of Dithionitrobenzoic Acid]; [ALB protein binds to Palmitic Acid] promotes the reaction [Pyruvaldehyde results in increased oxidation of ALB protein]; [ALB protein modified form binds to Palmitic Acid] which results in decreased reduction of Dithionitrobenzoic Acid; [Oleic Acid co-treated with Palmitic Acid] results in increased expression of ALB protein; Coptidis rhizoma extract inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of ALB protein]; Palmitic Acid inhibits the reaction [Fenoprofen binds to ALB protein] ALB protein binds to Palmitic Acid; Palmitic Acid binds to ALB protein
acetovanillone inhibits the reaction [Palmitic Acid results in increased expression of ALPL mRNA]; CYBA mutant form inhibits the reaction [Palmitic Acid results in increased expression of ALPL mRNA]; U 0126 inhibits the reaction [Palmitic Acid results in increased expression of ALPL mRNA]
[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of ANGPTL4 mRNA; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of ANGPTL4 mRNA
[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of ANXA2 mRNA; [Palmitic Acid co-treated with Oleic Acid] affects the expression of ANXA2 mRNA
[Oleic Acid co-treated with Palmitic Acid] results in increased expression of APOB mRNA; Ethanol inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of APOB mRNA]
morroniside inhibits the reaction [Palmitic Acid results in decreased expression of APOE mRNA]; morroniside inhibits the reaction [Palmitic Acid results in decreased expression of APOE protein] Palmitic Acid results in decreased expression of APOE mRNA; Palmitic Acid results in decreased expression of APOE protein
AICA ribonucleotide inhibits the reaction [Palmitic Acid results in decreased expression of ARG1 mRNA]; Metformin inhibits the reaction [Palmitic Acid results in decreased expression of ARG1 mRNA]; resveratrol inhibits the reaction [Palmitic Acid results in decreased expression of ARG1 mRNA]; Salicylic Acid inhibits the reaction [Palmitic Acid results in decreased expression of ARG1 mRNA] Palmitic Acid results in decreased expression of ARG1 protein amlexanox affects the reaction [Palmitic Acid affects the expression of ARG1 mRNA]; amlexanox inhibits the reaction [Palmitic Acid results in decreased expression of ARG1 protein]; mifobate affects the reaction [Palmitic Acid affects the expression of ARG1 mRNA] [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of ARG1 mRNA; [Palmitic Acid co-treated with Oleic Acid] affects the expression of ARG1 mRNA
Palmitic Acid results in increased expression of ATF4 mRNA; Palmitic Acid results in increased expression of ATF4 protein Cyclosporine inhibits the reaction [Palmitic Acid results in increased expression of ATF4 protein]; Palmitic Acid results in increased expression of and affects the localization of ATF4 protein 4-phenylbutyric acid inhibits the reaction [Palmitic Acid results in increased expression of ATF4 mRNA]; GSK2656157 inhibits the reaction [Palmitic Acid results in increased expression of ATF4 mRNA]; GSK2656157 inhibits the reaction [Palmitic Acid results in increased expression of ATF4 protein]
3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in increased expression of ATF6 mRNA]; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of ATF6 mRNA Palmitic Acid results in increased expression of ATF6 mRNA [4-phenylbutyric acid co-treated with Palmitic Acid] results in decreased expression of ATF6 protein
[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of ATG5 protein; ATG5 protein promotes the reaction [Resveratrol inhibits the reaction [Palmitic Acid results in increased expression of SREBF1 protein]]; Escin inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of ATG5 protein] ATG5 protein promotes the reaction [C1QTNF9 protein inhibits the reaction [Palmitic Acid results in increased expression of CASP3 protein modified form]]
Palmitic Acid results in decreased expression of ATG7 protein trigonelline inhibits the reaction [Palmitic Acid results in decreased expression of ATG7 protein] [Palmitic Acid co-treated with Oleic Acid] results in decreased expression of ATG7 protein; ATG7 protein affects the reaction [trigonelline inhibits the reaction [Palmitic Acid results in increased expression of PPARG protein]]; ATG7 protein affects the reaction [trigonelline inhibits the reaction [Palmitic Acid results in increased expression of SREBF1 protein]]; Escin inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of ATG7 protein]; trigonelline inhibits the reaction [Palmitic Acid results in decreased expression of ATG7 protein]
ATP2A2 protein promotes the reaction [7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid inhibits the reaction [Palmitic Acid results in increased expression of XBP1 mRNA alternative form]]
[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of B4GALT5 mRNA; [Palmitic Acid co-treated with Oleic Acid] affects the expression of B4GALT5 mRNA
[Oleic Acid co-treated with Palmitic Acid] results in increased expression of BACE1 mRNA; [Oleic Acid co-treated with Palmitic Acid] results in increased expression of BACE1 protein; BACE1 protein affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of DDIT3 protein]]; BACE1 protein affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of HSPA5 protein]]; BACE1 protein affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL1B protein]]; BACE1 protein affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL6 protein]]; BACE1 protein affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of TNF protein]]; MIR497 affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of BACE1 protein]]; SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of BACE1 protein]
Palmitic Acid results in increased expression of BAX 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in increased expression of BAX protein]]; [Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in increased expression of BAX protein]; MIR141 mRNA promotes the reaction [Palmitic Acid results in increased expression of BAX protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [[Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in increased expression of BAX protein]] Palmitic Acid affects the expression of BAX mRNA amlexanox inhibits the reaction [Palmitic Acid results in increased expression of BAX protein]; carnosol inhibits the reaction [Palmitic Acid results in increased expression of BAX protein]; PRDX3 protein inhibits the reaction [Palmitic Acid results in increased expression of BAX protein]; PRDX3 protein promotes the reaction [carnosol inhibits the reaction [Palmitic Acid results in increased expression of BAX protein]] 3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in increased expression of BAX mRNA]; [Palmitic Acid co-treated with Arsenic] affects the expression of BAX mRNA; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of BAX mRNA Palmitic Acid results in increased expression of BAX; Palmitic Acid results in increased expression of BAX protein
[Palmitic Acid co-treated with Glucose] results in increased expression of BBC3 mRNA; SIRT1 protein mutant form inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased expression of BBC3 mRNA]
Palmitic Acid results in decreased expression of BCL2; Palmitic Acid results in decreased expression of BCL2 protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in decreased expression of BCL2 protein]]; [Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in decreased expression of BCL2 protein]; MIR141 mRNA promotes the reaction [Palmitic Acid results in decreased expression of BCL2 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [[Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in decreased expression of BCL2 protein]] amlexanox inhibits the reaction [Palmitic Acid results in decreased expression of BCL2 protein]; carnosol inhibits the reaction [Palmitic Acid results in decreased expression of BCL2 protein]; PRDX3 protein promotes the reaction [carnosol inhibits the reaction [Palmitic Acid results in decreased expression of BCL2 protein]] 3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of BCL2 mRNA]; [Palmitic Acid co-treated with Arsenic] results in increased expression of BCL2 mRNA; [Palmitic Acid co-treated with Cyclosporine] results in increased expression of BCL2 protein; [Palmitic Acid co-treated with Oleic Acid] results in decreased expression of BCL2 mRNA
[Palmitic Acid co-treated with Arsenic] affects the expression of BECN1 mRNA; BECN1 protein promotes the reaction [Resveratrol inhibits the reaction [Palmitic Acid results in increased expression of SREBF1 protein]]; trigonelline inhibits the reaction [Palmitic Acid results in decreased expression of BECN1 protein] Palmitic Acid results in increased expression of BECN1 protein
acetovanillone inhibits the reaction [Palmitic Acid results in increased expression of BGLAP mRNA]; CYBA mutant form inhibits the reaction [Palmitic Acid results in increased expression of BGLAP mRNA]; U 0126 inhibits the reaction [Palmitic Acid results in increased expression of BGLAP mRNA]
C1QTNF9 protein results in decreased susceptibility to Palmitic Acid ATG5 protein promotes the reaction [C1QTNF9 protein inhibits the reaction [Palmitic Acid results in increased expression of CASP3 protein modified form]]; C1QTNF9 protein promotes the reaction [Palmitic Acid results in increased expression of MAP1LC3B protein modified form]
CA 074 methyl ester inhibits the reaction [Palmitic Acid results in increased cleavage of CASP1 protein]; NLRP3 inhibits the reaction [Palmitic Acid results in increased cleavage of CASP1 protein]; Palmitic Acid results in increased cleavage of and affects the localization of CASP1 protein Palmitic Acid results in increased activity of CASP1 protein imoxin inhibits the reaction [Palmitic Acid results in increased expression of CASP1 protein]; Lead promotes the reaction [Palmitic Acid results in increased activity of CASP1 protein]; Palmitic Acid promotes the reaction [Lead results in increased activity of CASP1 protein]; SRT1720 inhibits the reaction [Lead promotes the reaction [Palmitic Acid results in increased activity of CASP1 protein]]; SRT1720 inhibits the reaction [Palmitic Acid promotes the reaction [Lead results in increased activity of CASP1 protein]]
Palmitic Acid results in increased activity of CASP3 protein Palmitic Acid results in increased cleavage of CASP3 protein Palmitic Acid affects the expression of CASP3 mRNA Palmitic Acid results in increased expression of CASP3 mRNA; Palmitic Acid results in increased expression of CASP3 protein; Palmitic Acid results in increased expression of CASP3 protein modified form 3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in increased expression of CASP3 mRNA]; 7-hydroxycoumarin inhibits the reaction [Palmitic Acid results in increased activity of CASP3 protein]; [Fructose co-treated with Palmitic Acid] results in increased activity of CASP3 protein; [Palmitic Acid co-treated with Arsenic] affects the expression of CASP3 mRNA; [Palmitic Acid co-treated with Glucose] results in increased cleavage of CASP3 protein; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of CASP3 mRNA; Fenofibrate inhibits the reaction [[Fructose co-treated with Palmitic Acid] results in increased activity of CASP3 protein]; Palmitic Acid promotes the reaction [alpidem results in increased activity of CASP3 protein]; Palmitic Acid promotes the reaction [Clomipramine results in increased activity of CASP3 protein]; Palmitic Acid promotes the reaction [Clozapine results in increased activity of CASP3 protein]; Palmitic Acid promotes the reaction [Cyclosporine results in increased activity of CASP3 protein]; Palmitic Acid promotes the reaction [Dipyridamole results in increased activity of CASP3 protein]; Palmitic Acid promotes the reaction [Estrone results in increased activity of CASP3 protein]; Palmitic Acid promotes the reaction [fipexide results in increased activity of CASP3 protein]; Palmitic Acid promotes the reaction [Flecainide results in increased activity of CASP3 protein]; Palmitic Acid promotes the reaction [Fluoxetine results in increased activity of CASP3 protein]; Palmitic Acid promotes the reaction [Fluvoxamine results in increased activity of CASP3 protein]; Palmitic Acid promotes the reaction [Imipramine results in increased activity of CASP3 protein]; Palmitic Acid promotes the reaction [Loratadine results in increased activity of CASP3 protein]; Palmitic Acid promotes the reaction [Mitoxantrone results in increased activity of CASP3 protein]; Palmitic Acid promotes the reaction [nefazodone results in increased activity of CASP3 protein]; Palmitic Acid promotes the reaction [Nimodipine results in increased activity of CASP3 protein]; Palmitic Acid promotes the reaction [Nortriptyline results in increased activity of CASP3 protein]; Palmitic Acid promotes the reaction [Phentolamine results in increased activity of CASP3 protein]; Palmitic Acid promotes the reaction [Propranolol results in increased activity of CASP3 protein]; Palmitic Acid promotes the reaction [Pyrimethamine results in increased activity of CASP3 protein]; Palmitic Acid promotes the reaction [Riluzole results in increased activity of CASP3 protein]; Palmitic Acid promotes the reaction [Risperidone results in increased activity of CASP3 protein]; Palmitic Acid promotes the reaction [Spironolactone results in increased activity of CASP3 protein]; Palmitic Acid promotes the reaction [Ticlopidine results in increased activity of CASP3 protein]; Palmitic Acid promotes the reaction [Troglitazone results in increased activity of CASP3 protein]; Palmitic Acid promotes the reaction [zileuton results in increased activity of CASP3 protein]; Scopoletin inhibits the reaction [Palmitic Acid results in increased activity of CASP3 protein]; SIRT1 protein inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased cleavage of CASP3 protein] 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in increased expression of CASP3 protein modified form]]; [Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in increased expression of CASP3 protein modified form]; [T0901317 co-treated with Alitretinoin] promotes the reaction [Palmitic Acid results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Palmitic Acid results in increased expression of CASP3 mRNA]; ATG5 protein promotes the reaction [C1QTNF9 protein inhibits the reaction [Palmitic Acid results in increased expression of CASP3 protein modified form]]; geniposide inhibits the reaction [Palmitic Acid results in increased expression of and results in increased activity of CASP3 protein]; imoxin inhibits the reaction [Palmitic Acid results in increased expression of CASP3 mRNA]; imoxin inhibits the reaction [Palmitic Acid results in increased expression of CASP3 protein]; MIR141 mRNA promotes the reaction [Palmitic Acid results in increased expression of CASP3 protein modified form]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [[Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in increased expression of CASP3 protein modified form]]; Palmitic Acid results in increased cleavage of and results in increased activity of CASP3 protein; Palmitic Acid results in increased expression of and results in increased activity of CASP3 protein; parthenolide inhibits the reaction [Palmitic Acid results in increased expression of CASP3 mRNA]; pyrazolanthrone inhibits the reaction [Palmitic Acid results in increased expression of CASP3 mRNA]; pyrazolanthrone inhibits the reaction [Palmitic Acid results in increased expression of CASP3 protein]; SCD1 protein inhibits the reaction [Palmitic Acid results in increased activity of CASP3 protein]; SQSTM1 protein affects the reaction [Palmitic Acid results in increased cleavage of CASP3 protein]; T0901317 promotes the reaction [Palmitic Acid results in increased activity of CASP3 protein] amlexanox inhibits the reaction [Palmitic Acid results in increased cleavage of CASP3 protein]; Palmitic Acid results in decreased expression of and results in increased cleavage of CASP3 protein; PRDX3 protein inhibits the reaction [Palmitic Acid results in increased cleavage of CASP3 protein]; pyrrolidine dithiocarbamic acid inhibits the reaction [Palmitic Acid results in decreased expression of and results in increased cleavage of CASP3 protein]
[T0901317 co-treated with Alitretinoin] promotes the reaction [Palmitic Acid results in increased activity of CASP7 protein]; T0901317 promotes the reaction [Palmitic Acid results in increased activity of CASP7 protein] Palmitic Acid promotes the reaction [alpidem results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [Clomipramine results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [Clozapine results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [Cyclosporine results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [Dipyridamole results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [Estrone results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [fipexide results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [Flecainide results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [Fluoxetine results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [Fluvoxamine results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [Imipramine results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [Loratadine results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [Mitoxantrone results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [nefazodone results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [Nimodipine results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [Nortriptyline results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [Phentolamine results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [Pyrimethamine results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [Riluzole results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [Risperidone results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [Spironolactone results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [Ticlopidine results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [Troglitazone results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [zileuton results in increased activity of CASP7 protein]
3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in increased expression of CASP9 mRNA]; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of CASP9 mRNA Palmitic Acid results in increased expression of CASP9 protein modified form 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in increased expression of CASP9 protein modified form]]; [Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in increased expression of CASP9 protein modified form]; MIR141 mRNA promotes the reaction [Palmitic Acid results in increased expression of CASP9 protein modified form]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [[Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in increased expression of CASP9 protein modified form]]
[Oleic Acid co-treated with Palmitic Acid co-treated with Ethanol] results in increased activity of CAT protein; [Oleic Acid co-treated with Palmitic Acid] results in increased activity of CAT protein Palmitic Acid results in increased activity of CAT protein Palmitic Acid results in increased expression of CAT mRNA [Palmitic Acid co-treated with Arsenic] affects the expression of CAT mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of CAT mRNA
AICA ribonucleotide inhibits the reaction [Palmitic Acid results in increased expression of CCL2 mRNA]; Metformin inhibits the reaction [Palmitic Acid results in increased expression of CCL2 mRNA]; resveratrol inhibits the reaction [Palmitic Acid results in increased expression of CCL2 mRNA]; Salicylic Acid inhibits the reaction [Palmitic Acid results in increased expression of CCL2 mRNA] (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CCL2 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein; Bezafibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Fenofibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; lanifibranor inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Rosiglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; saroglitazar inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein] Palmitic Acid results in increased expression of CCL2 mRNA; Palmitic Acid results in increased expression of CCL2 protein Quercetin inhibits the reaction [Palmitic Acid results in increased expression of CCL2 mRNA]; Quercetin inhibits the reaction [Palmitic Acid results in increased expression of CCL2 protein]
AICA ribonucleotide inhibits the reaction [Palmitic Acid results in increased expression of CCL3 mRNA]; Bezafibrate inhibits the reaction [Palmitic Acid results in increased expression of CCL3 mRNA]; Capsaicin inhibits the reaction [Palmitic Acid results in increased expression of CCL3 mRNA]; N-(3-methoxyphenyl)-4-chlorocinnamanilide inhibits the reaction [Capsaicin inhibits the reaction [Palmitic Acid results in increased expression of CCL3 mRNA]]
[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CCL5 mRNA
Palmitic Acid results in increased expression of CCN2 protein CXCL12 protein inhibits the reaction [Palmitic Acid results in increased expression of CCN2 protein]; CXCR7 protein promotes the reaction [CXCL12 protein inhibits the reaction [Palmitic Acid results in increased expression of CCN2 protein]]; KLF15 protein promotes the reaction [CXCL12 protein inhibits the reaction [Palmitic Acid results in increased expression of CCN2 protein]]; MAPK11 protein promotes the reaction [CXCL12 protein inhibits the reaction [Palmitic Acid results in increased expression of CCN2 protein]]
Palmitic Acid results in decreased expression of CCND1 protein CYLD protein affects the reaction [Palmitic Acid results in decreased expression of CCND1 protein]; PKF115-584 inhibits the reaction [CYLD protein affects the reaction [Palmitic Acid results in decreased expression of CCND1 protein]]
Palmitic Acid results in increased expression of CD14 mRNA amlexanox inhibits the reaction [Palmitic Acid results in increased expression of CD14 mRNA]
Palmitic Acid results in increased expression of CD36 protein Palmitic Acid results in increased expression of CD36 mRNA; Palmitic Acid results in increased expression of CD36 protein (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; [Oleic Acid co-treated with Palmitic Acid] results in increased expression of CD36 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA; Coptidis rhizoma extract inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of CD36 mRNA]; Fenofibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; isosilybin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of CD36 mRNA]; lanifibranor inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Rosiglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; saroglitazar inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA] trigonelline inhibits the reaction [Palmitic Acid results in increased expression of CD36 protein]
Palmitic Acid results in increased expression of CD68 mRNA amlexanox inhibits the reaction [Palmitic Acid results in increased expression of CD68 mRNA]
3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in increased expression of CDKN1A mRNA]; [Cyclosporine co-treated with Palmitic Acid] results in decreased expression of CDKN1A protein; [Palmitic Acid co-treated with Glucose] results in increased expression of CDKN1A mRNA; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of CDKN1A mRNA; SIRT1 protein mutant form inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased expression of CDKN1A mRNA] Palmitic Acid results in increased expression of CDKN1A protein
Palmitic Acid results in increased expression of CDKN2A protein Cyclosporine inhibits the reaction [Palmitic Acid results in increased expression of CDKN2A protein]
[Palmitic Acid co-treated with Sincalide] results in increased expression of CEBPA mRNA; [Palmitic Acid co-treated with Sincalide] results in increased expression of CEBPA protein; Quercetin inhibits the reaction [[Sincalide co-treated with Palmitic Acid] results in increased expression of CEBPA protein] Palmitic Acid results in decreased expression of CEBPA mRNA [Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CEBPA mRNA; Palmitic Acid promotes the reaction [[sodium arsenite co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CEBPA mRNA]; Palmitic Acid promotes the reaction [sodium arsenite results in decreased expression of CEBPA mRNA]; sodium arsenite promotes the reaction [[Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CEBPA mRNA]
[Palmitic Acid co-treated with Sincalide] results in increased expression of CEBPB mRNA; [Palmitic Acid co-treated with Sincalide] results in increased expression of CEBPB protein; Quercetin inhibits the reaction [[Sincalide co-treated with Palmitic Acid] results in increased expression of CEBPB protein]
[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of CIDEC protein; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of CIDEC mRNA Palmitic Acid results in decreased expression of CIDEC mRNA
[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of COL1A1 mRNA Palmitic Acid results in increased expression of COL1A1 mRNA [Palmitic Acid co-treated with Ethanol] results in increased expression of COL1A1 mRNA
Palmitic Acid results in decreased expression of COX5A mRNA Palmitic Acid results in increased methylation of COX5A promoter decitabine inhibits the reaction [Palmitic Acid results in decreased expression of COX5A mRNA]; decitabine inhibits the reaction [Palmitic Acid results in increased methylation of COX5A promoter]
(R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; [Oleic Acid co-treated with Palmitic Acid] results in increased expression of CPT1A mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in decreased expression of CPT1A protein; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of CPT1A mRNA; [Palmitic Acid co-treated with Oleic Acid] results in decreased expression of CPT1A protein; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of CPT1A mRNA; Bezafibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Capsaicin promotes the reaction [Palmitic Acid results in increased expression of CPT1A mRNA]; Fenofibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; isosilybin promotes the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of CPT1A mRNA]; Ivermectin inhibits the reaction [Palmitic Acid results in increased expression of CPT1A mRNA]; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Permethrin inhibits the reaction [Palmitic Acid results in increased expression of CPT1A mRNA]; Pioglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA] Palmitic Acid results in decreased expression of CPT1A mRNA [Oleic Acid co-treated with Palmitic Acid] results in decreased expression of CPT1A mRNA; [Oleic Acid co-treated with Palmitic Acid] results in increased expression of CPT1A mRNA; [Oleic Acid co-treated with Palmitic Acid] results in increased expression of CPT1A protein; Bezafibrate inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of CPT1A mRNA]; Ethanol inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of CPT1A protein]; quercetin 3-O-glucuronide inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of CPT1A mRNA]; tetrabromobisphenol A promotes the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of CPT1A mRNA]; Triiodothyronine promotes the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of CPT1A mRNA] amlexanox inhibits the reaction [Palmitic Acid results in decreased expression of CPT1A mRNA]; obeticholic acid promotes the reaction [Palmitic Acid results in increased expression of CPT1A mRNA]
[Glucose co-treated with Palmitic Acid] results in decreased expression of CPT2 mRNA; [Palmitic Acid co-treated with Oleic Acid] results in decreased expression of CPT2 mRNA; Escin inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of CPT2 mRNA]
Palmitic Acid inhibits the reaction [SMIM20 protein results in increased phosphorylation of CREB1 protein] Palmitic Acid results in increased expression of CREB1 mRNA
Palmitic Acid results in decreased expression of CTNNB1 protein CYLD protein affects the reaction [Palmitic Acid results in decreased expression of CTNNB1 protein]
CXCL12 protein inhibits the reaction [Palmitic Acid results in decreased expression of KLF15 protein]; CXCL12 protein inhibits the reaction [Palmitic Acid results in increased expression of CCN2 protein]; CXCR7 protein promotes the reaction [CXCL12 protein inhibits the reaction [Palmitic Acid results in decreased expression of KLF15 protein]]; CXCR7 protein promotes the reaction [CXCL12 protein inhibits the reaction [Palmitic Acid results in increased expression of CCN2 protein]]; KLF15 protein promotes the reaction [CXCL12 protein inhibits the reaction [Palmitic Acid results in increased expression of CCN2 protein]]; MAPK11 protein promotes the reaction [CXCL12 protein inhibits the reaction [Palmitic Acid results in decreased expression of KLF15 protein]]; MAPK11 protein promotes the reaction [CXCL12 protein inhibits the reaction [Palmitic Acid results in increased expression of CCN2 protein]]
[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of CXCL2 mRNA; [Palmitic Acid co-treated with Oleic Acid] affects the expression of CXCL2 mRNA
CYBA mutant form inhibits the reaction [Palmitic Acid results in increased expression of ALPL mRNA]; CYBA mutant form inhibits the reaction [Palmitic Acid results in increased expression of BGLAP mRNA]; CYBA mutant form inhibits the reaction [Palmitic Acid results in increased expression of RUNX2 mRNA]; CYBA mutant form inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK1 protein]; CYBA mutant form inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK3 protein]
Palmitic Acid results in increased expression of CYBB mRNA geraniol inhibits the reaction [Palmitic Acid results in increased expression of CYBB protein] acetovanillone inhibits the reaction [Palmitic Acid results in increased expression of CYBB mRNA]; U 0126 inhibits the reaction [Palmitic Acid results in increased expression of CYBB mRNA]
[Fructose co-treated with Palmitic Acid] results in increased expression of CYCS protein; Fenofibrate inhibits the reaction [[Fructose co-treated with Palmitic Acid] results in increased expression of CYCS protein]
CYLD protein affects the reaction [Palmitic Acid results in decreased expression of CCND1 protein]; CYLD protein affects the reaction [Palmitic Acid results in decreased expression of CTNNB1 protein]; CYLD protein affects the reaction [Palmitic Acid results in increased expression of SQSTM1 protein]; CYLD protein affects the reaction [Palmitic Acid results in increased phosphorylation of GSK3B protein]; PKF115-584 inhibits the reaction [CYLD protein affects the reaction [Palmitic Acid results in decreased expression of CCND1 protein]]; PKF115-584 inhibits the reaction [CYLD protein affects the reaction [Palmitic Acid results in increased expression of SQSTM1 protein]]; PKF115-584 inhibits the reaction [CYLD protein affects the reaction [Palmitic Acid results in increased phosphorylation of GSK3B protein]] Palmitic Acid results in increased expression of CYLD mRNA; Palmitic Acid results in increased expression of CYLD protein
[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of CYP24A1 mRNA; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of CYP24A1 mRNA
[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of CYP26A1 mRNA; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of CYP26A1 mRNA
[Oleic Acid co-treated with Palmitic Acid] inhibits the reaction [Ethanol results in increased expression of CYP2E1 mRNA]; [Oleic Acid co-treated with Palmitic Acid] results in increased expression of CYP2E1 mRNA; Ethanol inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of CYP2E1 mRNA] Palmitic Acid results in increased expression of CYP2E1 mRNA; Palmitic Acid results in increased expression of CYP2E1 protein amlexanox inhibits the reaction [Palmitic Acid results in increased expression of CYP2E1 mRNA]; amlexanox inhibits the reaction [Palmitic Acid results in increased expression of CYP2E1 protein]
[Oleic Acid co-treated with Palmitic Acid co-treated with Ethanol] results in decreased expression of CYP4A1 mRNA Palmitic Acid results in decreased expression of CYP4A22 mRNA
[Oleic Acid co-treated with Palmitic Acid] results in increased expression of CYP7A1 mRNA; Coptidis rhizoma extract inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of CYP7A1 mRNA]
Palmitic Acid results in increased expression of DDIT3 mRNA; Palmitic Acid results in increased expression of DDIT3 protein Scopoletin inhibits the reaction [Palmitic Acid results in increased expression of DDIT3 mRNA] 3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in increased expression of DDIT3 mRNA]; [Palmitic Acid co-treated with Arsenic] results in increased expression of DDIT3 mRNA; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of DDIT3 mRNA; Ivermectin promotes the reaction [Palmitic Acid results in increased expression of DDIT3 protein]; Palmitic Acid results in increased expression of and affects the localization of DDIT3 protein; Permethrin inhibits the reaction [Palmitic Acid results in increased expression of DDIT3 mRNA] 4-phenylbutyric acid promotes the reaction [Palmitic Acid results in increased expression of DDIT3 mRNA]; 7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid inhibits the reaction [Palmitic Acid results in increased expression of DDIT3 protein]; [Oleic Acid co-treated with Palmitic Acid] results in increased expression of DDIT3 protein; BACE1 protein affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of DDIT3 protein]]; GSK2656157 inhibits the reaction [Palmitic Acid results in increased expression of DDIT3 mRNA]; GSK2656157 inhibits the reaction [Palmitic Acid results in increased expression of DDIT3 protein]; MIR497 affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of DDIT3 protein]]; SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of DDIT3 protein]; Thapsigargin inhibits the reaction [7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid inhibits the reaction [Palmitic Acid results in increased expression of DDIT3 protein]]
Palmitic Acid results in increased expression of DGAT1 mRNA [Palmitic Acid co-treated with Oleic Acid] results in increased expression of DGAT1 mRNA Palmitic Acid results in decreased expression of DGAT1 mRNA 7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid inhibits the reaction [Palmitic Acid results in increased expression of DGAT1 mRNA]; amlexanox inhibits the reaction [Palmitic Acid results in increased expression of DGAT1 mRNA]
[Fructose co-treated with Palmitic Acid] results in increased expression of DNM1L protein; Fenofibrate inhibits the reaction [[Fructose co-treated with Palmitic Acid] results in increased expression of DNM1L protein] Palmitic Acid results in increased expression of DNM1L protein carnosol inhibits the reaction [Palmitic Acid results in increased expression of DNM1L protein]; PRDX3 protein inhibits the reaction [Palmitic Acid results in increased expression of DNM1L protein]; PRDX3 protein promotes the reaction [carnosol inhibits the reaction [Palmitic Acid results in increased expression of DNM1L protein]]
[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in decreased expression of DST mRNA; [Palmitic Acid co-treated with Oleic Acid] affects the expression of DST mRNA
[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of DYNC1H1 mRNA; [Palmitic Acid co-treated with Oleic Acid] affects the expression of DYNC1H1 mRNA
[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of DYNC1I1 mRNA; [Palmitic Acid co-treated with Oleic Acid] affects the expression of DYNC1I1 mRNA
Palmitic Acid results in increased expression of EDN1 mRNA; Palmitic Acid results in increased expression of EDN1 protein Palmitic Acid results in decreased expression of EDN1 protein Agmatine inhibits the reaction [Palmitic Acid results in decreased expression of EDN1 protein]
[Oleic Acid co-treated with Palmitic Acid] results in increased expression of EGFR protein; [Palmitic Acid co-treated with Glucose] results in increased phosphorylation of EGFR protein; [Palmitic Acid co-treated with Oleic Acid] affects the expression of EGFR mRNA; albiflorin inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased phosphorylation of EGFR protein]; Coptidis rhizoma extract inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of EGFR protein]; zhenwu decoction inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased phosphorylation of EGFR protein]
nuciferine inhibits the reaction [Palmitic Acid results in decreased expression of EHHADH mRNA]; PPARGC1A protein promotes the reaction [nuciferine inhibits the reaction [Palmitic Acid results in decreased expression of EHHADH mRNA]]
imoxin inhibits the reaction [Palmitic Acid results in increased expression of EIF2AK2 mRNA]; imoxin inhibits the reaction [Palmitic Acid results in increased expression of EIF2AK2 protein] Palmitic Acid results in increased phosphorylation of EIF2AK2 protein Palmitic Acid results in increased expression of EIF2AK2 mRNA; Palmitic Acid results in increased expression of EIF2AK2 protein
3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in increased expression of EIF2AK3 mRNA]; [Palmitic Acid co-treated with Oleic Acid] affects the expression of EIF2AK3 mRNA; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of EIF2AK3 mRNA Palmitic Acid results in increased expression of EIF2AK3 mRNA; Palmitic Acid results in increased expression of EIF2AK3 protein
7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid inhibits the reaction [Palmitic Acid results in increased phosphorylation of EIF2S1 protein]; GSK2656157 inhibits the reaction [Palmitic Acid results in increased phosphorylation of EIF2S1 protein]; Thapsigargin inhibits the reaction [7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid inhibits the reaction [Palmitic Acid results in increased phosphorylation of EIF2S1 protein]]; trigonelline inhibits the reaction [Palmitic Acid results in increased phosphorylation of EIF2S1 protein]
(R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA; [Palmitic Acid co-treated with Oleic Acid] affects the expression of ELOVL6 mRNA; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]
[Palmitic Acid co-treated with Sincalide] results in increased expression of ERN1 mRNA; [Palmitic Acid co-treated with Sincalide] results in increased expression of ERN1 protein; Quercetin inhibits the reaction [[Sincalide co-treated with Palmitic Acid] results in increased expression of ERN1 protein] Palmitic Acid results in increased expression of ERN1 mRNA; Palmitic Acid results in increased expression of ERN1 protein 3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in increased expression of ERN1 mRNA]; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of ERN1 mRNA; Deferoxamine promotes the reaction [Palmitic Acid results in increased phosphorylation of ERN1 protein]; ferric ammonium citrate inhibits the reaction [Palmitic Acid results in increased phosphorylation of ERN1 protein]; Sirolimus inhibits the reaction [Palmitic Acid results in increased phosphorylation of ERN1 protein] 4-phenylbutyric acid promotes the reaction [Palmitic Acid results in increased expression of ERN1 mRNA]; 7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid inhibits the reaction [Palmitic Acid results in increased phosphorylation of ERN1 protein]; baicalin inhibits the reaction [Palmitic Acid results in increased phosphorylation of ERN1 protein]; Thapsigargin inhibits the reaction [7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid inhibits the reaction [Palmitic Acid results in increased phosphorylation of ERN1 protein]]; ursodoxicoltaurine inhibits the reaction [Palmitic Acid results in increased phosphorylation of ERN1 protein]
[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of FABP1 mRNA; [Palmitic Acid co-treated with Oleic Acid] affects the expression of FABP1 mRNA
Palmitic Acid results in increased expression of FAS protein 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Palmitic Acid results in increased expression of FAS protein]; [Oleic Acid co-treated with Palmitic Acid] results in increased expression of FAS protein; [Palmitic Acid co-treated with Arsenic] affects the expression of FAS mRNA; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of FAS mRNA; isosilybin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of FAS protein]; morroniside inhibits the reaction [Palmitic Acid results in increased expression of FAS protein]; Palmitic Acid inhibits the reaction [Permethrin results in decreased expression of FAS mRNA] [Oleic Acid co-treated with Palmitic Acid] results in increased expression of FAS mRNA; quercetin 3-O-glucuronide inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of FAS mRNA]
[osteum co-treated with Palmitic Acid] promotes the reaction [decabromobiphenyl ether results in increased expression of FASN protein]; [osteum co-treated with Palmitic Acid] results in increased expression of FASN protein; acanthoic acid inhibits the reaction [Palmitic Acid results in increased expression of FASN mRNA]; amlexanox inhibits the reaction [Palmitic Acid results in increased expression of FASN mRNA]; decabromobiphenyl ether promotes the reaction [[osteum co-treated with Palmitic Acid] results in increased expression of FASN protein]; GW 3965 inhibits the reaction [Palmitic Acid results in increased expression of FASN mRNA]; obeticholic acid inhibits the reaction [Palmitic Acid results in increased expression of FASN mRNA]; Orlistat inhibits the reaction [FASN protein results in increased chemical synthesis of Palmitic Acid] FASN protein affects the abundance of Palmitic Acid Palmitic Acid results in increased expression of FASN mRNA; Palmitic Acid results in increased expression of FASN protein [Fructose co-treated with Palmitic Acid] results in increased expression of FASN protein; [Oleic Acid co-treated with Palmitic Acid] results in increased expression of FASN mRNA; [Oleic Acid co-treated with Palmitic Acid] results in increased expression of FASN protein; [Palmitic Acid co-treated with Oleic Acid] results in decreased expression of FASN mRNA; Coptidis rhizoma extract inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of FASN mRNA]; Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of FASN mRNA]; Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of FASN protein]; dorsomorphin inhibits the reaction [Huangqin-Tang inhibits the reaction [Palmitic Acid results in increased expression of FASN protein]]; dorsomorphin inhibits the reaction [nuciferine inhibits the reaction [Palmitic Acid results in increased expression of FASN mRNA]]; Fenofibrate inhibits the reaction [[Fructose co-treated with Palmitic Acid] results in increased expression of FASN protein]; Huangqin-Tang inhibits the reaction [Palmitic Acid results in increased expression of FASN mRNA]; Huangqin-Tang inhibits the reaction [Palmitic Acid results in increased expression of FASN protein]; MTOR protein inhibits the reaction [Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of FASN mRNA]]; MTOR protein inhibits the reaction [Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of FASN protein]]; nuciferine inhibits the reaction [Palmitic Acid results in increased expression of FASN mRNA]; nuciferine inhibits the reaction [Palmitic Acid results in increased expression of FASN protein] Palmitic Acid results in increased phosphorylation of FASN protein [Oleic Acid co-treated with Palmitic Acid] inhibits the reaction [Ethanol results in increased expression of FASN mRNA]; [Oleic Acid co-treated with Palmitic Acid] results in decreased expression of FASN mRNA
Palmitic Acid results in increased expression of FBXO32 mRNA Quercetin inhibits the reaction [Palmitic Acid results in increased expression of FBXO32 mRNA]
[osteum co-treated with Palmitic Acid] results in increased expression of FGF2 mRNA; MRI-1867 inhibits the reaction [[osteum co-treated with Palmitic Acid] results in increased expression of FGF2 mRNA]
[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of FGF21 mRNA; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of FGF21 mRNA; nuciferine inhibits the reaction [Palmitic Acid results in decreased expression of FGF21 mRNA]; PPARGC1A protein promotes the reaction [nuciferine inhibits the reaction [Palmitic Acid results in decreased expression of FGF21 mRNA]]
3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in increased expression of FIS1 mRNA]; [Fructose co-treated with Palmitic Acid] results in increased expression of FIS1 protein; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of FIS1 mRNA; Fenofibrate inhibits the reaction [[Fructose co-treated with Palmitic Acid] results in increased expression of FIS1 protein] Palmitic Acid results in increased expression of FIS1 protein carnosol inhibits the reaction [Palmitic Acid results in increased expression of FIS1 protein]; PRDX3 protein inhibits the reaction [Palmitic Acid results in increased expression of FIS1 protein]; PRDX3 protein promotes the reaction [carnosol inhibits the reaction [Palmitic Acid results in increased expression of FIS1 protein]]
Palmitic Acid results in increased expression of FOSL2 mRNA Palmitic Acid inhibits the reaction [sodium arsenite results in increased expression of FOSL2 mRNA]; sodium arsenite inhibits the reaction [Palmitic Acid results in increased expression of FOSL2 mRNA]
[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of FOXA1 mRNA; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of FOXA1 mRNA
[Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of FOXL2 mRNA; Palmitic Acid promotes the reaction [[sodium arsenite co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of FOXL2 mRNA]; sodium arsenite promotes the reaction [[Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of FOXL2 mRNA]
4-methylumbelliferone 8-carbaldehyde inhibits the reaction [Palmitic Acid results in decreased expression of FOXO1 mRNA]; 4-methylumbelliferone 8-carbaldehyde inhibits the reaction [Palmitic Acid results in decreased expression of FOXO1 protein]; 4-phenylbutyric acid inhibits the reaction [Palmitic Acid results in decreased expression of FOXO1 mRNA]; 4-phenylbutyric acid inhibits the reaction [Palmitic Acid results in decreased expression of FOXO1 protein]; [GCG protein co-treated with candesartan] inhibits the reaction [Palmitic Acid results in decreased phosphorylation of FOXO1 protein]; [Oleic Acid co-treated with Palmitic Acid] results in decreased phosphorylation of FOXO1 protein; [Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of FOXO1 mRNA; [sodium arsenite co-treated with Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of FOXO1 mRNA; candesartan inhibits the reaction [Palmitic Acid results in decreased phosphorylation of FOXO1 protein]; FOXO1 protein affects the reaction [[Oleic Acid co-treated with Palmitic Acid] inhibits the reaction [INS1 protein inhibits the reaction [[Cyclic AMP co-treated with Dexamethasone] results in increased expression of G6PC1 protein]]]; FOXO1 protein affects the reaction [[Oleic Acid co-treated with Palmitic Acid] inhibits the reaction [INS1 protein inhibits the reaction [[Cyclic AMP co-treated with Dexamethasone] results in increased expression of PEPCK protein]]]; FOXO1 protein affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of NFE2L2 mRNA]; FOXO1 protein affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of NRF1 mRNA]; FOXO1 protein affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of PPARGC1A mRNA]; FOXO1 protein affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of TFAM mRNA]; GCG protein inhibits the reaction [Palmitic Acid results in decreased phosphorylation of FOXO1 protein]; GSK2656157 inhibits the reaction [Palmitic Acid results in decreased expression of FOXO1 mRNA]; Palmitic Acid inhibits the reaction [sodium arsenite results in increased expression of FOXO1 mRNA] Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of FOXO1 protein] Palmitic Acid results in increased expression of FOXO1 mRNA Palmitic Acid results in decreased expression of FOXO1 mRNA; Palmitic Acid results in decreased expression of FOXO1 protein geniposide inhibits the reaction [Palmitic Acid results in decreased phosphorylation of FOXO1 protein]; resveratrol inhibits the reaction [Palmitic Acid results in increased localization of FOXO1 protein]
Palmitic Acid results in increased expression of FTH1 protein salvianolic acid A inhibits the reaction [Palmitic Acid results in decreased expression of FTH1 protein] [Palmitic Acid co-treated with Oleic Acid] results in decreased expression of FTH1 protein; ferric ammonium citrate promotes the reaction [Palmitic Acid results in increased expression of FTH1 protein]; ginkgolide B inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of FTH1 protein]
[Oleic Acid co-treated with Palmitic Acid] inhibits the reaction [INS1 protein inhibits the reaction [[Cyclic AMP co-treated with Dexamethasone] results in increased expression of G6PC1 protein]]; FOXO1 protein affects the reaction [[Oleic Acid co-treated with Palmitic Acid] inhibits the reaction [INS1 protein inhibits the reaction [[Cyclic AMP co-treated with Dexamethasone] results in increased expression of G6PC1 protein]]] Palmitic Acid results in decreased expression of G6PC1 mRNA Palmitic Acid results in increased expression of G6PC1 mRNA
[[Palmitic Acid co-treated with Oleic Acid] results in increased abundance of Fatty Acids, Nonesterified] which results in increased expression of GBA1 mRNA; intybin inhibits the reaction [[[Palmitic Acid co-treated with Oleic Acid] results in increased abundance of Fatty Acids, Nonesterified] which results in increased expression of GBA1 mRNA]
[GCG protein co-treated with candesartan] inhibits the reaction [Palmitic Acid results in decreased phosphorylation of FOXO1 protein]; [GCG protein co-treated with candesartan] inhibits the reaction [Palmitic Acid results in decreased phosphorylation of IRS2 protein]; GCG protein inhibits the reaction [Palmitic Acid results in decreased phosphorylation of FOXO1 protein]; GCG protein inhibits the reaction [Palmitic Acid results in decreased phosphorylation of IRS2 protein]; isosteviol inhibits the reaction [Palmitic Acid promotes the reaction [Glucose results in increased secretion of GCG protein]]; Palmitic Acid promotes the reaction [Glucose results in increased secretion of GCG protein]
Palmitic Acid results in increased expression of GCLC mRNA [Palmitic Acid co-treated with Oleic Acid] results in decreased expression of GCLC protein; Escin inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of GCLC protein]
[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of GCLM protein; Escin inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of GCLM protein]
Palmitic Acid results in increased expression of GLB1 protein [Cyclosporine co-treated with Palmitic Acid] results in increased expression of GLB1 protein
GLRX protein inhibits the reaction [[Palmitic Acid co-treated with Glucose] promotes the reaction [Glutathione binds to SIRT1 protein]]; GLRX protein inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased oxidation of and results in decreased activity of SIRT1 protein]
[Cisplatin co-treated with Palmitic Acid] results in increased expression of GPT protein; [Palmitic Acid co-treated with Oleic Acid] results in increased activity of GPT protein; ginkgolide B inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in increased activity of GPT protein]
Palmitic Acid results in decreased expression of GPX1 mRNA Palmitic Acid results in increased activity of GPX1 protein Palmitic Acid results in increased expression of GPX1 mRNA [Palmitic Acid co-treated with Arsenic] affects the expression of GPX1 mRNA; Rosiglitazone inhibits the reaction [Palmitic Acid results in decreased expression of GPX1 mRNA]
Palmitic Acid results in increased expression of GPX4 mRNA Palmitic Acid results in decreased expression of GPX4 protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [ADORA2B protein affects the reaction [Palmitic Acid results in decreased expression of and results in decreased activity of GPX4 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Palmitic Acid results in decreased expression of and results in decreased activity of GPX4 protein]; ADORA2B protein affects the reaction [Palmitic Acid results in decreased expression of and results in decreased activity of GPX4 protein]; ADORA2B protein inhibits the reaction [MYC protein inhibits the reaction [Palmitic Acid results in decreased expression of and results in decreased activity of GPX4 protein]]; ADORA2B protein promotes the reaction [Palmitic Acid results in decreased expression of and results in decreased activity of GPX4 protein]; MYC protein inhibits the reaction [Palmitic Acid results in decreased expression of and results in decreased activity of GPX4 protein]; Palmitic Acid results in decreased expression of and results in decreased activity of GPX4 protein; salvianolic acid A inhibits the reaction [Palmitic Acid results in decreased expression of GPX4 protein] [Palmitic Acid co-treated with Oleic Acid] results in decreased expression of GPX4 protein; ginkgolide B inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of GPX4 protein]; NFE2L2 protein affects the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of GPX4 protein]
Palmitic Acid inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of GSK3B protein]; Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein] Palmitic Acid results in increased phosphorylation of GSK3B protein 4-hydroxyisoleucine inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]]; CYLD protein affects the reaction [Palmitic Acid results in increased phosphorylation of GSK3B protein]; Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]; PKF115-584 inhibits the reaction [CYLD protein affects the reaction [Palmitic Acid results in increased phosphorylation of GSK3B protein]]
[[Palmitic Acid co-treated with Oleic Acid] results in increased abundance of Fatty Acids, Nonesterified] which results in decreased expression of HADHA mRNA; [[Palmitic Acid co-treated with Oleic Acid] results in increased abundance of Fatty Acids, Nonesterified] which results in decreased expression of HADHA protein; intybin inhibits the reaction [[[Palmitic Acid co-treated with Oleic Acid] results in increased abundance of Fatty Acids, Nonesterified] which results in decreased expression of HADHA mRNA]; intybin inhibits the reaction [[[Palmitic Acid co-treated with Oleic Acid] results in increased abundance of Fatty Acids, Nonesterified] which results in decreased expression of HADHA protein]; lactucin inhibits the reaction [[[Palmitic Acid co-treated with Oleic Acid] results in increased abundance of Fatty Acids, Nonesterified] which results in decreased expression of HADHA mRNA]; lactucin inhibits the reaction [[[Palmitic Acid co-treated with Oleic Acid] results in increased abundance of Fatty Acids, Nonesterified] which results in decreased expression of HADHA protein]
[Oleic Acid co-treated with Palmitic Acid] results in increased expression of HIF1A mRNA; [Oleic Acid co-treated with Palmitic Acid] results in increased expression of HIF1A protein; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of HIF1A protein; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of HIF1A protein; Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of HIF1A mRNA]; Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of HIF1A protein]; MTOR protein inhibits the reaction [Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of HIF1A mRNA]]; MTOR protein inhibits the reaction [Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of HIF1A protein]] Palmitic Acid results in increased expression of HIF1A mRNA
[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of HILPDA protein; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of HILPDA protein
Palmitic Acid results in increased expression of HMOX1 mRNA Palmitic Acid results in decreased expression of HMOX1 protein Palmitic Acid results in increased expression of HMOX1 protein [Palmitic Acid co-treated with Oleic Acid] results in decreased expression of HMOX1 protein; Escin inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of HMOX1 protein]; ginkgolide B inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of HMOX1 protein]; NFE2L2 protein affects the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of HMOX1 protein]; nuciferine inhibits the reaction [Palmitic Acid results in decreased expression of HMOX1 protein] [amlexanox co-treated with Palmitic Acid] results in increased expression of HMOX1 mRNA
[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of HSDL2 mRNA; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of HSDL2 mRNA
Palmitic Acid results in increased expression of HSPA5 mRNA [7-hydroxycoumarin co-treated with Palmitic Acid] results in increased expression of HSPA5 mRNA; [Scopoletin co-treated with Palmitic Acid] results in increased expression of HSPA5 mRNA Palmitic Acid results in increased expression of HSPA5 protein [Palmitic Acid co-treated with Oleic Acid] affects the expression of HSPA5 mRNA 4-phenylbutyric acid inhibits the reaction [Palmitic Acid results in increased expression of HSPA5 mRNA]; 4-phenylbutyric acid inhibits the reaction [Palmitic Acid results in increased expression of HSPA5 protein]; [Oleic Acid co-treated with Palmitic Acid] results in increased expression of HSPA5 protein; BACE1 protein affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of HSPA5 protein]]; MIR497 affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of HSPA5 protein]]; obeticholic acid inhibits the reaction [Palmitic Acid results in increased expression of HSPA5 protein]; SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of HSPA5 protein]; trigonelline inhibits the reaction [Palmitic Acid results in increased expression of HSPA5 protein] Palmitic Acid results in increased expression of HSPA5 mRNA; Palmitic Acid results in increased expression of HSPA5 protein
Palmitic Acid results in increased expression of ICAM1 protein geraniol inhibits the reaction [Palmitic Acid results in increased expression of ICAM1 protein]
Palmitic Acid results in decreased expression of ID3 mRNA [Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ID3 mRNA; [sodium arsenite co-treated with Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ID3 mRNA; Palmitic Acid inhibits the reaction [sodium arsenite results in increased expression of ID3 mRNA]; sodium arsenite inhibits the reaction [Palmitic Acid results in decreased expression of ID3 mRNA]; sodium arsenite promotes the reaction [[Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ID3 mRNA]
Palmitic Acid results in increased expression of IFNB1 mRNA amlexanox inhibits the reaction [Palmitic Acid results in increased expression of IFNB1 mRNA]; pitavastatin inhibits the reaction [Palmitic Acid results in increased expression of IFNB1 mRNA]; Pravastatin inhibits the reaction [Palmitic Acid results in increased expression of IFNB1 mRNA]
Palmitic Acid results in increased phosphorylation of IKBKE protein amlexanox inhibits the reaction [Palmitic Acid results in increased phosphorylation of IKBKE protein]
Palmitic Acid affects the expression of IL10 mRNA Palmitic Acid results in decreased expression of IL10 protein amlexanox affects the reaction [Palmitic Acid affects the expression of IL10 mRNA]; amlexanox inhibits the reaction [Palmitic Acid results in decreased expression of IL10 protein]; mifobate affects the reaction [Palmitic Acid affects the expression of IL10 mRNA]
Lead promotes the reaction [Palmitic Acid results in increased cleavage of IL18 protein]; Lead promotes the reaction [Palmitic Acid results in increased expression of IL18 protein]; Palmitic Acid promotes the reaction [Lead results in increased cleavage of IL18 protein]; Palmitic Acid results in increased expression of and results in increased secretion of IL18 protein; SRT1720 inhibits the reaction [Lead promotes the reaction [Palmitic Acid results in increased expression of IL18 protein]]; STING1 protein promotes the reaction [Palmitic Acid results in increased secretion of IL18 protein] Palmitic Acid results in increased expression of IL18 mRNA; Palmitic Acid results in increased expression of IL18 protein
[Palmitic Acid co-treated with Arsenic] results in increased expression of IL1A mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of IL1A mRNA; [Palmitic Acid co-treated with Oleic Acid] affects the expression of IL1A mRNA
[Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL1B protein; [Palmitic Acid co-treated with Sincalide] results in increased expression of IL1B mRNA; [Palmitic Acid co-treated with Sincalide] results in increased expression of IL1B protein; Palmitic Acid results in increased expression of and results in increased secretion of IL1B protein; quercetin 3-O-glucuronide inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL1B protein]; Quercetin inhibits the reaction [[Sincalide co-treated with Palmitic Acid] results in increased expression of IL1B protein]; STING1 protein promotes the reaction [Palmitic Acid results in increased expression of and results in increased secretion of IL1B protein] Palmitic Acid results in increased expression of IL1B mRNA (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; [Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL1B mRNA; [Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL1B protein; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of PPARG mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of PPARA mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CCL2 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CCL5 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CXCL5 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of NFKB1 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of PPARD mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of RELA mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein; Bezafibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Bezafibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Bezafibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Bezafibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; Coptidis rhizoma extract inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL1B mRNA]; Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL1B protein]; Diosgenin inhibits the reaction [MTOR protein promotes the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL1B protein]]; Fenofibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Fenofibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Fenofibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; GW 506033X inhibits the reaction [Palmitic Acid results in increased expression of IL1B mRNA]; GW 506033X inhibits the reaction [Palmitic Acid results in increased expression of IL1B protein]; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; lanifibranor inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; lanifibranor inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; lanifibranor inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; MTOR protein inhibits the reaction [Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL1B protein]]; MTOR protein promotes the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL1B protein]; Pioglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Pioglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA]; Rosiglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Rosiglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Rosiglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; saroglitazar inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; saroglitazar inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; saroglitazar inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein] Palmitic Acid results in increased expression of IL1B mRNA; Palmitic Acid results in increased expression of IL1B protein Palmitic Acid results in increased secretion of IL1B protein 4-(4-fluorophenyl)sulfonyl-5-methylthio-2-phenyloxazole analog inhibits the reaction [[Palmitic Acid co-treated with Lipopolysaccharides] results in increased secretion of IL1B protein]; 4-(4-fluorophenyl)sulfonyl-5-methylthio-2-phenyloxazole inhibits the reaction [[Palmitic Acid co-treated with Lipopolysaccharides] results in increased expression of and results in increased cleavage of IL1B protein]; 4-(4-fluorophenyl)sulfonyl-5-methylthio-2-phenyloxazole inhibits the reaction [[Palmitic Acid co-treated with Lipopolysaccharides] results in increased secretion of IL1B protein]; [Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL1B protein; [Palmitic Acid co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased secretion of IL1B protein; [Palmitic Acid co-treated with Lipopolysaccharides] results in increased expression of and results in increased cleavage of IL1B protein; [Palmitic Acid co-treated with Lipopolysaccharides] results in increased secretion of IL1B protein; amlexanox inhibits the reaction [Palmitic Acid results in increased expression of IL1B mRNA]; amlexanox inhibits the reaction [Palmitic Acid results in increased secretion of IL1B protein]; BACE1 protein affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL1B protein]]; baicalin inhibits the reaction [Palmitic Acid results in increased secretion of IL1B protein]; CA 074 methyl ester inhibits the reaction [Palmitic Acid results in increased expression of IL1B protein]; MIR497 affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL1B protein]]; NLRP3 inhibits the reaction [Palmitic Acid results in increased expression of IL1B protein]; Silymarin inhibits the reaction [[Palmitic Acid co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased secretion of IL1B protein]; SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL1B protein]; ursodoxicoltaurine inhibits the reaction [Palmitic Acid results in increased secretion of IL1B protein]
Palmitic Acid results in increased expression of IL6 mRNA Palmitic Acid results in increased expression of IL6 mRNA; Palmitic Acid results in increased expression of IL6 protein Palmitic Acid affects the expression of IL6 mRNA Palmitic Acid results in increased secretion of IL6 protein 3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate promotes the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased secretion of IL6 protein]; [Oleic Acid co-treated with Palmitic Acid] results in increased secretion of IL6 protein; [Palmitic Acid co-treated with Sincalide] results in increased expression of IL6 mRNA; [Palmitic Acid co-treated with Sincalide] results in increased expression of IL6 protein; Acetylcysteine inhibits the reaction [Palmitic Acid results in increased expression of IL6 mRNA]; Adenosine Triphosphate promotes the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased secretion of IL6 protein]; AICA ribonucleotide inhibits the reaction [Palmitic Acid results in increased expression of IL6 mRNA]; coomassie Brilliant Blue inhibits the reaction [3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate promotes the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased secretion of IL6 protein]]; coomassie Brilliant Blue inhibits the reaction [Adenosine Triphosphate promotes the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased secretion of IL6 protein]]; imoxin inhibits the reaction [Palmitic Acid results in increased expression of IL6 mRNA]; Metformin inhibits the reaction [Palmitic Acid results in increased expression of IL6 mRNA]; parthenolide inhibits the reaction [Palmitic Acid results in increased expression of IL6 mRNA]; pyrazolanthrone inhibits the reaction [Palmitic Acid results in increased expression of IL6 mRNA]; Quercetin inhibits the reaction [[Sincalide co-treated with Palmitic Acid] results in increased expression of IL6 protein]; Resveratrol inhibits the reaction [3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate promotes the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased secretion of IL6 protein]]; Resveratrol inhibits the reaction [Adenosine Triphosphate promotes the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased secretion of IL6 protein]]; Resveratrol inhibits the reaction [Palmitic Acid results in increased expression of IL6 mRNA]; Salicylic Acid inhibits the reaction [Palmitic Acid results in increased expression of IL6 mRNA]; SB 203580 inhibits the reaction [3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate promotes the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased secretion of IL6 protein]]; SB 203580 inhibits the reaction [Adenosine Triphosphate promotes the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased secretion of IL6 protein]] 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Palmitic Acid results in increased secretion of IL6 protein]; [Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL6 mRNA; [Palmitic Acid co-treated with Arsenic] affects the expression of IL6 mRNA; [Palmitic Acid co-treated with Thioacetamide] results in increased secretion of IL6 protein; Coptidis rhizoma extract inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL6 mRNA]; Cyclosporine inhibits the reaction [Palmitic Acid results in increased expression of IL6 protein]; Huangqin-Tang inhibits the reaction [Palmitic Acid results in increased expression of IL6 mRNA]; Huangqin-Tang inhibits the reaction [Palmitic Acid results in increased secretion of IL6 protein]; tin protoporphyrin IX inhibits the reaction [3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Palmitic Acid results in increased secretion of IL6 protein]] [Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL6 protein; [Palmitic Acid co-treated with Ethanol] results in increased expression of IL6 mRNA; [Palmitic Acid co-treated with Ethanol] results in increased secretion of IL6 protein; amlexanox inhibits the reaction [Palmitic Acid results in increased expression of IL6 mRNA]; amlexanox inhibits the reaction [Palmitic Acid results in increased secretion of IL6 protein]; BACE1 protein affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL6 protein]]; baicalin inhibits the reaction [Palmitic Acid results in increased secretion of IL6 protein]; MIR497 affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL6 protein]]; pitavastatin inhibits the reaction [Palmitic Acid results in increased expression of IL6 mRNA]; Pravastatin inhibits the reaction [Palmitic Acid results in increased expression of IL6 mRNA]; SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL6 protein]; ursodoxicoltaurine inhibits the reaction [Palmitic Acid results in increased secretion of IL6 protein]
[Oleic Acid co-treated with Palmitic Acid] inhibits the reaction [INS1 protein inhibits the reaction [[Cyclic AMP co-treated with Dexamethasone] results in increased expression of G6PC1 protein]]; [Oleic Acid co-treated with Palmitic Acid] inhibits the reaction [INS1 protein inhibits the reaction [[Cyclic AMP co-treated with Dexamethasone] results in increased expression of PEPCK protein]]; [Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CEBPA mRNA; [Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of FOXL2 mRNA; [Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of FOXO1 mRNA; [Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of LEP mRNA; [Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of NFYC mRNA; [Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of SIRT1 mRNA; [Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of TFAP2B mRNA; [Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased secretion of LEP protein; [Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ID3 mRNA; [sodium arsenite co-treated with Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of ADIPOQ mRNA; [sodium arsenite co-treated with Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of ADIPOQ protein; [sodium arsenite co-treated with Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of and results in decreased secretion of LEP protein; [sodium arsenite co-treated with Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of FOXO1 mRNA; [sodium arsenite co-treated with Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of LEP mRNA; [sodium arsenite co-treated with Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of NFYC mRNA; [sodium arsenite co-treated with Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of PPARG mRNA; [sodium arsenite co-treated with Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ID3 mRNA; FFAR1 protein affects the reaction [Palmitic Acid promotes the reaction [Glucose results in increased secretion of INS1 protein]]; FOXO1 protein affects the reaction [[Oleic Acid co-treated with Palmitic Acid] inhibits the reaction [INS1 protein inhibits the reaction [[Cyclic AMP co-treated with Dexamethasone] results in increased expression of G6PC1 protein]]]; FOXO1 protein affects the reaction [[Oleic Acid co-treated with Palmitic Acid] inhibits the reaction [INS1 protein inhibits the reaction [[Cyclic AMP co-treated with Dexamethasone] results in increased expression of PEPCK protein]]]; FR900359 inhibits the reaction [Palmitic Acid promotes the reaction [Glucose results in increased secretion of INS1 protein]]; GNAQ protein affects the reaction [Palmitic Acid promotes the reaction [Glucose results in increased secretion of INS1 protein]]; isosteviol inhibits the reaction [Palmitic Acid inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Palmitic Acid inhibits the reaction [[sodium arsenite co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of TFAP2B mRNA]; Palmitic Acid inhibits the reaction [[sodium arsenite co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased secretion of ADIPOQ protein]; Palmitic Acid inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Palmitic Acid promotes the reaction [[sodium arsenite co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CEBPA mRNA]; Palmitic Acid promotes the reaction [[sodium arsenite co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of FOXL2 mRNA]; Palmitic Acid promotes the reaction [[sodium arsenite co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of SIRT1 mRNA]; Palmitic Acid promotes the reaction [Glucose results in increased secretion of INS1 protein]; sodium arsenite promotes the reaction [[Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CEBPA mRNA]; sodium arsenite promotes the reaction [[Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of FOXL2 mRNA]; sodium arsenite promotes the reaction [[Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of LEP mRNA]; sodium arsenite promotes the reaction [[Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of SIRT1 mRNA]; sodium arsenite promotes the reaction [[Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ID3 mRNA]; YM-254890 inhibits the reaction [Palmitic Acid promotes the reaction [Glucose results in increased secretion of INS1 protein]] Palmitic Acid results in decreased expression of INS1 protein 4-phenylbutyric acid inhibits the reaction [Palmitic Acid inhibits the reaction [INS1 protein results in increased uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose]]; bafilomycin A1 promotes the reaction [Palmitic Acid inhibits the reaction [INS1 protein results in increased uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose]]; ferric ammonium citrate inhibits the reaction [Palmitic Acid inhibits the reaction [INS1 protein results in increased uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose]]; NCOA4 protein affects the reaction [Palmitic Acid inhibits the reaction [INS1 protein results in increased uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose]]; NCOA4 protein inhibits the reaction [Palmitic Acid inhibits the reaction [INS1 protein results in increased uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose]]; Palmitic Acid inhibits the reaction [INS1 protein results in increased uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose]; Sirolimus inhibits the reaction [Palmitic Acid inhibits the reaction [INS1 protein results in increased uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose]]; STF 083010 inhibits the reaction [Palmitic Acid inhibits the reaction [INS1 protein results in increased uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose]]; Thapsigargin inhibits the reaction [ferric ammonium citrate inhibits the reaction [Palmitic Acid inhibits the reaction [INS1 protein results in increased uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose]]]; Thapsigargin inhibits the reaction [NCOA4 protein inhibits the reaction [Palmitic Acid inhibits the reaction [INS1 protein results in increased uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose]]] Exenatide inhibits the reaction [Palmitic Acid inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Palmitic Acid inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Palmitic Acid inhibits the reaction [INS1 protein results in increased phosphorylation of AKT1 protein]; Palmitic Acid inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose]; Palmitic Acid promotes the reaction [Glucose results in increased secretion of INS1 protein]; Quercetin inhibits the reaction [Palmitic Acid inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose]] Palmitic Acid results in increased secretion of INS1 protein
(R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; 2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Palmitic Acid results in decreased expression of INS protein]]; 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of IRS1 protein]]; 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of NOS3 protein]]; 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased uptake of Deoxyglucose]]; 4-phenylbutyric acid inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of AKT1 protein]]; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of PPARG mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of PPARA mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CCL2 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CCL5 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CXCL5 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of NFKB1 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of PPARD mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of RELA mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein; [Palmitic Acid co-treated with INS protein] affects the phosphorylation of IRS1 protein; Bezafibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Bezafibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Bezafibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Bezafibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; Fenofibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Fenofibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Fenofibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; ferric ammonium citrate inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of AKT1 protein]]; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; lanifibranor inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; lanifibranor inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; lanifibranor inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of AKT1 protein]; Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of FOXO1 protein]; Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]; Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of IRS1 protein]; Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of NOS3 protein]; Palmitic Acid inhibits the reaction [INS protein results in increased uptake of Deoxyglucose]; Pioglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Pioglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA]; Rosiglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Rosiglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Rosiglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; Rosiglitazone inhibits the reaction [Palmitic Acid results in decreased expression of INS protein]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; saroglitazar inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; saroglitazar inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; saroglitazar inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; STF 083010 inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of AKT1 protein]]; tin protoporphyrin IX inhibits the reaction [3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of IRS1 protein]]]; tin protoporphyrin IX inhibits the reaction [3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of NOS3 protein]]]; tin protoporphyrin IX inhibits the reaction [3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased uptake of Deoxyglucose]]] 4-hydroxyisoleucine inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein affects the localization of SLC2A4 protein]]; 4-hydroxyisoleucine inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of AKT1 protein]]; 4-hydroxyisoleucine inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]]; 4-hydroxyisoleucine inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]]; 4-hydroxyisoleucine inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of and results in increased activity of MAPK8 protein]]; 4-hydroxyisoleucine inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of and results in increased activity of MAPK9 protein]]; 4-hydroxyisoleucine inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]]; 4-hydroxyisoleucine inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of IRS1 protein]]; 4-hydroxyisoleucine inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of TBC1D4 protein]]; [Palmitic Acid co-treated with sodium bisulfide] inhibits the reaction [INS protein results in increased phosphorylation of RPS6KB1 protein]; Palmitic Acid inhibits the reaction [INS protein affects the localization of SLC2A4 protein]; Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of AKT1 protein]; Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of and results in increased activity of MAPK8 protein]; Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of and results in increased activity of MAPK9 protein]; Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]; Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of IRS1 protein]; Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of TBC1D4 protein]; Palmitic Acid inhibits the reaction [INS protein results in increased uptake of Glucose] [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased abundance of Palmitic Acid analog; [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased abundance of Palmitic Acid analog; Palmitic Acid inhibits the reaction [Glucose results in increased expression of INS2 mRNA alternative form]
Palmitic Acid results in increased phosphorylation of IRF3 protein amlexanox inhibits the reaction [Palmitic Acid results in increased phosphorylation of IRF3 protein]; pitavastatin inhibits the reaction [Palmitic Acid results in increased phosphorylation of IRF3 protein]; Pravastatin inhibits the reaction [Palmitic Acid results in increased phosphorylation of IRF3 protein]
3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of IRS1 protein]]; [Palmitic Acid co-treated with INS protein] affects the phosphorylation of IRS1 protein; Palmitic Acid inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of IRS1 protein]; Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of IRS1 protein]; tin protoporphyrin IX inhibits the reaction [3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of IRS1 protein]]] Palmitic Acid results in increased phosphorylation of IRS1 protein 4-hydroxyisoleucine inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of IRS1 protein]]; Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of IRS1 protein]
[GCG protein co-treated with candesartan] inhibits the reaction [Palmitic Acid results in decreased phosphorylation of IRS2 protein]; candesartan inhibits the reaction [Palmitic Acid results in decreased phosphorylation of IRS2 protein]; GCG protein inhibits the reaction [Palmitic Acid results in decreased phosphorylation of IRS2 protein] [Palmitic Acid co-treated with Arsenic] results in increased expression of IRS2 mRNA
[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of JAK1 protein; [Palmitic Acid co-treated with Oleic Acid] affects the expression of JAK1 mRNA; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of JAK1 protein
[Palmitic Acid co-treated with Oleic Acid] results in increased expression of KEAP1 protein; Escin inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in increased expression of KEAP1 protein]
Palmitic Acid results in decreased expression of KLF15 protein CXCL12 protein inhibits the reaction [Palmitic Acid results in decreased expression of KLF15 protein]; CXCR7 protein promotes the reaction [CXCL12 protein inhibits the reaction [Palmitic Acid results in decreased expression of KLF15 protein]]; KLF15 protein promotes the reaction [CXCL12 protein inhibits the reaction [Palmitic Acid results in increased expression of CCN2 protein]]; MAPK11 protein promotes the reaction [CXCL12 protein inhibits the reaction [Palmitic Acid results in decreased expression of KLF15 protein]]
[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of LAMB1 mRNA; [Palmitic Acid co-treated with Oleic Acid] affects the expression of LAMB1 mRNA
[Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of LEP mRNA; [Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased secretion of LEP protein; [Palmitic Acid co-treated with sodium arsenite] results in decreased expression of LEP mRNA; [Palmitic Acid co-treated with sodium arsenite] results in decreased expression of LEP protein; [sodium arsenite co-treated with Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of and results in decreased secretion of LEP protein; [sodium arsenite co-treated with Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of LEP mRNA; Palmitic Acid inhibits the reaction [sodium arsenite results in decreased secretion of LEP protein]; sodium arsenite promotes the reaction [[Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of LEP mRNA] Palmitic Acid results in decreased expression of LEP mRNA; Palmitic Acid results in decreased expression of LEP protein
Palmitic Acid results in increased expression of LGALS3 protein Cyclosporine inhibits the reaction [Palmitic Acid results in increased expression of LGALS3 protein]
[LIPC gene mutant form co-treated with LIPG gene mutant form] results in decreased abundance of Palmitic Acid Palmitic Acid results in decreased expression of LIPC mRNA LIPC gene mutant form results in decreased abundance of Palmitic Acid
dorsomorphin inhibits the reaction [nuciferine inhibits the reaction [Palmitic Acid results in decreased expression of LIPE mRNA]]; nuciferine inhibits the reaction [Palmitic Acid results in decreased expression of LIPE mRNA]; nuciferine inhibits the reaction [Palmitic Acid results in decreased expression of LIPE protein] Palmitic Acid results in decreased expression of LIPE mRNA; Palmitic Acid results in decreased expression of LIPE protein
Palmitic Acid results in increased expression of LONP1 protein [Cyclosporine co-treated with Palmitic Acid] results in increased expression of LONP1 protein
Palmitic Acid affects the localization of MAP1LC3B protein Palmitic Acid results in increased lipidation of MAP1LC3B protein Palmitic Acid results in increased expression of MAP1LC3B protein modified form C1QTNF9 protein promotes the reaction [Palmitic Acid results in increased expression of MAP1LC3B protein modified form] [Palmitic Acid co-treated with Oleic Acid] affects the expression of MAP1LC3B mRNA; [Palmitic Acid co-treated with Oleic Acid] results in increased lipidation of MAP1LC3B protein
carnosol inhibits the reaction [Palmitic Acid results in increased expression of MAP3K5 protein]; PRDX3 protein inhibits the reaction [Palmitic Acid results in increased expression of MAP3K5 protein]; PRDX3 protein promotes the reaction [carnosol inhibits the reaction [Palmitic Acid results in increased expression of MAP3K5 protein]] Palmitic Acid results in decreased expression of MAP3K5 mRNA
4-hydroxyisoleucine inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]]; 7-hydroxycoumarin inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK1 protein]; acetovanillone inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK1 protein]; CYBA mutant form inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK1 protein]; Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Scopoletin inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK1 protein]; U 0126 inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK1 protein] Palmitic Acid results in decreased expression of MAPK1 mRNA Quercetin inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK1 protein] Docosahexaenoic Acids inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK1 protein]
MAPK11 protein promotes the reaction [CXCL12 protein inhibits the reaction [Palmitic Acid results in decreased expression of KLF15 protein]]; MAPK11 protein promotes the reaction [CXCL12 protein inhibits the reaction [Palmitic Acid results in increased expression of CCN2 protein]]
[Palmitic Acid co-treated with Arsenic] results in increased expression of MAPK14 mRNA; Capsaicin inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK14 protein]
4-hydroxyisoleucine inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]]; 7-hydroxycoumarin inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK3 protein]; acetovanillone inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK3 protein]; CYBA mutant form inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK3 protein]; Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Scopoletin inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK3 protein]; U 0126 inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK3 protein] Quercetin inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK3 protein] Docosahexaenoic Acids inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK3 protein]
Capsaicin inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK8 protein] Palmitic Acid results in increased expression of MAPK8 mRNA 4-hydroxyisoleucine inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of and results in increased activity of MAPK8 protein]]; 7-hydroxycoumarin inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [Palmitic Acid results in increased expression of MAPK8 mRNA]; imoxin inhibits the reaction [Palmitic Acid results in increased expression of and results in increased phosphorylation of MAPK8 protein]; imoxin inhibits the reaction [Palmitic Acid results in increased expression of MAPK8 mRNA]; Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of and results in increased activity of MAPK8 protein]; Palmitic Acid results in increased expression of and results in increased phosphorylation of MAPK8 protein; parthenolide inhibits the reaction [Palmitic Acid results in increased expression of MAPK8 mRNA]; pyrazolanthrone inhibits the reaction [Palmitic Acid results in increased expression of MAPK8 mRNA]; pyrazolanthrone inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK8 protein]; Scopoletin inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK8 protein] carnosol inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK8 protein]; Chromium inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK8 protein]; PRDX3 protein inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK8 protein]; PRDX3 protein promotes the reaction [carnosol inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK8 protein]]
Capsaicin inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK9 protein] Palmitic Acid results in decreased expression of MAPK9 mRNA 4-hydroxyisoleucine inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of and results in increased activity of MAPK9 protein]]; Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of and results in increased activity of MAPK9 protein] carnosol inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK9 protein]; Chromium inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK9 protein]; PRDX3 protein inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK9 protein]; PRDX3 protein promotes the reaction [carnosol inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK9 protein]]
3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in increased expression of MFF mRNA]; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of MFF mRNA
3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of MFN1 mRNA]; [Palmitic Acid co-treated with Oleic Acid] results in decreased expression of MFN1 mRNA
[Fructose co-treated with Palmitic Acid] results in decreased expression of MFN2 protein; Fenofibrate inhibits the reaction [[Fructose co-treated with Palmitic Acid] results in decreased expression of MFN2 protein] carnosol inhibits the reaction [Palmitic Acid results in decreased expression of MFN2 protein]; PRDX3 protein inhibits the reaction [Palmitic Acid results in decreased expression of MFN2 protein]; PRDX3 protein promotes the reaction [carnosol inhibits the reaction [Palmitic Acid results in decreased expression of MFN2 protein]]
[Oleic Acid co-treated with Palmitic Acid] affects the reaction [Chlorpyrifos results in decreased activity of MGLL protein] Palmitic Acid results in decreased expression of MGLL mRNA
Palmitic Acid results in increased expression of MIR141 mRNA 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in decreased expression of BCL2 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in increased expression of BAX protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in increased expression of CASP3 protein modified form]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in increased expression of CASP9 protein modified form]]; [Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in decreased expression of BCL2 protein]; [Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in increased expression of BAX protein]; [Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in increased expression of CASP3 protein modified form]; [Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in increased expression of CASP9 protein modified form]; MIR141 mRNA promotes the reaction [Palmitic Acid results in decreased expression of BCL2 protein]; MIR141 mRNA promotes the reaction [Palmitic Acid results in decreased expression of NOTCH1 protein modified form]; MIR141 mRNA promotes the reaction [Palmitic Acid results in decreased expression of NOTCH1 protein]; MIR141 mRNA promotes the reaction [Palmitic Acid results in decreased expression of PSEN1 mRNA]; MIR141 mRNA promotes the reaction [Palmitic Acid results in decreased expression of PSEN1 protein]; MIR141 mRNA promotes the reaction [Palmitic Acid results in increased expression of BAX protein]; MIR141 mRNA promotes the reaction [Palmitic Acid results in increased expression of CASP3 protein modified form]; MIR141 mRNA promotes the reaction [Palmitic Acid results in increased expression of CASP9 protein modified form]; MIR141 mRNA promotes the reaction [Palmitic Acid results in increased expression of PTEN protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [[Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in decreased expression of BCL2 protein]]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [[Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in increased expression of BAX protein]]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [[Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in increased expression of CASP3 protein modified form]]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [[Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in increased expression of CASP9 protein modified form]]
[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of MIR497 mRNA; MIR497 affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of BACE1 protein]]; MIR497 affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of DDIT3 protein]]; MIR497 affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of HSPA5 protein]]; MIR497 affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL1B protein]]; MIR497 affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL6 protein]]; MIR497 affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of TNF protein]]; SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of MIR497 mRNA]
[Oleic Acid co-treated with Palmitic Acid] results in increased expression of MMP9 protein; Coptidis rhizoma extract inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of MMP9 protein]
[Oleic Acid co-treated with Palmitic Acid] inhibits the reaction [Ethanol results in increased expression of MT1 mRNA]; [Oleic Acid co-treated with Palmitic Acid] results in increased expression of MT1 mRNA; Ethanol inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of MT1 mRNA]
Palmitic Acid results in decreased expression of MT2A mRNA [Palmitic Acid co-treated with Arsenic] results in increased expression of MT2A mRNA [Oleic Acid co-treated with Palmitic Acid] results in increased expression of MT2A mRNA
[Oleic Acid co-treated with Palmitic Acid] results in increased expression of MTOR mRNA; [Oleic Acid co-treated with Palmitic Acid] results in increased phosphorylation of MTOR protein; Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of MTOR mRNA]; Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased phosphorylation of MTOR protein]; Diosgenin inhibits the reaction [MTOR protein promotes the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL1B protein]]; MTOR protein inhibits the reaction [Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of FASN mRNA]]; MTOR protein inhibits the reaction [Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of FASN protein]]; MTOR protein inhibits the reaction [Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of HIF1A mRNA]]; MTOR protein inhibits the reaction [Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of HIF1A protein]]; MTOR protein inhibits the reaction [Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL1B protein]]; MTOR protein inhibits the reaction [Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of RELA mRNA]]; MTOR protein inhibits the reaction [Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of RELA protein]]; MTOR protein inhibits the reaction [Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of VEGFA mRNA]]; MTOR protein inhibits the reaction [Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of VEGFA protein]]; MTOR protein promotes the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL1B protein]; sarpogrelate inhibits the reaction [Palmitic Acid results in increased activity of MTOR protein]; Sirolimus inhibits the reaction [Palmitic Acid results in increased activity of MTOR protein] trigonelline inhibits the reaction [Palmitic Acid results in increased phosphorylation of MTOR protein]
[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of MTTP mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of MTTP mRNA; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of MTTP mRNA; isosilybin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of MTTP mRNA] Palmitic Acid results in decreased expression of MTTP mRNA
ADORA2B protein inhibits the reaction [MYC protein inhibits the reaction [Palmitic Acid results in decreased expression of and results in decreased activity of GPX4 protein]]; ADORA2B protein inhibits the reaction [MYC protein inhibits the reaction [Palmitic Acid results in decreased expression of SLC7A11 protein]]; ADORA2B protein inhibits the reaction [MYC protein inhibits the reaction [Palmitic Acid results in decreased phosphorylation of AKT1 protein]]; ADORA2B protein inhibits the reaction [MYC protein inhibits the reaction [Palmitic Acid results in decreased phosphorylation of PIK3CG protein]]; MYC protein inhibits the reaction [Palmitic Acid results in decreased expression of and results in decreased activity of GPX4 protein]; MYC protein inhibits the reaction [Palmitic Acid results in decreased expression of SLC7A11 protein]; MYC protein inhibits the reaction [Palmitic Acid results in decreased phosphorylation of AKT1 protein]; MYC protein inhibits the reaction [Palmitic Acid results in decreased phosphorylation of PIK3CG protein]; MYC protein inhibits the reaction [Palmitic Acid results in increased expression of ADORA2B mRNA]; MYC protein inhibits the reaction [Palmitic Acid results in increased expression of ADORA2B protein] Palmitic Acid results in decreased expression of MYC mRNA; Palmitic Acid results in decreased expression of MYC protein
Palmitic Acid results in increased expression of MYD88 protein nuciferine inhibits the reaction [Palmitic Acid results in increased expression of MYD88 protein]
acetovanillone inhibits the reaction [Palmitic Acid results in increased expression of NCF1 mRNA]; U 0126 inhibits the reaction [Palmitic Acid results in increased expression of NCF1 mRNA]
Palmitic Acid results in increased expression of NCF2 mRNA acetovanillone inhibits the reaction [Palmitic Acid results in increased expression of NCF2 mRNA]; U 0126 inhibits the reaction [Palmitic Acid results in increased expression of NCF2 mRNA]
Deferoxamine promotes the reaction [Palmitic Acid results in increased expression of NCOA4 protein]; ferric ammonium citrate inhibits the reaction [Palmitic Acid results in increased expression of NCOA4 protein]; NCOA4 protein affects the reaction [Palmitic Acid inhibits the reaction [INS1 protein results in increased uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose]]; NCOA4 protein inhibits the reaction [Palmitic Acid inhibits the reaction [INS1 protein results in increased uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose]]; Thapsigargin inhibits the reaction [NCOA4 protein inhibits the reaction [Palmitic Acid inhibits the reaction [INS1 protein results in increased uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose]]]; Wortmannin inhibits the reaction [Palmitic Acid results in increased expression of NCOA4 protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [ADORA2B protein affects the reaction [Palmitic Acid results in decreased expression of NFE2L2 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Palmitic Acid results in decreased expression of NFE2L2 protein]; [Oleic Acid co-treated with Palmitic Acid] results in decreased expression of NFE2L2 mRNA; ADORA2B protein affects the reaction [Palmitic Acid results in decreased expression of NFE2L2 protein]; FOXO1 protein affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of NFE2L2 mRNA] Palmitic Acid results in decreased expression of NFE2L2 mRNA; Palmitic Acid results in decreased expression of NFE2L2 protein [Fructose co-treated with Palmitic Acid] results in decreased expression of NFE2L2 protein; [Palmitic Acid co-treated with Oleic Acid] results in decreased expression of and affects the localization of NFE2L2 protein; [Palmitic Acid co-treated with Oleic Acid] results in decreased expression of NFE2L2 protein; Escin inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of NFE2L2 protein]; Fenofibrate inhibits the reaction [[Fructose co-treated with Palmitic Acid] results in decreased expression of NFE2L2 protein]; ginkgolide B inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of and affects the localization of NFE2L2 protein]; neohesperidin inhibits the reaction [Palmitic Acid results in decreased expression of NFE2L2 mRNA]; NFE2L2 protein affects the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of GPX4 protein]; NFE2L2 protein affects the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of HMOX1 protein]; nuciferine inhibits the reaction [Palmitic Acid results in decreased expression of NFE2L2 protein]; SR18292 inhibits the reaction [neohesperidin inhibits the reaction [Palmitic Acid results in decreased expression of NFE2L2 mRNA]]
Acetylcysteine inhibits the reaction [Palmitic Acid results in increased expression of NFKB1 mRNA]; imoxin inhibits the reaction [Palmitic Acid results in increased expression of NFKB1 mRNA]; parthenolide inhibits the reaction [Palmitic Acid results in increased expression of NFKB1 mRNA]; pyrazolanthrone inhibits the reaction [Palmitic Acid results in increased expression of NFKB1 mRNA] Palmitic Acid results in decreased expression of NFKB1 mRNA [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of NFKB1 mRNA
Palmitic Acid results in increased degradation of NFKBIA protein nuciferine inhibits the reaction [Palmitic Acid results in increased phosphorylation of NFKBIA protein] Quercetin inhibits the reaction [Palmitic Acid results in decreased phosphorylation of NFKBIA protein] [Palmitic Acid co-treated with Sincalide] results in increased degradation of NFKBIA protein; Quercetin inhibits the reaction [[Sincalide co-treated with Palmitic Acid] results in increased degradation of NFKBIA protein]
[Palmitic Acid co-treated with Sincalide] results in increased degradation of NFKBIB protein; Quercetin inhibits the reaction [[Sincalide co-treated with Palmitic Acid] results in increased degradation of NFKBIB protein]
[Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of NFYC mRNA; [sodium arsenite co-treated with Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of NFYC mRNA
baicalin inhibits the reaction [Palmitic Acid results in increased expression of NLRP3 protein]; NLRP3 inhibits the reaction [Palmitic Acid results in increased cleavage of CASP1 protein]; NLRP3 inhibits the reaction [Palmitic Acid results in increased expression of IL1B protein]; ursodoxicoltaurine inhibits the reaction [Palmitic Acid results in increased expression of NLRP3 protein] Acetylcysteine inhibits the reaction [Palmitic Acid results in increased expression of NLRP3 mRNA]; imoxin inhibits the reaction [Palmitic Acid results in increased expression of NLRP3 mRNA]; Lead promotes the reaction [Palmitic Acid results in increased expression of NLRP3 protein]; Palmitic Acid promotes the reaction [Lead results in increased expression of NLRP3 protein]; parthenolide inhibits the reaction [Palmitic Acid results in increased expression of NLRP3 mRNA]; pyrazolanthrone inhibits the reaction [Palmitic Acid results in increased expression of NLRP3 mRNA]; SRT1720 inhibits the reaction [Lead promotes the reaction [Palmitic Acid results in increased expression of NLRP3 protein]]; SRT1720 inhibits the reaction [Palmitic Acid promotes the reaction [Lead results in increased expression of NLRP3 protein]]; SRT1720 inhibits the reaction [Palmitic Acid results in increased expression of NLRP3 protein] Palmitic Acid results in increased expression of NLRP3 mRNA; Palmitic Acid results in increased expression of NLRP3 protein
Palmitic Acid results in increased expression of NOS2 mRNA Acetylcysteine inhibits the reaction [Palmitic Acid results in increased expression of NOS2 mRNA]; AICA ribonucleotide inhibits the reaction [Palmitic Acid results in increased expression of NOS2 mRNA]; imoxin inhibits the reaction [Palmitic Acid results in increased expression of NOS2 mRNA]; Metformin inhibits the reaction [Palmitic Acid results in increased expression of NOS2 mRNA]; parthenolide inhibits the reaction [Palmitic Acid results in increased expression of NOS2 mRNA]; pyrazolanthrone inhibits the reaction [Palmitic Acid results in increased expression of NOS2 mRNA]; Quercetin inhibits the reaction [Palmitic Acid results in increased expression of NOS2 mRNA]; Resveratrol inhibits the reaction [Palmitic Acid results in increased expression of NOS2 mRNA]; Salicylic Acid inhibits the reaction [Palmitic Acid results in increased expression of NOS2 mRNA] amlexanox inhibits the reaction [Palmitic Acid results in increased expression of NOS2 mRNA]; amlexanox inhibits the reaction [Palmitic Acid results in increased expression of NOS2 protein]; mifobate inhibits the reaction [amlexanox inhibits the reaction [Palmitic Acid results in increased expression of NOS2 mRNA]]; pitavastatin inhibits the reaction [Palmitic Acid results in increased expression of NOS2 mRNA]; Pravastatin inhibits the reaction [Palmitic Acid results in increased expression of NOS2 mRNA] Palmitic Acid results in increased expression of NOS2 mRNA; Palmitic Acid results in increased expression of NOS2 protein rosiglitazone inhibits the reaction [Palmitic Acid results in increased expression of NOS2 mRNA]
AICA ribonucleotide inhibits the reaction [Palmitic Acid inhibits the reaction [Acetylcholine results in increased phosphorylation of NOS3 protein]]; Metformin inhibits the reaction [Palmitic Acid inhibits the reaction [Acetylcholine results in increased phosphorylation of NOS3 protein]]; Palmitic Acid inhibits the reaction [Acetylcholine results in increased phosphorylation of NOS3 protein]; Resveratrol inhibits the reaction [Palmitic Acid inhibits the reaction [Acetylcholine results in increased phosphorylation of NOS3 protein]]; Salicylic Acid inhibits the reaction [Palmitic Acid inhibits the reaction [Acetylcholine results in increased phosphorylation of NOS3 protein]] 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of NOS3 protein]]; Agmatine inhibits the reaction [Palmitic Acid results in increased activity of and results in decreased phosphorylation of NOS3 protein]; dorsomorphin inhibits the reaction [Agmatine inhibits the reaction [Palmitic Acid results in increased activity of and results in decreased phosphorylation of NOS3 protein]]; Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of NOS3 protein]; Palmitic Acid results in increased activity of and results in decreased phosphorylation of NOS3 protein; tin protoporphyrin IX inhibits the reaction [3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of NOS3 protein]]]
Palmitic Acid results in decreased expression of NOTCH1 protein; Palmitic Acid results in decreased expression of NOTCH1 protein modified form MIR141 mRNA promotes the reaction [Palmitic Acid results in decreased expression of NOTCH1 protein modified form]; MIR141 mRNA promotes the reaction [Palmitic Acid results in decreased expression of NOTCH1 protein]
Palmitic Acid results in increased expression of NOX1 mRNA geraniol inhibits the reaction [Palmitic Acid results in increased expression of NOX1 protein] Palmitic Acid results in increased expression of NOX1 mRNA; Palmitic Acid results in increased expression of NOX1 protein
acetovanillone inhibits the reaction [Palmitic Acid results in increased expression of NOXA1 mRNA]; U 0126 inhibits the reaction [Palmitic Acid results in increased expression of NOXA1 mRNA]
acetovanillone inhibits the reaction [Palmitic Acid results in increased expression of NOXO1 mRNA]; U 0126 inhibits the reaction [Palmitic Acid results in increased expression of NOXO1 mRNA]
[Palmitic Acid co-treated with Arsenic] results in increased expression of NQO1 mRNA; [Palmitic Acid co-treated with Oleic Acid] results in decreased expression of NQO1 protein; Escin inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of NQO1 protein]; nuciferine inhibits the reaction [Palmitic Acid results in decreased expression of NQO1 protein]
Palmitic Acid results in decreased expression of NR1H2 mRNA; Palmitic Acid results in decreased expression of NR1H2 protein acanthoic acid inhibits the reaction [Palmitic Acid results in decreased expression of NR1H2 mRNA]; acanthoic acid inhibits the reaction [Palmitic Acid results in decreased expression of NR1H2 protein]; GW 3965 inhibits the reaction [Palmitic Acid results in decreased expression of NR1H2 mRNA]; GW 3965 inhibits the reaction [Palmitic Acid results in decreased expression of NR1H2 protein]; morroniside inhibits the reaction [Palmitic Acid results in decreased expression of NR1H2 mRNA]; morroniside inhibits the reaction [Palmitic Acid results in decreased expression of NR1H2 protein]; pregna-4,17-diene-3,16-dione promotes the reaction [Palmitic Acid results in decreased expression of NR1H2 mRNA]
[Oleic Acid co-treated with Palmitic Acid] results in increased expression of NR1H3 mRNA acanthoic acid inhibits the reaction [Palmitic Acid results in decreased expression of NR1H3 mRNA]; acanthoic acid inhibits the reaction [Palmitic Acid results in decreased expression of NR1H3 protein]; GW 3965 inhibits the reaction [Palmitic Acid results in decreased expression of NR1H3 mRNA]; GW 3965 inhibits the reaction [Palmitic Acid results in decreased expression of NR1H3 protein] Palmitic Acid results in decreased expression of NR1H3 mRNA; Palmitic Acid results in decreased expression of NR1H3 protein
[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of NR1H4 mRNA; [Palmitic Acid co-treated with Oleic Acid] affects the expression of NR1H4 mRNA; Permethrin inhibits the reaction [Palmitic Acid results in increased expression of NR1H4 mRNA] Palmitic Acid affects the expression of NR1H4 mRNA Palmitic Acid results in decreased expression of NR1H4 mRNA; Palmitic Acid results in decreased expression of NR1H4 protein acanthoic acid inhibits the reaction [Palmitic Acid results in decreased expression of NR1H4 mRNA]; acanthoic acid inhibits the reaction [Palmitic Acid results in decreased expression of NR1H4 protein]; GW 3965 inhibits the reaction [Palmitic Acid results in decreased expression of NR1H4 mRNA]; GW 3965 inhibits the reaction [Palmitic Acid results in decreased expression of NR1H4 protein]; pregna-4,17-diene-3,16-dione promotes the reaction [Palmitic Acid results in decreased expression of NR1H4 mRNA]
[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of NR1I2 mRNA Palmitic Acid affects the expression of NR1I2 mRNA NR1I2 protein affects the abundance of Palmitic Acid
[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of NRF1 mRNA; FOXO1 protein affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of NRF1 mRNA] Palmitic Acid results in increased expression of NRF1 mRNA
[Fructose co-treated with Palmitic Acid] results in decreased expression of OPA1 protein; Fenofibrate inhibits the reaction [[Fructose co-treated with Palmitic Acid] results in decreased expression of OPA1 protein]
Palmitic Acid results in decreased phosphorylation of OXR1 protein [Palmitic Acid co-treated with Arsenic] results in increased expression of OXR1 mRNA
[Oleic Acid co-treated with Palmitic Acid] results in increased expression of P2RX7 mRNA; [Oleic Acid co-treated with Palmitic Acid] results in increased expression of P2RX7 protein; Resveratrol inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of P2RX7 mRNA]; Resveratrol inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of P2RX7 protein]
carnosol inhibits the reaction [Palmitic Acid results in increased expression of PARP1 protein modified form]; PRDX3 protein inhibits the reaction [Palmitic Acid results in increased expression of PARP1 protein modified form]; PRDX3 protein promotes the reaction [carnosol inhibits the reaction [Palmitic Acid results in increased expression of PARP1 protein modified form]]; trigonelline inhibits the reaction [Palmitic Acid results in increased cleavage of PARP1 protein] Palmitic Acid results in increased expression of PARP1 mRNA; Palmitic Acid results in increased expression of PARP1 protein
[Oleic Acid co-treated with Palmitic Acid] inhibits the reaction [INS1 protein inhibits the reaction [[Cyclic AMP co-treated with Dexamethasone] results in increased expression of PEPCK protein]]; FOXO1 protein affects the reaction [[Oleic Acid co-treated with Palmitic Acid] inhibits the reaction [INS1 protein inhibits the reaction [[Cyclic AMP co-treated with Dexamethasone] results in increased expression of PEPCK protein]]]
[osteum co-treated with Palmitic Acid] results in increased expression of PDGFA mRNA; MRI-1867 inhibits the reaction [[osteum co-treated with Palmitic Acid] results in increased expression of PDGFA mRNA]
[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of PDK4 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of PDK4 protein; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of PDK4 mRNA; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of PDK4 protein Palmitic Acid results in increased expression of PDK4 mRNA
Palmitic Acid results in decreased expression of PDX1 mRNA 3-aminobenzamide inhibits the reaction [Palmitic Acid results in decreased expression of PDX1 protein]; geniposide inhibits the reaction [Palmitic Acid results in decreased expression of PDX1 protein] Palmitic Acid inhibits the reaction [Glucose affects the localization of PDX1 protein] Palmitic Acid inhibits the reaction [Glucose results in increased expression of PDX1 mRNA]
[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of PEBP1 mRNA; [Palmitic Acid co-treated with Oleic Acid] affects the expression of PEBP1 mRNA
Palmitic Acid results in decreased phosphorylation of PIK3CG protein ADORA2B protein affects the reaction [Palmitic Acid results in decreased phosphorylation of PIK3CG protein]; ADORA2B protein inhibits the reaction [MYC protein inhibits the reaction [Palmitic Acid results in decreased phosphorylation of PIK3CG protein]]; ADORA2B protein promotes the reaction [Palmitic Acid results in decreased phosphorylation of PIK3CG protein]; MYC protein inhibits the reaction [Palmitic Acid results in decreased phosphorylation of PIK3CG protein]
3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of PINK1 mRNA]; [Palmitic Acid co-treated with Oleic Acid] results in decreased expression of PINK1 mRNA; Palmitic Acid inhibits the reaction [Cyclosporine results in decreased expression of PINK1 protein] Palmitic Acid results in increased expression of PINK1 protein Palmitic Acid results in decreased expression of PINK1 mRNA
[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of PKLR mRNA; [Palmitic Acid co-treated with Oleic Acid] affects the expression of PKLR mRNA Palmitic Acid results in decreased expression of PKLR mRNA
[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of PLIN2 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of PLIN2 protein; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of PLIN2 mRNA; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of PLIN2 protein [Oleic Acid co-treated with Palmitic Acid] results in increased expression of PLIN2 mRNA
[Oleic Acid co-treated with Palmitic Acid] results in increased expression of PLIN5 mRNA; tetrabromobisphenol A promotes the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of PLIN5 mRNA]
Palmitic Acid results in decreased expression of PNPLA2 protein nuciferine inhibits the reaction [Palmitic Acid results in decreased expression of PNPLA2 protein]
[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of PNPLA3 mRNA; [Palmitic Acid co-treated with Oleic Acid] affects the expression of PNPLA3 mRNA
[Glucose co-treated with Palmitic Acid] results in decreased expression of PPARA mRNA; [nuciferine co-treated with Palmitic Acid] results in increased expression of PPARA mRNA; [Oleic Acid co-treated with Palmitic Acid] results in decreased expression of PPARA mRNA; [Oleic Acid co-treated with Palmitic Acid] results in decreased expression of PPARA protein; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of PPARA mRNA; [Palmitic Acid co-treated with Arsenic] results in increased expression of PPARA mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of PPARA mRNA; [Palmitic Acid co-treated with Oleic Acid] affects the expression of PPARA mRNA; acadesine inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of PPARA mRNA]; Coptidis rhizoma extract inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of PPARA mRNA]; dorsomorphin promotes the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of PPARA mRNA]; isosilybin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of PPARA mRNA]; isosilybin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of PPARA protein]; Ivermectin inhibits the reaction [Palmitic Acid results in increased expression of PPARA mRNA]; nuciferine inhibits the reaction [Palmitic Acid results in decreased expression of PPARA protein]; Palmitic Acid binds to and results in increased activity of PPARA protein; Permethrin inhibits the reaction [Palmitic Acid results in increased expression of PPARA mRNA]; PPARGC1A protein affects the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of PPARA mRNA]; TERT protein inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of PPARA mRNA] Palmitic Acid results in decreased expression of PPARA mRNA; Palmitic Acid results in decreased expression of PPARA protein [Oleic Acid co-treated with Palmitic Acid] results in decreased expression of PPARA mRNA; [Oleic Acid co-treated with Palmitic Acid] results in decreased expression of PPARA protein; [Oleic Acid co-treated with Palmitic Acid] results in increased expression of PPARA mRNA; [tetrabromobisphenol A co-treated with Oleic Acid co-treated with Palmitic Acid] results in decreased expression of PPARA mRNA; [Triiodothyronine co-treated with Oleic Acid co-treated with Palmitic Acid] results in decreased expression of PPARA mRNA; Bezafibrate inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of PPARA mRNA]; Bezafibrate inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of PPARA protein]; quercetin 3-O-glucuronide inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of PPARA mRNA]; quercetin 3-O-glucuronide inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of PPARA protein] PPARA protein affects the abundance of Palmitic Acid [decabromobiphenyl ether co-treated with osteum co-treated with Palmitic Acid] results in increased expression of PPARA protein; [osteum co-treated with Palmitic Acid] results in increased expression of PPARA protein; amlexanox inhibits the reaction [Palmitic Acid results in decreased expression of PPARA mRNA]; amlexanox inhibits the reaction [Palmitic Acid results in decreased expression of PPARA protein]; amlexanox promotes the reaction [Palmitic Acid results in increased expression of PPARA protein]; Diethylhexyl Phthalate inhibits the reaction [PPARA protein affects the abundance of Palmitic Acid]; Palmitic Acid inhibits the reaction [obeticholic acid results in increased expression of PPARA mRNA]; PPARA protein promotes the reaction [[GW 7647 results in increased oxidation of Palmitic Acid] which results in increased abundance of Carbon Dioxide]; PPARA protein promotes the reaction [[GW 7647 results in increased oxidation of Palmitic Acid] which results in increased abundance of Fatty Acids metabolite] Palmitic Acid results in increased activity of PPARA protein Palmitic Acid results in increased expression of PPARA mRNA; Palmitic Acid results in increased expression of PPARA protein
[Oleic Acid co-treated with Palmitic Acid co-treated with Ethanol] results in increased expression of PPARD mRNA; [Oleic Acid co-treated with Palmitic Acid] results in decreased expression of PPARB mRNA; [Oleic Acid co-treated with Palmitic Acid] results in decreased expression of PPARD mRNA; Bezafibrate inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of PPARB mRNA]; tetrabromobisphenol A inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of PPARD mRNA] Palmitic Acid results in decreased expression of PPARD mRNA [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of PPARD mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of PPARD mRNA; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of PPARD mRNA
Palmitic Acid results in increased expression of PPARG mRNA; Palmitic Acid results in increased expression of PPARG protein [Palmitic Acid co-treated with Ethanol] results in increased expression of PPARG mRNA; [Palmitic Acid co-treated with sodium arsenite] results in decreased expression of PPARG mRNA; [sodium arsenite co-treated with Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of PPARG mRNA; trigonelline inhibits the reaction [Palmitic Acid results in increased expression of PPARG protein] [Glucose co-treated with Palmitic Acid] results in decreased expression of PPARG mRNA; [Oleic Acid co-treated with Palmitic Acid] results in increased expression of PPARG mRNA; [Oleic Acid co-treated with Palmitic Acid] results in increased expression of PPARG protein; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of PPARG mRNA; [Palmitic Acid co-treated with Oleic Acid] results in decreased expression of PPARG protein; acadesine inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of PPARG mRNA]; ATG7 protein affects the reaction [trigonelline inhibits the reaction [Palmitic Acid results in increased expression of PPARG protein]]; Coptidis rhizoma extract inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of PPARG mRNA]; Coptidis rhizoma extract inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of PPARG protein]; dorsomorphin promotes the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of PPARG mRNA]; Escin inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of PPARG protein]; PPARGC1A protein affects the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of PPARG mRNA]; TERT protein inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of PPARG mRNA]; trigonelline inhibits the reaction [Palmitic Acid results in increased expression of PPARG protein] [Oleic Acid co-treated with Palmitic Acid] inhibits the reaction [Ethanol results in increased expression of PPARG mRNA]; [Oleic Acid co-treated with Palmitic Acid] results in increased expression of PPARG mRNA; AICA ribonucleotide inhibits the reaction [Palmitic Acid results in decreased expression of PPARG mRNA]; Ethanol inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of PPARG mRNA]; Metformin inhibits the reaction [Palmitic Acid results in decreased expression of PPARG mRNA]; Resveratrol inhibits the reaction [Palmitic Acid results in decreased expression of PPARG mRNA]; Salicylic Acid inhibits the reaction [Palmitic Acid results in decreased expression of PPARG mRNA]; tetrabromobisphenol A inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of PPARG mRNA]; Triiodothyronine inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of PPARG mRNA]
Palmitic Acid results in increased expression of PPARGC1A mRNA Palmitic Acid results in decreased expression of PPARGC1A mRNA; Palmitic Acid results in decreased expression of PPARGC1A protein [Fructose co-treated with Palmitic Acid] results in decreased expression of PPARGC1A protein; [Glucose co-treated with Palmitic Acid] results in decreased expression of PPARGC1A mRNA; [Glucose co-treated with Palmitic Acid] results in decreased expression of PPARGC1A protein; acadesine inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of PPARGC1A mRNA]; acadesine inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of PPARGC1A protein]; dorsomorphin promotes the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of PPARGC1A mRNA]; dorsomorphin promotes the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of PPARGC1A protein]; Fenofibrate inhibits the reaction [[Fructose co-treated with Palmitic Acid] results in decreased expression of PPARGC1A protein]; nuciferine inhibits the reaction [Palmitic Acid results in decreased expression of PPARGC1A mRNA]; nuciferine inhibits the reaction [Palmitic Acid results in decreased expression of PPARGC1A protein]; PPARGC1A protein affects the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of PPARA mRNA]; PPARGC1A protein affects the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of PPARG mRNA]; PPARGC1A protein affects the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of TERT mRNA]; PPARGC1A protein affects the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of TERT protein]; PPARGC1A protein affects the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of TFAM mRNA]; PPARGC1A protein promotes the reaction [nuciferine inhibits the reaction [Palmitic Acid results in decreased expression of ACOX1 mRNA]]; PPARGC1A protein promotes the reaction [nuciferine inhibits the reaction [Palmitic Acid results in decreased expression of EHHADH mRNA]]; PPARGC1A protein promotes the reaction [nuciferine inhibits the reaction [Palmitic Acid results in decreased expression of FGF21 mRNA]]; TERT protein inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of PPARGC1A protein] [Oleic Acid co-treated with Palmitic Acid] results in decreased expression of PPARGC1A mRNA; FOXO1 protein affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of PPARGC1A mRNA]; morroniside inhibits the reaction [Palmitic Acid results in decreased expression of PPARGC1A mRNA]; morroniside inhibits the reaction [Palmitic Acid results in decreased expression of PPARGC1A protein]
carnosol inhibits the reaction [Palmitic Acid results in decreased expression of PRDX3 protein]; PRDX3 protein inhibits the reaction [Palmitic Acid results in decreased expression of MFN2 protein]; PRDX3 protein inhibits the reaction [Palmitic Acid results in increased cleavage of CASP3 protein]; PRDX3 protein inhibits the reaction [Palmitic Acid results in increased expression of BAX protein]; PRDX3 protein inhibits the reaction [Palmitic Acid results in increased expression of DNM1L protein]; PRDX3 protein inhibits the reaction [Palmitic Acid results in increased expression of FIS1 protein]; PRDX3 protein inhibits the reaction [Palmitic Acid results in increased expression of MAP3K5 protein]; PRDX3 protein inhibits the reaction [Palmitic Acid results in increased expression of PARP1 protein modified form]; PRDX3 protein inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK8 protein]; PRDX3 protein inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK9 protein]; PRDX3 protein promotes the reaction [carnosol inhibits the reaction [Palmitic Acid results in decreased expression of BCL2 protein]]; PRDX3 protein promotes the reaction [carnosol inhibits the reaction [Palmitic Acid results in decreased expression of MFN2 protein]]; PRDX3 protein promotes the reaction [carnosol inhibits the reaction [Palmitic Acid results in increased expression of BAX protein]]; PRDX3 protein promotes the reaction [carnosol inhibits the reaction [Palmitic Acid results in increased expression of DNM1L protein]]; PRDX3 protein promotes the reaction [carnosol inhibits the reaction [Palmitic Acid results in increased expression of FIS1 protein]]; PRDX3 protein promotes the reaction [carnosol inhibits the reaction [Palmitic Acid results in increased expression of MAP3K5 protein]]; PRDX3 protein promotes the reaction [carnosol inhibits the reaction [Palmitic Acid results in increased expression of PARP1 protein modified form]]; PRDX3 protein promotes the reaction [carnosol inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK8 protein]]; PRDX3 protein promotes the reaction [carnosol inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK9 protein]]
[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of PRKAA1 mRNA; nuciferine inhibits the reaction [Palmitic Acid results in decreased phosphorylation of PRKAA1 protein] PRKAA1 protein results in increased oxidation of Palmitic Acid
[Palmitic Acid co-treated with Oleic Acid] affects the expression of PRKAA2 mRNA; nuciferine inhibits the reaction [Palmitic Acid results in decreased phosphorylation of PRKAA2 protein]
Palmitic Acid results in decreased expression of PSEN1 mRNA; Palmitic Acid results in decreased expression of PSEN1 protein MIR141 mRNA promotes the reaction [Palmitic Acid results in decreased expression of PSEN1 mRNA]; MIR141 mRNA promotes the reaction [Palmitic Acid results in decreased expression of PSEN1 protein]
Palmitic Acid results in increased expression of PTEN protein MIR141 mRNA promotes the reaction [Palmitic Acid results in increased expression of PTEN protein]
Palmitic Acid results in increased phosphorylation of RELA protein Palmitic Acid results in decreased expression of RELA mRNA 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Palmitic Acid results in increased phosphorylation of and results in increased activity of RELA protein]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Palmitic Acid results in increased phosphorylation of RELA protein]; [Oleic Acid co-treated with Palmitic Acid] results in increased expression of RELA mRNA; [Oleic Acid co-treated with Palmitic Acid] results in increased expression of RELA protein; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of RELA mRNA; cyanidin-3-O-beta-glucopyranoside inhibits the reaction [Palmitic Acid affects the localization of and results in increased activity of RELA protein]; Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of RELA mRNA]; Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of RELA protein]; morroniside inhibits the reaction [Palmitic Acid results in increased phosphorylation of RELA protein]; MTOR protein inhibits the reaction [Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of RELA mRNA]]; MTOR protein inhibits the reaction [Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of RELA protein]]; nuciferine inhibits the reaction [Palmitic Acid results in increased phosphorylation of RELA protein]; Palmitic Acid affects the localization of and results in increased activity of RELA protein; Palmitic Acid results in increased phosphorylation of and results in increased activity of RELA protein; RELA protein affects the reaction [Palmitic Acid results in increased expression of SREBF1 protein]; RELA protein affects the reaction [Palmitic Acid results in increased expression of TNF protein]; tin protoporphyrin IX inhibits the reaction [3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Palmitic Acid results in increased phosphorylation of and results in increased activity of RELA protein]]; wedelolactone inhibits the reaction [Palmitic Acid affects the localization of and results in increased activity of RELA protein] AICA ribonucleotide inhibits the reaction [Palmitic Acid results in increased phosphorylation of RELA protein]; dorsomorphin inhibits the reaction [AICA ribonucleotide inhibits the reaction [Palmitic Acid results in increased phosphorylation of RELA protein]]; dorsomorphin inhibits the reaction [Metformin inhibits the reaction [Palmitic Acid results in increased phosphorylation of RELA protein]]; dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Palmitic Acid results in increased phosphorylation of RELA protein]]; dorsomorphin inhibits the reaction [Salicylic Acid inhibits the reaction [Palmitic Acid results in increased phosphorylation of RELA protein]]; Metformin inhibits the reaction [Palmitic Acid results in increased phosphorylation of RELA protein]; Niacinamide inhibits the reaction [AICA ribonucleotide inhibits the reaction [Palmitic Acid results in increased phosphorylation of RELA protein]]; Niacinamide inhibits the reaction [Metformin inhibits the reaction [Palmitic Acid results in increased phosphorylation of RELA protein]]; Niacinamide inhibits the reaction [Resveratrol inhibits the reaction [Palmitic Acid results in increased phosphorylation of RELA protein]]; Niacinamide inhibits the reaction [Salicylic Acid inhibits the reaction [Palmitic Acid results in increased phosphorylation of RELA protein]]; Resveratrol inhibits the reaction [Palmitic Acid results in increased phosphorylation of RELA protein]; Salicylic Acid inhibits the reaction [Palmitic Acid results in increased phosphorylation of RELA protein]; STING1 protein promotes the reaction [Palmitic Acid results in increased phosphorylation of RELA protein]
[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of RHOB mRNA; [Palmitic Acid co-treated with Oleic Acid] affects the expression of RHOB mRNA
[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of ROCK2 protein; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of ROCK2 protein
Palmitic Acid results in decreased phosphorylation of RPS6KB1 protein [Palmitic Acid co-treated with sodium bisulfide] inhibits the reaction [INS protein results in increased phosphorylation of RPS6KB1 protein]
Palmitic Acid results in increased expression of RUNX2 mRNA acetovanillone inhibits the reaction [Palmitic Acid results in increased expression of RUNX2 mRNA]; CYBA mutant form inhibits the reaction [Palmitic Acid results in increased expression of RUNX2 mRNA]; U 0126 inhibits the reaction [Palmitic Acid results in increased expression of RUNX2 mRNA]
Palmitic Acid results in increased expression of SCD1 mRNA Palmitic Acid results in increased expression of SCD protein [osteum co-treated with Palmitic Acid] results in increased expression of SCD1 protein; acanthoic acid inhibits the reaction [Palmitic Acid results in increased expression of SCD1 mRNA]; decabromobiphenyl ether promotes the reaction [[osteum co-treated with Palmitic Acid] results in increased expression of SCD1 protein]; GW 3965 inhibits the reaction [Palmitic Acid results in increased expression of SCD1 mRNA]; pregna-4,17-diene-3,16-dione inhibits the reaction [Palmitic Acid results in increased expression of SCD1 mRNA] (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Palmitic Acid results in increased expression of SCD1 protein]; [Oleic Acid co-treated with Palmitic Acid] results in increased expression of SCD1 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of SCD mRNA; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of SCD mRNA; Bezafibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Coptidis rhizoma extract inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of SCD1 mRNA]; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; morroniside inhibits the reaction [Palmitic Acid results in increased expression of SCD protein]; Pioglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA] Palmitic Acid results in increased expression of SCD1 mRNA; Palmitic Acid results in increased expression of SCD1 protein SCD1 protein results in decreased susceptibility to Palmitic Acid SCD1 protein inhibits the reaction [Palmitic Acid results in increased abundance of Ceramides]; SCD1 protein inhibits the reaction [Palmitic Acid results in increased abundance of Reactive Oxygen Species]; SCD1 protein inhibits the reaction [Palmitic Acid results in increased activity of CASP3 protein]
Palmitic Acid results in increased expression of SELE mRNA cyanidin-3-O-beta-glucopyranoside inhibits the reaction [Palmitic Acid results in increased expression of SELE mRNA]; wedelolactone inhibits the reaction [Palmitic Acid results in increased expression of SELE mRNA]
Palmitic Acid results in increased expression of SERPINE1 mRNA [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of SERPINE1 mRNA
Palmitic Acid results in decreased expression of SIRT1 mRNA; Palmitic Acid results in decreased expression of SIRT1 protein Palmitic Acid results in increased expression of SIRT1 mRNA [Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of SIRT1 mRNA; Palmitic Acid inhibits the reaction [sodium arsenite results in increased expression of SIRT1 mRNA]; Palmitic Acid promotes the reaction [[sodium arsenite co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of SIRT1 mRNA]; sodium arsenite inhibits the reaction [Palmitic Acid results in increased expression of SIRT1 mRNA]; sodium arsenite promotes the reaction [[Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of SIRT1 mRNA] Palmitic Acid results in decreased activity of SIRT1 protein 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Resveratrol inhibits the reaction [Palmitic Acid results in decreased activity of SIRT1 protein]]; 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide promotes the reaction [Palmitic Acid results in decreased activity of SIRT1 protein]; [Fructose co-treated with Palmitic Acid] results in decreased expression of SIRT1 protein; [Palmitic Acid co-treated with Glucose] promotes the reaction [Glutathione binds to SIRT1 protein]; [Palmitic Acid co-treated with Glucose] results in increased oxidation of and results in decreased activity of SIRT1 protein; Fenofibrate inhibits the reaction [[Fructose co-treated with Palmitic Acid] results in decreased expression of SIRT1 protein]; GLRX protein inhibits the reaction [[Palmitic Acid co-treated with Glucose] promotes the reaction [Glutathione binds to SIRT1 protein]]; GLRX protein inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased oxidation of and results in decreased activity of SIRT1 protein]; Resveratrol inhibits the reaction [Palmitic Acid results in decreased activity of SIRT1 protein]; SIRT1 protein inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased acetylation of TP53 protein]; SIRT1 protein inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased cleavage of CASP3 protein]; SIRT1 protein inhibits the reaction [Palmitic Acid results in decreased activity of SIRT1 protein]; SIRT1 protein mutant form inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased expression of BBC3 mRNA]; SIRT1 protein mutant form inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased expression of CDKN1A mRNA]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Palmitic Acid results in decreased activity of SIRT1 protein]] [Ethanol co-treated with Oleic Acid co-treated with Palmitic Acid] results in decreased expression of SIRT1 protein; Lead promotes the reaction [Palmitic Acid results in decreased expression of SIRT1 protein]; Palmitic Acid promotes the reaction [Lead results in decreased expression of SIRT1 protein]; Resveratrol inhibits the reaction [Palmitic Acid results in decreased expression of SIRT1 mRNA]; SRT1720 inhibits the reaction [Lead promotes the reaction [Palmitic Acid results in decreased expression of SIRT1 protein]]; SRT1720 inhibits the reaction [Palmitic Acid promotes the reaction [Lead results in decreased expression of SIRT1 protein]]
[Glucose co-treated with Palmitic Acid] results in decreased expression of SLC27A2 mRNA; [Oleic Acid co-treated with Palmitic Acid] results in decreased expression of SLC27A2 mRNA Palmitic Acid results in decreased expression of SLC27A2 mRNA
Palmitic Acid results in decreased expression of SLC2A4 protein [Palmitic Acid co-treated with Arsenic] affects the expression of SLC2A4 mRNA; Cyclosporine inhibits the reaction [Palmitic Acid results in decreased expression of SLC2A4 protein] 4-hydroxyisoleucine inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein affects the localization of SLC2A4 protein]]; Palmitic Acid inhibits the reaction [INS protein affects the localization of SLC2A4 protein]; Quercetin inhibits the reaction [Palmitic Acid results in decreased expression of SLC2A4 protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [ADORA2B protein affects the reaction [Palmitic Acid results in decreased expression of SLC7A11 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Palmitic Acid results in decreased expression of SLC7A11 protein]; ADORA2B protein affects the reaction [Palmitic Acid results in decreased expression of SLC7A11 protein]; ADORA2B protein inhibits the reaction [MYC protein inhibits the reaction [Palmitic Acid results in decreased expression of SLC7A11 protein]]; ADORA2B protein promotes the reaction [Palmitic Acid results in decreased expression of SLC7A11 protein]; MYC protein inhibits the reaction [Palmitic Acid results in decreased expression of SLC7A11 protein]
[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of SNAP23 mRNA; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of SNAP23 mRNA
[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of SOCS2 mRNA; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of SOCS2 mRNA
[Palmitic Acid co-treated with Arsenic] affects the expression of SOCS3 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of SOCS3 mRNA Palmitic Acid affects the expression of SOCS3 mRNA
Palmitic Acid results in decreased expression of SOD1 mRNA [Glucose co-treated with Palmitic Acid] results in decreased expression of SOD1 protein rosiglitazone inhibits the reaction [Palmitic Acid results in decreased expression of SOD1 mRNA]
Palmitic Acid results in increased expression of SOD2 mRNA [osteum co-treated with Palmitic Acid] results in decreased expression of SOD2 protein [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of SOD2 mRNA Palmitic Acid results in decreased expression of SOD2 mRNA; Palmitic Acid results in decreased expression of SOD2 protein
Cycloheximide promotes the reaction [Palmitic Acid results in increased degradation of SORT1 protein]; Docosahexaenoic Acids inhibits the reaction [Cycloheximide promotes the reaction [Palmitic Acid results in increased degradation of SORT1 protein]]; Docosahexaenoic Acids inhibits the reaction [Palmitic Acid results in decreased expression of SORT1 protein]; Eicosapentaenoic Acid inhibits the reaction [Palmitic Acid results in decreased expression of SORT1 protein] Palmitic Acid results in increased phosphorylation of SORT1 protein
Palmitic Acid results in increased expression of SQSTM1 protein CYLD protein affects the reaction [Palmitic Acid results in increased expression of SQSTM1 protein]; PKF115-584 inhibits the reaction [CYLD protein affects the reaction [Palmitic Acid results in increased expression of SQSTM1 protein]]; SQSTM1 protein affects the reaction [Palmitic Acid affects the localization of AIFM1 protein]; SQSTM1 protein affects the reaction [Palmitic Acid results in increased cleavage of CASP3 protein] [[Palmitic Acid co-treated with Oleic Acid] results in increased abundance of Fatty Acids, Nonesterified] which results in increased expression of SQSTM1 mRNA; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of SQSTM1 protein; Deferoxamine promotes the reaction [Palmitic Acid results in increased expression of SQSTM1 protein]; Escin inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in increased expression of SQSTM1 protein]; lactucin inhibits the reaction [[[Palmitic Acid co-treated with Oleic Acid] results in increased abundance of Fatty Acids, Nonesterified] which results in increased expression of SQSTM1 mRNA]; Palmitic Acid inhibits the reaction [Arsenic Trioxide results in decreased expression of SQSTM1 protein]; trigonelline inhibits the reaction [Palmitic Acid results in increased expression of SQSTM1 protein]
3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Palmitic Acid results in increased expression of SREBF1 protein]; [Oleic Acid co-treated with Palmitic Acid] results in increased expression of SREBF1 mRNA; [Oleic Acid co-treated with Palmitic Acid] results in increased expression of SREBF1 protein; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of SREBF1 mRNA; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of SREBF1 protein; ATG5 protein promotes the reaction [Resveratrol inhibits the reaction [Palmitic Acid results in increased expression of SREBF1 protein]]; ATG7 protein affects the reaction [trigonelline inhibits the reaction [Palmitic Acid results in increased expression of SREBF1 protein]]; BECN1 protein promotes the reaction [Resveratrol inhibits the reaction [Palmitic Acid results in increased expression of SREBF1 protein]]; Coptidis rhizoma extract inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of SREBF1 mRNA]; Dibutyl Phthalate inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of SREBF1 mRNA]; dorsomorphin inhibits the reaction [Huangqin-Tang inhibits the reaction [Palmitic Acid results in increased expression of SREBF1 protein]]; dorsomorphin inhibits the reaction [nuciferine inhibits the reaction [Palmitic Acid results in increased expression of SREBF1 mRNA]]; Escin inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in increased expression of SREBF1 mRNA]; Escin inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in increased expression of SREBF1 protein]; Huangqin-Tang inhibits the reaction [Palmitic Acid results in increased expression of SREBF1 mRNA]; Huangqin-Tang inhibits the reaction [Palmitic Acid results in increased expression of SREBF1 protein]; isosilybin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of SREBF1 protein]; morroniside inhibits the reaction [Palmitic Acid results in increased expression of SREBF1 protein]; nuciferine inhibits the reaction [Palmitic Acid results in increased expression of SREBF1 mRNA]; RELA protein affects the reaction [Palmitic Acid results in increased expression of SREBF1 protein]; Resveratrol inhibits the reaction [Palmitic Acid results in increased expression of SREBF1 protein]; trigonelline inhibits the reaction [Palmitic Acid results in increased expression of SREBF1 protein] Palmitic Acid results in decreased expression of SREBF1 mRNA [osteum co-treated with Palmitic Acid] results in increased expression of SREBF1 protein; [Palmitic Acid co-treated with Ethanol] results in increased expression of SREBF1 mRNA; [Palmitic Acid co-treated with sodium arsenite] results in decreased expression of SREBF1 mRNA; acanthoic acid inhibits the reaction [Palmitic Acid results in increased expression of SREBF1 mRNA]; acanthoic acid inhibits the reaction [Palmitic Acid results in increased expression of SREBF1 protein]; amlexanox inhibits the reaction [Palmitic Acid results in increased expression of SREBF1 mRNA]; decabromobiphenyl ether promotes the reaction [[osteum co-treated with Palmitic Acid] results in increased expression of SREBF1 protein]; GW 3965 inhibits the reaction [Palmitic Acid results in increased expression of SREBF1 mRNA]; GW 3965 inhibits the reaction [Palmitic Acid results in increased expression of SREBF1 protein]; trigonelline inhibits the reaction [Palmitic Acid results in increased expression of SREBF1 protein] Palmitic Acid results in increased expression of SREBF1 mRNA; Palmitic Acid results in increased expression of SREBF1 protein; Palmitic Acid results in increased expression of SREBF1 protein modified form [Oleic Acid co-treated with Palmitic Acid co-treated with Ethanol] results in increased expression of SREBF1 protein; [Oleic Acid co-treated with Palmitic Acid] results in increased expression of SREBF1 mRNA; quercetin 3-O-glucuronide inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of SREBF1 mRNA]
STING1 protein promotes the reaction [Palmitic Acid results in increased expression of and results in increased secretion of IL1B protein]; STING1 protein promotes the reaction [Palmitic Acid results in increased phosphorylation of RELA protein]; STING1 protein promotes the reaction [Palmitic Acid results in increased secretion of IL18 protein] Palmitic Acid results in increased expression of STING1 mRNA; Palmitic Acid results in increased expression of STING1 protein
5-methyltetrahydrofolate inhibits the reaction [Palmitic Acid results in decreased phosphorylation of STK11 protein]; dorsomorphin inhibits the reaction [5-methyltetrahydrofolate inhibits the reaction [Palmitic Acid results in decreased phosphorylation of STK11 protein]]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [5-methyltetrahydrofolate inhibits the reaction [Palmitic Acid results in decreased phosphorylation of STK11 protein]]
Palmitic Acid results in decreased expression of SYN1 protein Lead promotes the reaction [Palmitic Acid results in decreased expression of SYN1 protein]; Palmitic Acid promotes the reaction [Lead results in decreased expression of SYN1 protein]; SRT1720 inhibits the reaction [Lead promotes the reaction [Palmitic Acid results in decreased expression of SYN1 protein]]; SRT1720 inhibits the reaction [Palmitic Acid promotes the reaction [Lead results in decreased expression of SYN1 protein]]
Palmitic Acid results in increased phosphorylation of TBC1D4 protein 4-hydroxyisoleucine inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of TBC1D4 protein]]; Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of TBC1D4 protein]
[Glucose co-treated with Palmitic Acid] results in decreased expression of TERT mRNA; [Glucose co-treated with Palmitic Acid] results in decreased expression of TERT protein; acadesine inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of TERT mRNA]; acadesine inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of TERT protein]; dorsomorphin promotes the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of TERT mRNA]; dorsomorphin promotes the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of TERT protein]; PPARGC1A protein affects the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of TERT mRNA]; PPARGC1A protein affects the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of TERT protein]; TERT protein inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of PPARA mRNA]; TERT protein inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of PPARG mRNA]; TERT protein inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of PPARGC1A protein]; TERT protein inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of TFAM mRNA]
[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of TFAM mRNA; FOXO1 protein affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of TFAM mRNA] Palmitic Acid results in decreased expression of TFAM mRNA [Glucose co-treated with Palmitic Acid] results in decreased expression of TFAM mRNA; acadesine inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of TFAM mRNA]; dorsomorphin promotes the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of TFAM mRNA]; neohesperidin inhibits the reaction [Palmitic Acid results in decreased expression of TFAM mRNA]; PPARGC1A protein affects the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of TFAM mRNA]; SR18292 inhibits the reaction [neohesperidin inhibits the reaction [Palmitic Acid results in decreased expression of TFAM mRNA]]; TERT protein inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of TFAM mRNA]
[Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of TFAP2B mRNA; Palmitic Acid inhibits the reaction [[sodium arsenite co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of TFAP2B mRNA]; Palmitic Acid promotes the reaction [sodium arsenite results in increased expression of TFAP2B mRNA]; sodium arsenite promotes the reaction [Palmitic Acid results in increased expression of TFAP2B mRNA]
[Palmitic Acid co-treated with Oleic Acid] results in increased expression of TFRC protein; ginkgolide B inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in increased expression of TFRC protein]
Palmitic Acid results in increased secretion of TGFB1 protein [Palmitic Acid co-treated with Ethanol] results in increased secretion of TGFB1 protein [Palmitic Acid co-treated with Thioacetamide] results in increased secretion of TGFB1 protein
[Oleic Acid co-treated with Palmitic Acid] results in increased expression of TIMP1 mRNA; [Palmitic Acid co-treated with Oleic Acid] affects the expression of TIMP1 mRNA
Palmitic Acid results in decreased expression of TJP1 protein [Palmitic Acid co-treated with Arsenic] affects the expression of TJP1 mRNA CA 074 methyl ester inhibits the reaction [Palmitic Acid results in decreased expression of TJP1 protein]; Glycyrrhizic Acid inhibits the reaction [Palmitic Acid results in decreased expression of TJP1 protein]; L 709049 analog inhibits the reaction [Palmitic Acid results in decreased expression of TJP1 protein]
CA 074 methyl ester inhibits the reaction [Palmitic Acid results in decreased expression of TJP2 protein]; Glycyrrhizic Acid inhibits the reaction [Palmitic Acid results in decreased expression of TJP2 protein]; L 709049 analog inhibits the reaction [Palmitic Acid results in decreased expression of TJP2 protein]
Quercetin inhibits the reaction [Palmitic Acid results in increased expression of TLR4 mRNA] nuciferine inhibits the reaction [Palmitic Acid results in increased expression of TLR4 protein]
(R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Palmitic Acid results in increased secretion of TNF protein]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Palmitic Acid results in increased expression of TNF protein]; [Oleic Acid co-treated with Palmitic Acid] results in increased expression of TNF mRNA; [Oleic Acid co-treated with Palmitic Acid] results in increased expression of TNF protein; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of PPARG mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of PPARA mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CCL2 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CCL5 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CXCL5 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of NFKB1 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of PPARD mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of RELA mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of ABCA1 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of ACSL1 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of AGPAT2 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of AGPAT5 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of AHR mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of ARG1 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of B4GALT5 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of CAT mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of CXCL2 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of CXCL3 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of DYNC1H1 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of DYNC1I1 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of ENO3 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of ERLIN1 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of FOXA1 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of GLUD1 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of GLUD2 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of HSDL2 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of IL1A mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of LAMB1 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of NR1H4 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of PEBP1 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of PKLR mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of PLD1 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of PNPLA3 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of PPARD mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of PRKAA1 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of RAB18 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of RHEB mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of RHOB mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of SCD mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of SERPINE1 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of SLC2A1 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of SOCS1 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of SOD2 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of TGFB2 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of TNFAIP2 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of TUBB2A mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of UGCG mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of VAMP4 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of VCAN mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in decreased expression of CPT1A protein; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in decreased expression of DST mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of ACSL4 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of ANGPTL4 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of ANXA2 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of CIDEC protein; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of CPT1A mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of CXCL8 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of CYP24A1 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of CYP26A1 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of FGF21 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of FLOT1 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of HIF1A protein; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of HILPDA protein; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of JAK1 protein; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of LDLR mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of MAP3K8 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of MAP4K4 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of MTTP mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of PDK4 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of PDK4 protein; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of PLIN2 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of PLIN2 protein; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of PPARA mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of ROCK2 protein; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of SNAP23 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of SOCS2 mRNA; [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of SOCS3 mRNA; [Palmitic Acid co-treated with Thioacetamide] results in increased secretion of TNF protein; Bezafibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Bezafibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Bezafibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Bezafibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; Coptidis rhizoma extract inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of TNF mRNA]; Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of TNF protein]; Fenofibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Fenofibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Fenofibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Huangqin-Tang inhibits the reaction [Palmitic Acid results in increased expression of TNF mRNA]; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; lanifibranor inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; lanifibranor inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; lanifibranor inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; morroniside inhibits the reaction [Palmitic Acid results in increased expression of TNF protein]; Palmitic Acid inhibits the reaction [TNF protein results in increased phosphorylation of AKT1 protein]; Pioglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Pioglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; RELA protein affects the reaction [Palmitic Acid results in increased expression of TNF protein]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA]; Rosiglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Rosiglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Rosiglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; saroglitazar inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; saroglitazar inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; saroglitazar inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; tin protoporphyrin IX inhibits the reaction [3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Palmitic Acid results in increased secretion of TNF protein]] Palmitic Acid results in increased expression of TNF mRNA; Palmitic Acid results in increased expression of TNF protein [Oleic Acid co-treated with Palmitic Acid] results in increased expression of TNF protein; [Palmitic Acid co-treated with Sincalide] results in increased expression of TNF mRNA; [Palmitic Acid co-treated with Sincalide] results in increased expression of TNF protein; Acetylcysteine inhibits the reaction [Palmitic Acid results in increased expression of TNF mRNA]; AICA ribonucleotide inhibits the reaction [Palmitic Acid results in increased expression of TNF mRNA]; imoxin inhibits the reaction [Palmitic Acid results in increased expression of TNF mRNA]; Metformin inhibits the reaction [Palmitic Acid results in increased expression of TNF mRNA]; parthenolide inhibits the reaction [Palmitic Acid results in increased expression of TNF mRNA]; pyrazolanthrone inhibits the reaction [Palmitic Acid results in increased expression of TNF mRNA]; quercetin 3-O-glucuronide inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of TNF protein]; Quercetin inhibits the reaction [[Sincalide co-treated with Palmitic Acid] results in increased expression of TNF protein]; Quercetin inhibits the reaction [Palmitic Acid results in increased expression of TNF mRNA]; Resveratrol inhibits the reaction [Palmitic Acid results in increased expression of TNF mRNA]; Salicylic Acid inhibits the reaction [Palmitic Acid results in increased expression of TNF mRNA] [Oleic Acid co-treated with Palmitic Acid] results in increased expression of TNF protein; [Palmitic Acid co-treated with Ethanol] results in increased expression of TNF mRNA; [Palmitic Acid co-treated with Ethanol] results in increased secretion of TNF protein; amlexanox inhibits the reaction [Palmitic Acid results in increased expression of TNF mRNA]; amlexanox inhibits the reaction [Palmitic Acid results in increased secretion of TNF protein]; BACE1 protein affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of TNF protein]]; MIR497 affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of TNF protein]]; Quercetin inhibits the reaction [Palmitic Acid results in increased expression of TNF mRNA]; Quercetin inhibits the reaction [Palmitic Acid results in increased expression of TNF protein]; SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of TNF protein] Palmitic Acid results in increased susceptibility to TNF protein
Palmitic Acid results in increased expression of TNFRSF9 mRNA Quercetin inhibits the reaction [Palmitic Acid results in increased expression of TNFRSF9 mRNA]
3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in increased expression of TP53 mRNA]; [Palmitic Acid co-treated with Glucose] results in increased acetylation of TP53 protein; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of TP53 mRNA; SIRT1 protein inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased acetylation of TP53 protein]
Palmitic Acid results in increased expression of TRIM63 mRNA; Palmitic Acid results in increased expression of TRIM63 protein Quercetin inhibits the reaction [Palmitic Acid results in increased expression of TRIM63 mRNA]; Quercetin inhibits the reaction [Palmitic Acid results in increased expression of TRIM63 protein]
Palmitic Acid results in increased expression of TXNIP protein AICA ribonucleotide inhibits the reaction [Palmitic Acid results in increased expression of TXNIP protein]; baicalin inhibits the reaction [Palmitic Acid results in increased expression of TXNIP protein]; dorsomorphin inhibits the reaction [baicalin inhibits the reaction [Palmitic Acid results in increased expression of TXNIP protein]]
Palmitic Acid results in increased activity of UCP2 protein [Oleic Acid co-treated with Palmitic Acid co-treated with Ethanol] results in decreased expression of UCP2 protein; [Oleic Acid co-treated with Palmitic Acid] results in decreased expression of UCP2 mRNA; [Oleic Acid co-treated with Palmitic Acid] results in increased expression of UCP2 mRNA; [Oleic Acid co-treated with Palmitic Acid] results in increased expression of UCP2 protein; tetrabromobisphenol A promotes the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of UCP2 mRNA]; tetrabromobisphenol A promotes the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of UCP2 protein]; Triiodothyronine promotes the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of UCP2 mRNA]; Triiodothyronine promotes the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of UCP2 protein] Palmitic Acid results in increased expression of UCP2 mRNA candesartan inhibits the reaction [Palmitic Acid results in increased expression of UCP2 mRNA]
[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of UGCG mRNA; [Palmitic Acid co-treated with Oleic Acid] affects the expression of UGCG mRNA
[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of VAMP4 mRNA; [Palmitic Acid co-treated with Oleic Acid] affects the expression of VAMP4 mRNA
Palmitic Acid results in increased expression of VCAM1 mRNA; Palmitic Acid results in increased expression of VCAM1 protein cyanidin-3-O-beta-glucopyranoside inhibits the reaction [Palmitic Acid results in increased expression of VCAM1 mRNA]; geraniol inhibits the reaction [Palmitic Acid results in increased expression of VCAM1 protein]; wedelolactone inhibits the reaction [Palmitic Acid results in increased expression of VCAM1 mRNA]
[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of VCAN mRNA; [Palmitic Acid co-treated with Oleic Acid] affects the expression of VCAN mRNA Palmitic Acid results in increased expression of VCAN mRNA
[Oleic Acid co-treated with Palmitic Acid] results in increased expression of VEGFA mRNA; [Oleic Acid co-treated with Palmitic Acid] results in increased expression of VEGFA protein; Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of VEGFA mRNA]; Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of VEGFA protein]; MTOR protein inhibits the reaction [Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of VEGFA mRNA]]; MTOR protein inhibits the reaction [Diosgenin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of VEGFA protein]]
[Palmitic Acid co-treated with Sincalide] results in increased expression of XBP1 mRNA alternative form; [Palmitic Acid co-treated with Sincalide] results in increased expression of XBP1 protein alternative form; Quercetin inhibits the reaction [[Sincalide co-treated with Palmitic Acid] results in increased expression of XBP1 protein alternative form] Palmitic Acid results in increased expression of XBP1 protein 3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in increased splicing of XBP1 mRNA]; [Palmitic Acid co-treated with Oleic Acid] results in increased splicing of XBP1 mRNA; Deferoxamine promotes the reaction [Palmitic Acid results in increased expression of XBP1 protein]; ferric ammonium citrate inhibits the reaction [Palmitic Acid results in increased expression of XBP1 protein] Palmitic Acid results in increased expression of XBP1 mRNA alternative form; Palmitic Acid results in increased expression of XBP1 protein alternative form 4-methylumbelliferone 8-carbaldehyde inhibits the reaction [Palmitic Acid results in increased expression of XBP1 mRNA alternative form]; 4-methylumbelliferone 8-carbaldehyde inhibits the reaction [Palmitic Acid results in increased expression of XBP1 protein alternative form]; 7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid inhibits the reaction [Palmitic Acid results in increased expression of XBP1 mRNA alternative form]; ATP2A2 protein promotes the reaction [7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid inhibits the reaction [Palmitic Acid results in increased expression of XBP1 mRNA alternative form]]; Thapsigargin inhibits the reaction [7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid inhibits the reaction [Palmitic Acid results in increased expression of XBP1 mRNA alternative form]]
1-Butanol inhibits the reaction [Linoleic Acid inhibits the reaction [ABCA1 protein results in increased export of Cholesterol]]; Linoleic Acid inhibits the reaction [ABCA1 protein results in increased export of Cholesterol]; Linoleic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Cholesterol]]; Linoleic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Phospholipids]]; PLD2 protein inhibits the reaction [Linoleic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased export of Cholesterol]]]; triacsin C inhibits the reaction [Linoleic Acid inhibits the reaction [ABCA1 protein results in increased transport of Cholesterol]]; triacsin C inhibits the reaction [Linoleic Acid inhibits the reaction [ABCA1 protein results in increased transport of Phospholipids]]; triacsin C inhibits the reaction [Linoleic Acid results in increased degradation of ABCA1 protein] Linoleic Acid analog results in decreased expression of ABCA1 mRNA Linoleic Acid results in increased expression of ABCA1 mRNA Linoleic Acid inhibits the reaction [27-hydroxycholesterol results in increased expression of ABCA1 mRNA] Linoleic Acid results in increased phosphorylation of ABCA1 protein
AGER protein results in increased susceptibility to [Azoxymethane co-treated with Glucose co-treated with Linoleic Acid]; Glucose promotes the reaction [Linoleic Acid promotes the reaction [Azoxymethane results in increased expression of AGER protein]]; Linoleic Acid promotes the reaction [Azoxymethane results in increased expression of AGER protein]; Linoleic Acid promotes the reaction [Glucose promotes the reaction [Azoxymethane results in increased expression of AGER protein]]; Losartan inhibits the reaction [Glucose promotes the reaction [Linoleic Acid promotes the reaction [Azoxymethane results in increased expression of AGER protein]]]; Losartan inhibits the reaction [Linoleic Acid promotes the reaction [Glucose promotes the reaction [Azoxymethane results in increased expression of AGER protein]]]; Metformin inhibits the reaction [Glucose promotes the reaction [Linoleic Acid promotes the reaction [Azoxymethane results in increased expression of AGER protein]]]; Metformin inhibits the reaction [Linoleic Acid promotes the reaction [Glucose promotes the reaction [Azoxymethane results in increased expression of AGER protein]]]
Linoleic Acid inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP1A1 promoter]]; Linoleic Acid inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to PTGS2 promoter]]
Linoleic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Cholesterol]]; Linoleic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Phospholipids]]; PLD2 protein inhibits the reaction [Linoleic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased export of Cholesterol]]]
[APP protein mutant form co-treated with PSEN1 protein mutant form] results in decreased abundance of Linoleic Acid; PF-06840003 inhibits the reaction [[APP protein mutant form co-treated with PSEN1 protein mutant form] results in decreased abundance of Linoleic Acid]
[Linoleic Acid co-treated with Glucose] affects the reaction [Azoxymethane affects the expression of BCL2 protein]; Linoleic Acid affects the reaction [Azoxymethane affects the expression of BCL2 protein]
Linoleic Acid results in increased expression of CAT protein Linoleic Acid inhibits the reaction [amyloid beta-protein (1-42) results in decreased activity of CAT protein]
CNR1 protein affects the reaction [Linoleic Acid results in increased secretion of GCG protein] CNR1 protein affects the susceptibility to Linoleic Acid
[Linoleic Acid co-treated with Testosterone] results in increased expression of FADS2 mRNA FADS2 protein inhibits the reaction [Linoleic Acid results in increased activity of LOX protein] Linoleic Acid results in increased expression of FADS2 mRNA; Linoleic Acid results in increased expression of FADS2 protein
Linoleic Acid results in increased expression of GSTA1 mRNA NFE2L2 protein promotes the reaction [Linoleic Acid results in increased expression of GSTA1 mRNA]
NFE2L2 mRNA promotes the reaction [Linoleic Acid metabolite results in increased expression of HMOX1 mRNA] Linoleic Acid metabolite results in increased expression of HMOX1 mRNA; Linoleic Acid metabolite results in increased expression of HMOX1 protein
Linoleic Acid results in increased expression of IL1B protein Linoleic Acid inhibits the reaction [amyloid beta-protein (1-42) results in increased expression of IL1B mRNA]
Linoleic Acid affects the expression of IL6 protein Linoleic Acid inhibits the reaction [amyloid beta-protein (1-42) results in increased expression of IL6 mRNA] Linoleic Acid results in increased expression of IL6 mRNA Linoleic Acid results in increased secretion of IL6 protein
FADS2 protein inhibits the reaction [Linoleic Acid results in increased activity of LOX protein]; TGFB1 protein promotes the reaction [Linoleic Acid results in increased activity of LOX protein]
Linoleic Acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of MAPK3 protein]
Linoleic Acid results in decreased expression of and results in decreased activity of MMP9 protein [Linoleic Acid co-treated with Glucose] affects the reaction [Azoxymethane affects the expression of MMP9 protein]; Linoleic Acid affects the reaction [Azoxymethane affects the expression of MMP9 protein] Linoleic Acid results in decreased expression of MMP9 mRNA
Linoleic Acid metabolite results in increased expression of NFE2L2 protein; Linoleic Acid results in increased expression of NFE2L2 mRNA; Linoleic Acid results in increased expression of NFE2L2 protein NFE2L2 mRNA promotes the reaction [Linoleic Acid metabolite results in increased expression of HMOX1 mRNA]; NFE2L2 protein promotes the reaction [Linoleic Acid results in increased expression of CYP2A6 mRNA]; NFE2L2 protein promotes the reaction [Linoleic Acid results in increased expression of CYP2A6 protein]; NFE2L2 protein promotes the reaction [Linoleic Acid results in increased expression of GSTA1 mRNA]
[Linoleic Acid co-treated with Glucose] affects the reaction [Azoxymethane affects the expression of NOS2 protein]; Linoleic Acid affects the reaction [Azoxymethane affects the expression of NOS2 protein]
PLD2 protein inhibits the reaction [Linoleic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased export of Cholesterol]]]
Linoleic Acid inhibits the reaction [PON1 protein results in increased hydrolysis of Paraoxon]; Linoleic Acid inhibits the reaction [PON1 protein results in increased hydrolysis of phenylacetic acid] Linoleic Acid results in decreased activity of PON1 protein
[Bezafibrate binds to and results in increased activity of PPARA protein] which results in increased oxidation of Linoleic Acid; Linoleic Acid affects the reaction [PPARA protein binds to CREBBP protein]; Linoleic Acid binds to and results in increased activity of PPARA protein; Linoleic Acid promotes the reaction [PPARA protein binds to NCOA1 protein]; Linoleic Acid promotes the reaction [PPARA protein binds to NCOA2 protein] Linoleic Acid results in increased expression of PPARA mRNA PPARA protein affects the abundance of Linoleic Acid Diethylhexyl Phthalate inhibits the reaction [PPARA protein affects the abundance of Linoleic Acid]; Linoleic Acid binds to and results in increased activity of PPARA protein Linoleic Acid results in increased expression of PPARA mRNA; Linoleic Acid results in increased expression of PPARA protein Linoleic Acid results in increased activity of PPARA protein Linoleic Acid binds to PPARA protein
Linoleic Acid binds to and results in increased activity of PPARB protein Linoleic Acid results in decreased expression of PPARD mRNA Linoleic Acid results in increased expression of PPARD mRNA Linoleic Acid results in increased activity of PPARD protein Linoleic Acid binds to PPARB protein
Linoleic Acid binds to PPARG protein Linoleic Acid binds to and results in increased activity of PPARG protein Linoleic Acid results in increased expression of PPARG mRNA resveratrol inhibits the reaction [Linoleic Acid results in increased expression of PPARG protein] Linoleic Acid results in increased activity of PPARG protein Linoleic Acid results in decreased expression of PPARG mRNA; Linoleic Acid results in decreased expression of PPARG protein
[APP protein mutant form co-treated with PSEN1 protein mutant form] results in decreased abundance of Linoleic Acid; PF-06840003 inhibits the reaction [[APP protein mutant form co-treated with PSEN1 protein mutant form] results in decreased abundance of Linoleic Acid]
Linoleic Acid results in increased expression of PTGS2 mRNA Linoleic Acid inhibits the reaction [Benzo(a)pyrene results in increased expression of PTGS2 mRNA]; Linoleic Acid inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to PTGS2 promoter]]; Linoleic Acid inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA]
[Linoleic Acid co-treated with Testosterone] results in increased expression of SCD mRNA Linoleic Acid results in increased expression of SCD mRNA; Linoleic Acid results in increased expression of SCD protein
Linoleic Acid results in decreased susceptibility to TNF protein Linoleic Acid inhibits the reaction [amyloid beta-protein (1-42) results in increased expression of TNF mRNA]
pelargonic acid results in increased expression of IL12B mRNA; pelargonic acid results in increased expression of IL12B protein pelargonic acid affects the expression of IL12B mRNA
[GNA15 protein results in increased susceptibility to pelargonic acid] which results in increased activity of OR51A5 protein [pelargonic acid results in increased activity of OR51A5 protein] which results in increased abundance of Cyclic AMP; octanoic acid promotes the reaction [[pelargonic acid results in increased activity of OR51A5 protein] which results in increased abundance of Cyclic AMP]; octanoic acid promotes the reaction [pelargonic acid results in increased activity of OR51A5 protein]
stearic acid results in decreased expression of ADIPOQ mRNA resveratrol inhibits the reaction [stearic acid results in decreased expression of ADIPOQ mRNA]
ALB protein binds to stearic acid; stearic acid binds to ALB protein [[[stearic acid binds to ALB protein] which affects the susceptibility to Clozapine] which affects the reduction of Cysteine] which affects the activity of ALB protein; [[stearic acid binds to ALB protein] which affects the susceptibility to Clozapine] which affects the reduction of Cysteine; [ALB protein binds to stearic acid] promotes the reaction [ALB protein results in increased reduction of Dithionitrobenzoic Acid]; [ALB protein binds to stearic acid] promotes the reaction [Pyruvaldehyde results in increased oxidation of ALB protein]; [ALB protein modified form binds to stearic acid] which results in decreased reduction of Dithionitrobenzoic Acid; [stearic acid binds to ALB protein] which affects the susceptibility to Clozapine; stearic acid inhibits the reaction [Clozapine binds to ALB protein]; stearic acid inhibits the reaction [ziprasidone binds to ALB protein]
SCD1 protein inhibits the reaction [stearic acid results in increased activity of CASP3 protein]; stearic acid results in increased cleavage of and results in increased activity of CASP3 protein
stearic acid results in increased expression of CSF2 mRNA [CSF2 protein affects the susceptibility to stearic acid] which affects the abundance of Adenosine Triphosphate
INS protein inhibits the reaction [stearic acid results in decreased expression of CYP3A4 mRNA] stearic acid results in decreased expression of CYP3A4 mRNA; stearic acid results in decreased expression of CYP3A4 protein
INS protein inhibits the reaction [stearic acid results in decreased expression of CYP3A4 mRNA]; INS protein inhibits the reaction [stearic acid results in increased chemical synthesis of 6-hydroxychlorzoxazone]; INS protein inhibits the reaction [stearic acid results in increased hydroxylation of Chlorzoxazone] [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased abundance of stearic acid analog; [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased abundance of stearic acid analog
SCD1 protein inhibits the reaction [stearic acid results in increased abundance of Ceramides]; SCD1 protein inhibits the reaction [stearic acid results in increased abundance of Reactive Oxygen Species]; SCD1 protein inhibits the reaction [stearic acid results in increased activity of CASP3 protein] SCD1 protein results in decreased susceptibility to stearic acid stearic acid results in increased expression of SCD1 mRNA
[octanoic acid co-treated with Dexamethasone] results in increased expression of CAV1 protein; [SB 203580 results in decreased activity of MAPK14 protein] inhibits the reaction [[octanoic acid co-treated with Dexamethasone] results in increased expression of CAV1 protein]
GNA15 protein results in increased susceptibility to octanoic acid [GNA15 protein results in increased susceptibility to octanoic acid] which results in increased activity of OR51A5 protein; [GNA15 protein results in increased susceptibility to octanoic acid] which results in increased activity of OR55B4 protein
[SB 203580 results in decreased activity of MAPK14 protein] inhibits the reaction [[octanoic acid co-treated with Dexamethasone] results in increased expression of CAV1 protein]; [SB 203580 results in decreased activity of MAPK14 protein] inhibits the reaction [[octanoic acid co-treated with Dexamethasone] results in increased expression of PPARG protein alternative form]
octanoic acid promotes the reaction [[pelargonic acid results in increased activity of OR51A5 protein] which results in increased abundance of Cyclic AMP]; octanoic acid promotes the reaction [pelargonic acid results in increased activity of OR51A5 protein] [GNA15 protein results in increased susceptibility to octanoic acid] which results in increased activity of OR51A5 protein
[octanoic acid co-treated with Dexamethasone] results in increased expression of PPARG protein alternative form; [SB 203580 results in decreased activity of MAPK14 protein] inhibits the reaction [[octanoic acid co-treated with Dexamethasone] results in increased expression of PPARG protein alternative form] octanoic acid binds to PPARG protein
palmitoleic acid results in increased degradation of ABCA1 protein palmitoleic acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Cholesterol]]; palmitoleic acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Phospholipids]] palmitoleic acid results in increased phosphorylation of ABCA1 protein
palmitoleic acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Cholesterol]]; palmitoleic acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Phospholipids]]
[APP protein mutant form co-treated with PSEN1 protein mutant form] results in decreased abundance of palmitoleic acid; PF-06840003 inhibits the reaction [[APP protein mutant form co-treated with PSEN1 protein mutant form] results in decreased abundance of palmitoleic acid]
palmitoleic acid inhibits the reaction [[Ascorbic Acid co-treated with Copper Sulfate] results in decreased activity of PON1 protein]; palmitoleic acid inhibits the reaction [PON1 protein results in increased hydrolysis of Paraoxon] palmitoleic acid results in decreased activity of PON1 protein
[APP protein mutant form co-treated with PSEN1 protein mutant form] results in decreased abundance of palmitoleic acid; PF-06840003 inhibits the reaction [[APP protein mutant form co-treated with PSEN1 protein mutant form] results in decreased abundance of palmitoleic acid]
royal jelly inhibits the reaction [Nicotine results in decreased expression of BCL2 mRNA] royal jelly inhibits the reaction [Fluorides results in increased expression of BCL2 protein]
royal jelly inhibits the reaction [Nicotine results in increased expression of CASP3 mRNA] royal jelly inhibits the reaction [Fluorides results in decreased expression of CASP3 protein]
royal jelly inhibits the reaction [Cisplatin results in decreased activity of CAT protein]; royal jelly inhibits the reaction [Fluorides results in decreased activity of CAT protein]; royal jelly inhibits the reaction [Tartrazine results in decreased activity of CAT protein] royal jelly inhibits the reaction [Nicotine results in decreased activity of CAT protein]
Estradiol inhibits the reaction [royal jelly binds to ESR1 protein]; royal jelly binds to and results in increased activity of ESR1 protein; royal jelly inhibits the reaction [Estradiol binds to ESR1 protein] royal jelly results in increased activity of ESR1 protein
Estradiol inhibits the reaction [royal jelly binds to ESR2 protein]; royal jelly binds to and results in increased activity of ESR2 protein; royal jelly inhibits the reaction [Estradiol binds to ESR2 protein]
royal jelly inhibits the reaction [phenylhydrazine results in decreased expression of MYC mRNA] royal jelly inhibits the reaction [Paclitaxel results in decreased expression of MYC mRNA] royal jelly results in decreased expression of MYC mRNA
Soybean Oil promotes the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of GSTP1 mRNA]; Soybean Oil promotes the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of GSTP1 protein]
[APP protein mutant form co-treated with PSEN1 protein mutant form] results in decreased abundance of tetracosapentaenoic acid; PF-06840003 inhibits the reaction [[APP protein mutant form co-treated with PSEN1 protein mutant form] results in decreased abundance of tetracosapentaenoic acid]
[APP protein mutant form co-treated with PSEN1 protein mutant form] results in decreased abundance of tetracosapentaenoic acid; PF-06840003 inhibits the reaction [[APP protein mutant form co-treated with PSEN1 protein mutant form] results in decreased abundance of tetracosapentaenoic acid]
[ALB protein binds to Myristic Acid] promotes the reaction [ALB protein results in increased reduction of Dithionitrobenzoic Acid]; [ALB protein binds to Myristic Acid] promotes the reaction [Pyruvaldehyde results in increased oxidation of ALB protein]; [ALB protein modified form binds to Myristic Acid] which results in decreased reduction of Dithionitrobenzoic Acid
browse the term
